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ABSTRACT 
Phosphoinositide 3-kinase signalling pathways are critical in the regulation of 
several cellular mechanisms studied in mammalian and yeast cells. Recent studies have 
identified and characterised two putative phosphoinositide 3-kinase (PI3K) genes in 
Giardia intestinalis called GiPI3K1 and GiPI3K2, which have homology to Class I and 
Class III PI3K isoforms, respectively. G. intestinalis is a parasitic protozoan causing 
diarrhoea and malabsorption throughout the world. It has been hypothesised that Giardia 
processes such as cell growth, differentiation and vesicle trafficking, all of which are 
important for parasite proliferation and disease transmission, may be mediated by the PI3K 
signalling mechanism. This research aims to test this hypothesis using bioinformatics and a 
range of experimental approaches. 
We used BLAST and Clustal W analysis to further characterise PI3K genes and 
identify and characterise additional putative ancillary components of lipid signalling 
cascades. A limited number of such components was identified in the Giardia genome by 
homology searching, but two genes with high homology to Saccharomyces cerevisae 
glycogen synthases kinase-3 (GSK-3) were found with 40% identity to Giardia GSK 
sequence alignment. To investigate the putative functionality of these lipid signalling 
kinases in Giardia, we exposed parasite trophozoites to a range of well characterised 
specific inhibitors of GSK and PI3K and measured their effect on parasite growth. Also, we 
initiated encystation of trophozoites to cysts cells and exposed to inhibitors to observe their 
effect. As an alternative to cell counting, we developed a quantitative spectrophotometric 
method that correlates cell number to methylene blue staining. The PI3K inhibitor 
LY294002 showed the strong inhibition of trophozoite growth. However PI-103, a recently 
described specific inhibitor of PI3K, showed no evidence of reducing trophozoites’ 
proliferation. Neither did wortmanin, a potent and irreversible inhibitor of PI3K. The 
structural features of Giardia PI3K that may explain these observations will be discussed. 
Exposure to inhibitory concentrations of CT99021, a specific inhibitor of GSK-3, had no 
detectable effect on Giardia growth. This was not unexpected as, in mammalian cells and 
other eukaryotes, protein kinase B-mediated phosphorylation of GSK-3 prevents cell cycle 
arrest as a result of GSK3-mediated phosphorylation of specific cyclins. This result, 
however, rules out the possibility that the growth inhibition of Giardia trophozoites 
observed with LY294002 could be the result of non-specific GSK-3 inhibition. 
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CHAPTER 1: Introduction 
 
1.1 The biology of Giardia 
 Giardia intestinalis (also known as Giardia lamblia and Giardia duodenalis) is a 
flagellated unicellular eukaryotic microorganism that inhabits the upper small intestine of 
its vertebrate hosts and causes the most common waterborne diarrhoea in the United States 
and worldwide (Barwick et al., 2000). In developing countries, there is a very high 
prevalence and incidence of infection, with data suggesting that long-term growth 
retardation can result from chronic giardiasis (Fraser et al., 2000). Giardiasis is believed to 
have an estimated worldwide prevalence of hundreds of millions cases annually. Moreover, 
giardial infections affect the 2.5 million annual deaths that results from diarrheal disease 
(Adam, 2001). Giardia infect the host through contaminated food and water or via faecal-
oral route (Lauwaet et al., 2007). This often occur in places with inadequate sanitation such 
as in less-developed countries. The clinical manifestations of giardiasis in humans vary 
from an acute or chronic disease to asymptomatic infection with the latter being more 
common in humans (Farthing, 1994). The symptoms in humans caused by G. intestinalis 
include abdominal pain, diarrhoea, malabsorption, weight loss, nausea and vomiting. 
Parasite colonisation occurs in the small intestine, where G. intestinalis is able to cause 
illness in humans. Attempt to control intestinal protozoa such as Giardia demands further 
research into the biology of the parasite as well as effective drug treatments. Current 
available treatments for Giardia infection include the use of anti-protozoal drugs, 
particularly metronidazole and tinidazole, other susceptible drugs include albendazole, 
furazolidone, nitazoxanide and paromycin are used to lesser extent with the cure rate of 
similar to or less than metronidazole and tinidazole (Upcroft, 2001). However, reports of 
drug failures and drug resistance have been known, raising concern that the present drugs 
use for treatment will become increasingly ineffective (Upcroft, 2001). Therefore, this 
highlight the importance of developing new drug treatment to combat Giardia infection. 
When G. intestinalis multiplies, it causes damage to the intestinal mucosal wall by 
shortening of the crypts and villi (Buret, 1990). This might be one of the many ways in 
which G. intestinalis is able to cause diarrhoea, through the disruption of epithelial walls in 
the small intestine, resulting in malabsorption. The life cycle of Giardia consists of two 
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specific stages; the cyst and the trophozoite. The infection stage is initiated through 
ingestion of the cyst form, which later excysts into trophozoites in the upper small intestine 
of the host (Figure 1.1). The trophozoites divide by binary fission and increase the 
population on the intestinal surface; they move with the help of flagella and attach 
themselves to the epithelium by a unique cytoskeletal organelle called the ventral disk, thus 
causing diarrhoea and malabsorption. However, some trophozoites differentiate again, 
through the process of encystation into the cyst form that allows them to survive in an 
unfavourable environment in the jejunum. The infective cysts are then passed in the faeces, 
therefore completing the life cycle by infecting new hosts (Adam, 2001, Lujan et al., 1997).  
 
Figure 1.1: Giardia intestinalis interaction with the human intestine. 
The initiation of Giardia infection in the small intestine begins with ingestion of cysts. These cysts 
then excyst on the upper surface of the small intestine releasing excyzoites. The excyzoite 
differentiates into trophozoites and multiplies in number in a matter of days in the intestinal lumen. 
Once a certain number of trophozoites is reached, the symptoms of Giardiasis follows; this usually 
takes about six to fifteen days following the initial infection. An overview of the complex immune 
system in the intestine with natural barriers, innate and adaptive immune responses are shown here 
in the order in which they interact with Giardia during infection. Image adapted from Roxström-
Lindquist et al. (2006). 
 
1.2 Parasite encystation 
Encystation is an adaptive process of G. intestinalis that is triggered                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
when trophozoites detect a depletion of nutrients in the lower small intestine. This process 
can be explained in four basic stages: i) Detection of the stimulus for initiation of 
encystation and the regulation of encystation gene expression; ii) Formation of encystation-
specific secretory vesicles (ESVs) and the synthesis, intracellular signalling and transport of 
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the cyst wall components via ESVs; iii) Assembly of the extracellular cyst wall; and iv) 
Nuclear division and DNA replication (Adam, 2001 and Lujan et al., 1997). Once 
encystation has been initiated, the trophozoites will no longer be able to replicate and attach 
to enterocytes. At the later stage, the trophozoites are more rounded and their oxygen and 
glucose uptake decreases. Cyst wall construction takes place as encystation ESVs transport 
soluble cyst wall proteins (CWPs) and release them at the cell surface. Due to the higher 
level of calcium concentration surrounding the cell’s outer membrane, once CWPs are 
deposited, they aggregate to form the network of fibres of the protein/carbohydrate-rich 
cyst wall (Stefanic et al., 2006). The cyst wall mostly consists of a novel N-
acetylgalactosamine (GalNAc) polysaccharide. It is only synthesised during encystation 
through a five-enzyme pathway which is stimulated at the transcription level (Lopez et al., 
2003). During encystation, DNA replication occurs twice with no interference from 
cytokinesis; thus, each cyst formed is quadranucleate (Lujan et al., 1997).  
Giardia, like most eukaryotic cells, requires cholesterol for membrane biogenesis, 
but it is unable to synthesise cholesterol and phospholipids. The initial work of Gillin et al. 
(1987) demonstrated the process of Giardia encystation in vitro for the first time. The 
studies on Giardia encystation have revealed essentially how Giardia initiates the process 
of differentiating into infective cysts which is vital for the transmission of Giardia. Giardia 
encystation in the laboratory can be demonstrated through two methods: i) Cholesterol 
starvation, and ii) Uptake of bile salt. The studies on encystation by several research groups 
have made important observations that cholesterol and bile salt availability is important in 
the differentiation of this parasite (Lujan et al., 1996). Cholesterol is crucial for the parasite 
because it is utilised to make a new membrane during growth; evidence from in vitro 
studies suggests that cholesterol deprivation induces encystation (Lujan et al., 1996). 
Because cholesterol starvation triggers encystation, this suggests the involvement of lipid 
and lipid signalling in parasite differentiation. Bile salts are steroids that aid in the 
degradation, solubilisation and absorption of lipids from the intestinal lumen. These bile 
salts are synthesised by the liver from cholesterol and released into the proximal duodenum 
which is later reabsorbed by an active transport system in the distal ileum (Thomson et al., 
1993). The research of Lujan et al. (1997) on in vitro encystation reported three 
observations: i) Giardia can grow in the absence of bile salts, indicating that these 
compounds are not essential for trophozoites; ii) Small amounts of bile salts in Giardia 
increase growth because they solubilise lipids and increase their availability to the cells; 
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and iii) High concentrations of bile salts prevent the uptake of cholesterol and therefore 
favour encystation. Moreover, recent studies have suggested that components of lipid 
signalling pathways are present in the Giardia genome and may be functional (Cox et al., 
2006; Tovar et al., unpublished data). 
 
1.3 Lipids and lipid signalling 
The metabolic pathway of Giardia involves lipids and how they utilise exogenous 
lipids for metabolic purposes is important for the survival of the parasite. Giardia 
trophozoites are found in the infected host’s small intestine and are therefore continuously 
exposed to bile acids and dietary fats, therefore it was suggested that lipids and cholesterol 
may play important roles in the parasite life cycle. Giardia are able to take up the lipids and 
cholesterol that they need from lipoprotein particles present in the host intestine and tissue 
in vivo and from growth medium in vitro. It has been reported that in vitro cultured 
trophozoites are capable of internalising the surrounding lipids in the culture medium and 
transporting these lipids to different locations of the cell. The locations where these lipids 
are transported include: plasma membrane, cytoplasm, ER and nuclear membranes (Yichoy 
et al., 2011). Once acquired, these exogenous phospholipids have been shown to undergo 
fatty acid remodelling (by deacylation/reacylation reactions), which allow these protozoa to 
alter lipids, bypassing the need to synthesise entirely new phospholipid molecules (Das et 
al., 2002). 
Phosphatidylinositol belongs to a class of the phosphatidylglycerides, which contain 
a glycerol backbone, acyl chains, phosphodiester linkage and an inositol ring. 
Phosphorylated forms of phosphatidylinositol are called phosphoinositides, and play 
important roles in lipid signalling, intracellular signalling and membrane trafficking. The 
inositol ring can be phosphorylated onto phosphatidylinositol (PI) to form 
polyphosphoinositides (PPIn) (Michell et al., 2006). Both PI and PPIn can be 
phosphorylated by Phosphoinositide 3-kinase (PI3K) to form many different PPln species. 
Their structures and nomenclature are described below (Figure 1.2): 
Phosphatidylinositol monophosphates: 
 Phosphatidylinositol 3-phosphate (Ptdlns(3)P or PI(3)P) 
 Phosphatidylinositol 4-phosphate (Ptdlns(4)P or PI(4)P) 
 Phosphatidylinositol 5-phosphate (Ptdlns(5)P or PI(5)P) 
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Phosphatidylinositol bisphophosphates: 
 Phosphatidylinositol 3,4-bisphosphate (Ptdlns(3,4)P or PI(3,4)P2 
 Phosphatidylinositol 3,5-bisphosphate (Ptdlns(3,5)P or PI(3,5)P2 
 Phosphatidylinositol 4,5-bisphosphate (Ptdlns(4,5)P or PI(4,5)P2 
Phosphatidylinositol triphosphate: 
 Phosphatidylinositol 3,4,5-trisphosphate (Ptdlns(3,4,5)P or PI(3,4,5)P3 
 
  
Phosphatidylinositol (PI) 
 
 
    
Acyl chains-inserted 
into the inner leaflet 
of bilayer membrane 
 Phosphodiester link 
Inositol ring - 
cytosolic 
A B C 
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Phosphatidylinositol (3)-phosphate   Phosphatidylinositol (4,5)-bisphosphate    Phosphatidylinositol (3,4,5)-triphosphate 
Figure 1.2: Phosphatidylinositol and examples of phosphorylated phosphatidylinositol. 
The skeletal structures of phosphatidylinositol (PI) and polyphosphoinositides (PPIn). The 
structures of phosphorylated phosphatidylinositol are shown here as a result of PI3K activity: A 
phosphatidylinositol (3)-phosphate (PI(3)P), B phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) 
and C phosphatidylinositol (3,4,5)-triphosphate (PI(3,4,5)P3).  
The structures of the illustrated phosphatidylinositol and polyphosphoinositides were taken from 
Backer (2000).  
These PPIn types make up a minor fraction of the complete cellular lipids in 
eukaryotic cells. However, the cell continuously monitors its regulation because of its vital 
roles. The function of PI3Ks in a living cell is crucial in many cellular signal transduction 
pathways. When it is triggered in response to a variety of agonists, PI3K activity results in 
the 3-phosphorylated PPIn. The resulting 3-phosphorylated PPIn initiates an array of 
intracellular pathways. An example would be where the PPIn attaches itself to signalling 
molecules that may bind to the cellular membrane. This would then trigger the interaction 
between the membrane signalling components, allowing downstream signalling pathways 
to be controlled. However, PI3K signalling can be inhibited by the action of these two PPln 
phosphatases: i) myotubularin-related protein (MTMR) and PTEN (a phosphatase and 
tensin homologue deleted on chromosome 10) (Zhou et al., 2003). Thus, one can see that 
PPln phosphatases such as MTMR and PTEN act as antagonists of PI3K signalling by 
dephosphorylating PPln species. 
 
1.4 Phosphoinositide 3-kinase (PI3K) 
PI3Ks were discovered in the 1980s and are a family of related intracellular signal 
transducer enzymes. They are capable of phosphorylating the D3 position hydroxyl group 
of the inositol ring of PI, therefore generating intracellular lipid second messengers. 
Moreover, PI3Ks are also able to place the phosphate moiety on positions 4 and 5 of the 
inositol rings (Figure 1.2). 
The PI3K family is divided into three different classes. The classifications of PI3Ks are 
based on primary structure, regulation and in vitro lipid substrate specificity.  
Class I – Class I PI3Ks are responsible for the production of phosphatidylinositol 3-
phosphate. PI3Ks can be activated by different types of cell surface receptors, including G-
protein-coupled receptors and protein tyrosine kinase receptor. Class I PI3K are divided 
into class IA and IB (Fruman et al., 1998; Gharbi et al., 2007). Class IA PI3K are 
heterodimeric molecules composed of a 55-85 kilo Dalton (kDa) regulatory subunit and a 
110 kDa catalytic subunit. Class IA PI3K each contain one of five regulatory subunits: 
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p85α, p55α, p50α, p85β or p55γ. These regulatory subunits are attached to catalytic 
subunits such as p110α, p110β and p110δ, which are present in the human genome. All of 
the regulatory subunits contain two Src homology 2 domains flanking a p110-binding site. 
The Src homology 2 (SH2 domain) is a structurally conserved domain contained within the 
Src oncoprotein and is present in many other intracellular signal-transducing proteins. The 
most highly expressed regulatory subunit is p85α; p85 isoforms also possesses an N-
terminal Src homology 2 and Src homology 3 domain. The Src homology 2 and Src 
homology 3 domains, also known as SH2 and SH3 domains, are approximately 100 and 60 
amino acids in length, respectively. The SH2 domain plays a vital role in cellular 
communication, whereas the SH3 domain recognises specific cellular proteins by 
interactions with short contiguous peptide sequences that are rich in proline residues (Ren 
et al., 1993). Both of these domains mediate the recruitment and regulation of class IA 
PI3Ks by activated protein tyrosine kinases (PTKs), with PI3K typically being recruited 
directly to the receptor via binding to the auto-phosphorylation site or via substrate proteins 
such as insulin-regulator substrate 1 (IRS1) (Fry et al., 1994). Class IB PI3K is named PI3γ 
and consists of the 110 kDa catalytic subunit. PI3K in class IB only interacts with the 
regulatory subunit p101 (Vanhaesebroeck et al., 1999). The regulatory subunit p101 
contains no obvious signalling modules or motifs; class IB PI3Ks indirectly interact with 
G-protein-coupled receptors such as the formyl-methionyl-leucyl-phenylalanine (fMLP) 
receptor (Foster et al., 2003). Therefore, the class IB PI3K can be activated by the G-
protein-coupled receptor through the unique regulatory subunit p101 (Stephens et al., 
1997).  
Class II – The first isoform of class II PI3Ks was identified in Drosophila 
melanogaster (MacDougall et al., 1995). Class II PI3Ks are structurally different from class 
I PI3Ks, in that they do not have p85 or p101 regulatory subunits; however, they do have 
additional regulatory domains, including the Phox homology (PX) and C-terminal C2 
domain. PX domains function in localising the protein to PPIn-containing membranes, 
through binding with PtdIns3P (Djordjevic and Driscoll, 2002). C-terminal C2 domains 
present in other proteins are understood to act as a calcium-dependent phospholipid binding 
motif to mediate the translocation of proteins to membranes (Foster et al., 2003). The 
function of class II PI3Ks, like class I PI3Ks, is linked to diverse receptor-mediated 
signalling processes that include integrin signalling in platelets, chemokine signalling, 
insulin, and epidermal growth factor (EGF) and platelet-derived growth factor signalling 
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(Arcaro et al., 2000, MacDougall et al., 2004). There are three mammalian isoforms of 
class II PI3Ks: PI3K-C2α, PI3K-C2β and PI3K-C2γ (Foster et al., 2003). In mammalian 
studies, most PI3K-C2α and PI3K-C2β forms are ubiquitously expressed, whereas PI3K-
C2γ can be found only in hepatocytes. In vitro experiments by Foster et al. (2003) showed 
that Class II PI3Ks are able to phosphorylate PI and PI(4)P but not PI(4,5)P2. Although 
little is known about the functions of class II PI3Ks in vivo, upon lysophosphatidic acid 
(LPA) stimulation, PI(3)P formation can be inhibited at the plasma membrane in PI3K-C2β 
knockdown cells (Maffucci et al., 2005). Moreover, a study by Maffucci et al. (2005) 
highlighted that once PI3K-C2β is activated, they are recruited towards the plasma 
membrane which is similar to the behaviour of class I PI3Ks. PI3K-C2α is reported to be a 
target for a growing number of receptors in the plasma membrane and is associated with 
clathrin-coated vesicles (CCVs) (Domin et al., 2000). It is important to note that of all the 
mammalian enzymes, PI3K-C2α is the most resistant to wortmannin, a common inhibitor 
of PI3K (Arcaro et al., 2000). It is known that class II PI3Ks are the least common of all 
three classes of PI3K. 
Class III – The first class III PI3K was identified in Saccharomyces cerevisiae as a 
structure known as Vacuole protein sorting mutant 34 (Vps 34). Vps 34 is reported to be 
associated with a protein kinase, Vps 15, which is described to be the regulatory subunit of 
Vps 34. Class III PI3Ks are different from class I and II in that they are PI-specific enzymes 
producing only PI(3)P, which is an important phospholipid for the processes of membrane 
trafficking. S. cerevisiae class III PI3K, Vps 34 and Vps 15, are required for the secretion 
and sorting of proteins from the trans-Golgi to the vacuole (Stack et al., 1993). The Class 
III PI3K Vps 34 is regulated by Vps 15 regulatory subunit through phosphorylation, 
allowing Vps 34 to be targeted to the Golgi membrane in S. cerevisiae (Stack et al., 1995). 
Vps 34 enzymes are the sole PI3K that will only utilise phosphatidylinositol as a substrate; 
this is due to the make-up of the substrate recognition loop. However, class I and II PI3K 
have multiple basic residues that bind to PIP and PIP2. In comparison to class I and II 
enzymes, the substrate region of Vps 34 is relatively uncharged; therefore, only limiting it 
to phosphatidylinositol (Backer, 2008). 
Class III PI3Ks enzymes are localised at the cytoplasm of the intracellular 
membrane and are involved in the regulation of autophagy, phagosome formation and 
maturation and endosome to Golgi retrograde transport (Kihara et al., 2001, Vieira et al., 
2001, Burda et al., 2002). Schizosaccharomyces pombe and S. cerevisiae do not have class 
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I PI3Ks to generate PI(3,4,5)P3 as they only possess class III PI3K. However, research 
suggests that the synthesis of PI(3,4,5)P3 requires Vps 34 and PI(4,5)kinase (Mitra et al., 
2004). In the study of autophagy, one group found that in mammalian cells 
autophagosomes function is largely impaired in Vps 34-null cells. This statement was 
supported by the lack of electron-dense material in intracellular vacuoles identified through 
EM studies (Jaber et al., 2012). The studies of Vps 34-null cells (deletion of 755 of the 887 
amino acids of Vps 34) show that Vps 34 is important in functional autophagy and crucial 
for normal liver and heart function in mice (Jaber et al., 2012). Apart from yeast and human 
cells, the homologues of Vps 34 have been identified in Dictyostelium discoideum, 
Drosophila melanogaster and Caenorhabditis elegans (Yan and Backer, 2007). 
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Figure 1.3: Overview of intracellular signalling transduction pathways to regulate chemotaxis 
involving PI3K, Akt/PKB and other components.  
PI(3,4,5)P3 is essential to the recruitment and activation of several molecules such as PKB, PDK1 
and other kinases. Growth factor binding to the receptor tyrosine kinase (RTK) initiates PI3K 
activation. Activated PI3K produces PIP3 at the leading edge, thus initiating several molecules such 
as AKt/PKB, PDK1, and mTOR, which then continue to further activate other components within 
the signalling pathway. This Figure illustrates the importance of PI3K and the critical role it has in 
the formation of PI(3,4,5)P3, an essential component in this intracellular signalling cascade. 
Furthermore, PTEN acting as a phosphatase to dephosphorylate phosphatidylinositol can negatively 
regulate intracellular levels of PI(3,4,5)P3. Image adapted from Merck Biosciences. 
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1.5 Phosphatases 
Polyphosphoinositide phosphatase PTEN protein has been identified in the human 
body and linked to human diseases. PTEN is a phosphatase protein and its role in 
dephosphorylation leads to its involvement in regulation of the cell cycle, preventing cells 
from growing and dividing too rapidly (Chu et al., 2004). PTEN is a phosphatidylinositol 
3,4,5-triphosphate phosphatase that negatively regulates intracellular levels of PI(3,4,5)P3 
in cells and functions as a tumour suppressor by negatively regulating the PKB signalling 
pathway. It is described as a tumour suppressor because the mutated PTEN gene increases 
the risk of tumorigenesis. If PTEN is mutated, the level of PI(3,4,5)P3 in the cell will 
increase, which results in uncontrolled downstream signalling through the PKB signalling 
pathway. The consequences include increased cell cycling, cell division and the prevention 
of programmed cell death, all of which can lead to tumour formation (Pendaries et al., 
2003). 
The dual-specific lipid phosphatases, Myotubularin (MTM) and MTMR, are dual-
specific phosphatases that dephosphorylate PI(3)P and PI(3,5)P2, suggesting an 
involvement in intracellular trafficking and membrane signalling (Majerus et al., 2003). 
There are 14 members of the ubiquitously expressed MTMR phosphatases, eight of which 
are catalyst active phosphatases, while six are inactive due to their lack of catalytically 
essential residues (Bolis et al., 2006). In recent studies, a truncating mutation has been 
found in the hMTMR2 gene, which has 65% sequence homology to hMTM1. Patients with 
these mutations were found to develop an autosomal recessive form of Charcot-Marie-
Tooth disease (type 4B), which is a demyelinating motor and sensory neuropathy linked to 
chromosome 11q23 (Laporte et al., 2001, Nicot and Laporte, 2008). Mutation in the MTM1 
gene causes an X-linked myotubular myopathy, a severe congenital myopathy disorder that 
affects new-born males with an estimated 1 out of every 50,000 worldwide (McEntagart et 
al., 2002). 
 
1.6 PI3K inhibitors 
The study of PI3Ks has determined the important functional roles they play in 
various cell types with the help of PI3Ks inhibitors. Several approaches can be applied to 
measure the effects of PI3K inhibition with the treatment of wortmannin and LY294002, 
two common PI3K inhibitors. Exposure of PI3K inhibitors on mammalian cells at high 
concentrations causes the inhibition of cell growth and apoptosis (Stein and Waterfield, 
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2000). The in vivo approach aims to investigate the function of PI3K and has been carried 
out by labelling cells directly with a radioactive phosphate and the subsequent harvesting of 
lipids for analysis following inhibitor treatment. The inhibition is measured by determining 
the level of radioactive phosphate in phosphorylated products compared with untreated 
controls by separation, using either thin layer chromatography or high pressure liquid 
chromatography (Vlahos et al., 1994, Woscholski et al., 1994a, Arcaro and Wymann, 
1993). 
The PI3K inhibitor wortmannin, derived from the fungal metabolite Penicillium 
funiculosum, was originally known as a potent inhibitor of the phagocytes, neutrophils 
respiratory burst and was subsequently shown to inhibit smooth muscle myosin light chain 
kinase (smMLCK) (Baggiolini et al., 1987; Nakanishi et al., 1992). However, it later 
became apparent that wortmannin is a far more potent inhibitor of PI3Ks family in yeasts 
and mammalians. Although Wortmannin was the first inhibitor of PI3K to be described, it 
has a broad inhibitory profile across different classes of PI3Ks (Gharbi et al., 2007). It is 
important to note that when using wortmannin, its mode of action is through the irreversible 
inhibition of PI3Ks by covalent modification of a key ATP binding site (Walker et al., 
1999). Wortmannin causes a large conformational change to the ATP-binding site when it 
covalently modifies Lys 833 (Class IB PI3K), preventing the binding of substrates from 
taking place (Figure 1.4) (Walker et al., 2000). In mammalian cells, wortmannin is 
effective in nanomolar concentrations; at higher concentrations, wortmannin can inhibit 
several protein kinases such as polo-like kinase 1 (PLK1), phosphoinositide 4-kinase 
(PI4K) and the mammalian target of rapamycin (mTOR) (Bain et al., 2007). 
LY294002 is another commonly used inhibitor of PI3K. Although a less potent 
inhibitor of PI3Ks, LY294002 has been the inhibitor of choice when cells are incubated for 
prolonged periods because of its greater stability in aqueous solution (Walker et al., 2000). 
LY294002 was synthetically generated based on the chemical structure of the bioflavonoid 
quercetin, which was shown to inhibit mammalian PI3Ks (Matter et al., 1992). LY294002 
inhibits PI3Ks and other protein kinases by acting as a competitive inhibitor for the ATP 
binding site within the kinase domain (Walker et al., 2000). A study by Bains et al. (2007) 
showed that using a cell-based assay, LY294002 inhibits class I PI3Ks at a concentration of 
10-50 μM. It has also been reported to inhibit other kinases, such as Target of rapamycin 
complex 1 (TORC1), Casein kinase II (CKII) and Polo-like kinase (PLK1) at 
concentrations similar to those that inhibit PI3Ks (Bains et al., 2007). The inhibition of 
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these enzymes by LY294002 is reversible upon the removal of the inhibitor. The molecular 
structure of LY294002 is presented in Figure 1.4.  
PI-103 is a small synthetic molecule of the pyridofuropyrimidine class. In cell-based 
assays PI-103 blocks class I PI3Ks completely at a concentration of 0.5 μM (Bain et al., 
2007). Although PI-103 is more potent than inhibitors that are selective only for PI3K 
(Wortmannin, LY294002), PI-103 was shown to inhibit TORC1 with similar potency to 
Class I PI3K (Fan et al. 2006). The study of PI-103 showed high anti-tumour activity in 
glioma xenografts, where PI-103 induced G(0) – G(1) phase causing cell cycle arrest and 
apoptosis, as characterised by activation of caspase-3 and caspase-9 (Chiarini et al., 2009). 
Furthermore, PI-103 caused PKB dephosphorylation leading to the activation of a 
downstream protein kinase, glycogen synthase kinase-3β. 
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Figure 1.4: The mechanism of two common inhibitors binding into PI3K active site. 
A, illustration of the molecular structure of wortmannin, LY294002 and PI-103. Both wortmannin 
and LY294002 bind within the ATP-binding site of Sus scrofa PI3Kγ and interact with Val 882 
(circled in red). B, illustration of wortmannin and LY294002 binding to the PI3K active site. Unlike 
LY294002, wortmannin causes a large conformational change to the ATP-binding site when it 
covalently modifies Lys 833 so that the residues 832-838 and 871-876 move away from the pocket. 
This illustration was adapted from Walker et al. (2000). 
 
1.7 Specificity and targets of PI3K inhibitors 
To understand the effect of PI3K in cellular proliferation, a PI3K inhibitor was used 
to determine this through cell counts over a given time course in vitro. LY294002, inhibitor 
of PI3K, was used at different concentrations to see whether the inhibition of cell 
proliferation occurred in the trophozoite of G. intestinalis (Cox et al., 2006). One of the 
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main reasons behind the development of PI3K inhibitors is the fact that mutations in PI3K 
or PTEN can cause cancers (Bain et al., 2007).  
Giardia has 276 putative protein kinases, none of which are tyrosine-specific or 
histidine kinases. However, it is important to note that 180 of these putative protein kinases 
belong to the NIMA (Never in mitosis Gene A)-Related Kinase (NEK) family and that 137 
of them are predicted to be catalytically inactive. Most organisms on the other hand have 
fewer than 10 NEK kinases (Morrison et al., 2007). Below are some of the important 
protein kinases and their descriptions: 
Casein Kinase II (CKII) – This is a serine/threonine-selective protein kinase that 
phosphorylates acidic proteins such as Casein. It consists of a tetramer of 2α subunits and 
2β subunits. Casein kinase II plays a key role in cell cycle control, cellular differentiation 
and proliferation (Allende et al., 1995; McElhinny et al., 1996). Furthermore, it has been 
reported that CKII activity is increased in response to Wnt3a stimulation and is essential for 
the Wnt signalling pathway (Gao and Wang, 2006). The mammalian study of CKII 
suggests that inhibitors of CKII could increase the host’s innate and adaptive immunity 
against cancer by enhancing the cytotoxicity of NK cells and cytotoxic T cells (Kim et al., 
2008). The precise mechanism of CKII function is not clearly explained; however, high 
levels of CKII are associated with rapid proliferating cells even though CKII is expressed in 
all stages of the cell cycle (Bosc et al., 1999, Bain et al., 2007). Bain et al. (2007) 
illustrated that upon exposure of LY294002 at a concentration of 50 µM to CKII, the 
percentage activity of CKII was reduced by >75% relative to untreated enzyme.  
Polo-like kinase 1 (PLK1) – This enzyme is involved in cell cycle regulation. It 
mediates G2/M transition, the activation of cdc 5 and mitotic processes, including 
centrosome maturation, bipolar spindle formation, activation of the anaphase-promoting 
complex, chromosome segregation and actin ring formation (cytokinesis). They are all 
important in the regulation of key steps during cell division, like DNA damage repair 
pathways, apoptosis and progression of the cell cycle (van de Weerdt and Medema, 2006). 
Studies have shown that the loss of PLK1 expression can induce pro-apoptotic pathways 
and inhibit growth (Spankuch-schmitt et al., 2002). Polo-like kinase therefore is important 
for the study of cell cycle regulation in a variety of organisms as well as Giardia. To 
determine the roles of PLK in Giardia cell cycle regulation, exposure of trophozoites to 
LY294002 (50 µM) could lead to cell cycle arrest. Bain et al. (2007) demonstrated that 
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exposure of purified PLK1 protein to LY294002 will reduce the percentage activity of the 
purified protein by 73%.  
Homeo-domain interacting protein kinase 2 (HIPK2) – This protein kinase belongs 
to the HIPK serine-threonine kinase family, which also includes two other members, 
HIPK1 and HIPK3. HIPK2 is a polypeptide composed of 1189 amino acids and was 
reported to act as a co-repressor for homeodomain transcription factors and is highly 
conserved in various organisms (Pierantoni et al., 2002; Giraud et al., 2004). HIPK2 
localises to nuclear speckles, since it contains multiple nuclear localisation signals and a 
speckle retention signal (SRS) (Kim et al., 1999). Nuclear speckles are also known as 
splicing speckles. Speckles are subnuclear structures that are enriched in pre-mRNA 
splicing factors that are located in the interchromatin regions of the nucleoplasm of 
mammalian cells. The proteins encoded by HIPK family genes all have functional domains, 
such as a kinase domain, a homeodomain-interacting domain, a PEST sequence and a 
tyrosine and histidine residue-rich domain (Kim et al., 1999). Recent studies have shown 
that HIPK2 interacts with p53, a tumour suppressor protein, and carboxyl-terminal-binding 
protein, a co-repressor protein for various transcription factors. These interactions were 
reported to induce apoptosis, involving the kinase activity of HIPK2 (D’Orazi et al., 2002). 
The tumour suppressor p53 is believed to play a central role in detecting DNA damage and 
directs the nature of the subsequent cell responses. These reports suggest that HIPK2 
interacts with some proteins that regulate cell growth and cell differentiation. Therefore, 
studying the inhibition of HIPK2 in Giardia may influence the cell growth and 
differentiation of trophozoites. Bain et al. (2007) showed that HIPK2 can be inhibited when 
exposed to LY294002 at 10 µM with 38% of activity remaining. 
Glycogen synthase kinase-3 (GSK-3) is another essential putative protein kinase in 
Giardia that is involved in signal transduction, cell survival and protein synthesis. GSK-3 is 
a ubiquitously expressed, highly conserved serine/threonine protein kinase found in all 
eukaryotes. Originally, it was identified as a regulator of glycogen metabolism, GSK-3 acts 
as a downstream regulatory switch for many signalling pathways, for example, cellular 
responses to Growth factors (Figure 1.5), Insulin, WNT, RTKs (receptor tyrosine kinases) 
and GPCR (Sayas et al., 2006; Ciaraldi et al., 2010; Wu and Pan, 2010). The activity of 
GSK-3 is inhibited by PKB phosphorylation in response to growth factor stimulation 
(Cantley, 2002). In addition to glycogen synthase, GSK-3 phosphorylates a broad range of 
substrates including several transcription factors and translation initiation factor (eIF2B) 
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(Welsh et al., 1996). GSK-3 has been implicated in the signalling pathways in 
Dictyostelium (Harwood et al., 1995), Drosophila (Siegfried et al., 1992) and Xenopus 
(Dominguez et al., 1995).  
 
 
 
Figure 1.5: Signalling pathways illustrating GSK3 putative protein kinase regulation in 
mammalian cells. 
This is a complex signalling pathway involving many types of proteins which affect cell growth, 
cell survival and cell movement. Activation of the growth factor receptor protein stimulates PI3K 
phosphorylation, thus in turn activating signalling molecules such as PKB/Akt. PKB/Akt then 
triggers many different pathways blocked by GSK3, because GSK3 can be inhibited by PKB/Akt 
phosphorylation (which is part of the insulin signal transduction). This diagram is an overview of 
the complex pathway that is regulated throughout the mammalian cells. This image was adapted 
from Cantley (2002). 
 
 
In mammalian cells, there are two isoforms of GSK3 encoded by distinct genes: GSK-3α 
and GSK-3β (Woodgett, 1990). GSK-3α has a mass of 51 kDa, whereas GSK-3β has a mass of 47 
kDa. The main reason for the size difference is due to a glycine-rich extension at the N-terminus of 
GSK-3α (Figure 1.6). 
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Figure 1.6: The mammalian schematic of GSK-3α and GSK-3β. 
The site of serine (S21 and S9) and tyrosine (Y279 and Y216) phosphorylation indicated through 
the blue arrowheads. The N-terminal domain on GSK-3α and GSK-3β are unique glycine enriched 
conserved kinase domains. Adapted from Doble and Woodgett (2003). 
 
GSK-3 is a key regulator in several physiological processes; many pathways that 
use GSK-3 as a regulator have links to human diseases. In mammalian cells, GSK-3 has 
been implicated in non-insulin-dependent Diabetes Mellitus and the generation of 
neurofibrillary tangles (NFTs) that are associated with Alzheimer’s disease (Doble et al., 
2003). GSK-3 inhibitors can play an important role in treating disease affected by aberrant 
GSK-3 activity. Inhibitors of GSK-3 are being developed as potential drugs to treat 
diabetes, stroke, Alzheimer’s and other diseases (Cohen and Goedert, 2004). A study found 
that CT99021 is the most potent and specific inhibitor in vitro (Bain et al., 2007). CT99021 
inhibits GSK-3 at nanoMolar concentrations and it inhibits CDK2-cyclin A about 50-fold 
less potency and did not significantly affect other protein kinases tested in the same panel at 
1 μM (Bain et al., 2007). Another inhibitor of GSK-3 is lithium ions; LiCl inhibit GSK-3 at 
the millimolar level and it has been found to stabilise the mood in patients suffering from 
bipolar disorder (Geddes et al., 2010). The biochemical actions of lithium have been 
identified but the mechanisms for its therapeutic action are unknown (Jope, 1999, Phiel and 
Klein, 2001). Lithium has been shown to be a direct, reversible inhibitor of GSK-3 with an 
IC50 value of approximately 2 mM, acting as a competitive inhibitor of Mg
2+ (Ryves and 
Harwood, 2001). The half maximal inhibitory concentration (IC50) represents the 
concentration of a drug that is required for 50% inhibition in vitro. A more recent study 
found that LiCl inhibited GSK-3β activity in vitro more strongly than any of the other 
protein kinases tested (Bain et al., 2007). On the other hand, LiCl also inhibits other protein 
kinases with slightly lower potency, such as MAPK-integrating protein kinase 1 and 2 
(MNK1, MNK2), smooth muscle myosin light chain kinase (SmMLCK), phosphate kinase 
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(PHK), checkpoint kinase 2 (CHK2), NIMA (never in mitosis in Aspergillus nidulans)-
related kinase 6 (NEK6), elongation-factor-2 kinase (EF2K), homeodomain-interacting 
protein kinase 3 (HIPK3), inhibitory kB kinase (IKK) and TANK-binding kinase 1 (TBK1) 
(Bain et al., 2007). 
 
1.8 Putative PI3Ks in Giardia 
In a report by Cox et al. (2006), it was shown that the G. intestinalis genome encodes two 
PI3Ks which share homology with the Class I and Class III PI3Ks. The evidence obtained 
from bioinformatics showed alignment of Giardia PI3Ks and Class I PI3K-kinase domain 
from Sus scofa, Ss PI3Kγ (GenePept: NP_999104), a structurally and functionally 
characterised PI3K sequence (Figure 1.7).  
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Figure 1.7: Detailed sequence analysis of the kinase domains of GiPI3K1 and GiPI3K2. 
This figure illustrates the multiple sequence alignment of the kinase domain of giardial PI3Ks with 
a structurally characterised Class I PI3K-kinase domain from Sus scofa, Ss PI3Kγ (GenePept: 
NP_999104) highlighting the conserved region of functional residues. Sequences were aligned 
using Clustal W. Arrows indicate the boundary between the N- and C-terminal lobes of the kinase 
domain for the S. scofa sequence. Insertions in the kinase domain of GiPI3K1 and GiPI3K2 are 
shown in boxes. Solid underlined residues indicate activation loop residues in the S. scrofa 
sequence essential for substrate specificity. Dashed underlined residues indicate catalytic loop 
residues in the S. scrofa sequence. Key:   , ATP binding residues; ▲, PI-binding residues; ❍, metal 
binding residues; �, possible substrate-activating base/nucleophile to that attack γ-phosphate of 
ATP. Figure was taken directly from Cox et al. (2006).  
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This detailed multiple alignment analysis of GiPI3K1 and GiPI3K2 kinase domains 
against PI3Ky (class IB PI3K) shows that all of the residues required for ATP binding and 
kinase activity in the S. scrofa PI3Kγ are conserved in both GiPI3K1 and GiPI3K2 (Cox et 
al., 2006). GiPI3K2 is reported to lack one of the lysine residues that is thought to interact 
with the I-phosphate of PI substrate (Lys-807 in the S. scrofa sequence) and a second lysine 
thought to act as a ligand for the 5-phosphate of PI(4,5)P2 (Walker et al., 1999). These 
features are common to other functional class III PI3K isoforms such as D. discoideum 
DdPIK5, which are also thought to be specific to PI only, since their short activation loops 
cannot accommodate the 4-phosphate of PI(4)P substrate. Therefore, this analysis 
highlighted that GiPI3K1 and GiPI3K2 could be functional PI3Ks belonging to the Class I 
and Class III isoforms, respectively (Table 1.1). 
Table 1.1: Analysis of the giardial PI3K domains.  
Percentage identity values for the full-length and domain-only sequences of GiPI3K1 and GiPI3K2 
with other PI3K isoforms following their sequence alignment. This table was taken directly from 
Cox et al. (2006). 
 GiPI3K1 GiPI3K2 
 
Full- length 
39% to Dictyostelium discoideum 
PIK1, a Class I PI3K 
34% to Glycine max Vps34-like 
(Class III) PI3K 
Ras Binding 
Domain (RBD) 
41% to Homo sapiens Class IB 
p110γ PI3K 
Absent 
PIK 
28% to H. sapiens Class IA 
p110α PI3K 
27% to Caenorhabditis elegans 
Vps34-like (Class III) PI3K 
Kinase 39% to D. discoideum PIK1 
33% to Glycine max Vps34-like 
(Class III) PI3K 
 
 
The catalytic domain sequences of Class I, II and III PI3Ks were used to search for 
sequence similarity to identify giardial genes encoding putative PI3Ks. Table 1-1 shows the 
open reading frames of sequences that are similar to PI3K genes and are therefore called 
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GiPI3K1 and GiPI3K2. The predicted open reading frames are 6,468 bp and 4,917 bp in 
length, respectively. GiPI3K1 is predicted to encode a 2,155 amino acid protein (GenPept: 
EAA41385) with a molecular mass of 242 kDa and GiPI3K2 is predicted to encode a 1,638 
amino acid protein (GenPept: EAA40923) with a molecular mass of 183 kDa.  
The characteristic domains of PI3K are present in the typical conformation for both 
GiPI3K1 and GiPI3K2, with the former consisting of Ubiquitin/RBD-like, C2, PIK and 
kinase domains and the latter consisting of C2, PIK and kinase domains. Interestingly, it 
was found that both putative kinase domains appeared to be interrupted by long insertions 
compared to other well-studied PI3Ks. This is shown in Figure 1.8. 
 
 
Figure 1.8: Domain structure of GiPI3K1 and GiPI3K2 compared to other PI3Ks. 
Here, GiPI3KI is compared to Dd PIK I, D. discoideum class PI3K (GenPept: AAA85721) and to 
Hs p110γ, H. sapiens class I PI3K (GenPept: NP_002640). The GiPI3KI sequence is interrupted for 
the sake of clarity. The second half shows GiPI3K2 compared to G. max class III PI3K (GenPept: 
AAA64468) and to Sp Vps 34, Schizosaccharomyces pombe Class III PI3K (GenPept: AAC49133). 
The number indicates the count of amino acid residues. Different shading illustrates various 
domains: checked, Ras binding; dotted, C2; striped, PIK; gradient, kinase. Figure taken from Cox et 
al. (2006). 
Characterisation of GiPI3K1 and GiPI3K2 gene products through RT-PCR analysis 
provides evidence that both GiPI3K genes are expressed in trophozoites and encysting cells 
(Figure 1.9). This suggests that GiPI3K plays an important role during growth and 
encystation. Long insertions of giardial PI3Ks were highlighted, and appear to separate the 
two lobes of their putative kinase domains. They are unique to the giardial sequences and it 
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is possible that they may form part of the protein sequence as they are not intron-derived. 
These insertions in giardial sequences have been suggested to serve as useful drug targets 
(He et al., 2005). This would allow the drugs to specifically and effectively select and 
target giardial PI3Ks on the basis of their insertion sequences because PI3K activity in G. 
intestinalis is important for parasite proliferation. 
 
 
Figure 1.9: The analysis of GiPI3K1 and GiPI3K2 using RT-PCR. 
(T) Extracted and purified RNA from trophozoites and (En) 36-hour encysting cells converted to 
cDNA via a reverse transcriptase (RT) reaction and subjected to PCR to amplify regions encoding 
the apparent insertions in GiPI3K1 and GiPI3K2. The resulting PCR products were separated on an 
agarose gel. Negative controls were included to ensure that the products originated from RNA only. 
Molecular size markers are in kilobases. This figure was taken from Cox et al. (2006). 
 
The work of Cox et al. (2006) also illustrated the inhibitory effect of LY294002 on 
exponentially growing trophozoites. The results showed that cells remain approximately 
constant with no significant growth observed at the concentration of 50 μM LY294002. 
This suggests that LY294002 may affect cell proliferation by inducing cell cycle arrest. 
LY294002 has been the inhibitor of choice when cells are incubated for prolonged periods 
because wortmannin is unstable in aqueous solutions. When trophozoites were exposed to 
wortmannin in a range of concentrations (50 – 500 nM) there was no effect observed on 
cell number relative to the control (Cox and Tovar unpublished work). Moreover, 
observation in the work of Cox et al. (2006) showed that trophozoites treated with 
LY294002 did not undergo any dramatic changes in their morphology or motility, thus 
demonstrating the selective effect of LY294002 on the cell cycle of Giardia. 
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When the PI3K inhibitor LY294002 was added to cultured trophozoites, it 
specifically and significantly inhibited the proliferation of trophozoites at a concentration of 
50 µM. However, the effect of the LY294002 inhibitor is reversible; once the inhibitor is 
removed, the trophozoites grow exponentially up to equivalent numbers in the untreated 
control sample. These data (Cox and Tovar, unpublished work) suggest that cell cycling in 
G. intestinalis is controlled by PI3K activity. PI3K-inhibited trophozoites remain stationary 
through the addition of LY294002. Further observations show increased levels of cyst wall 
protein 2 (CWP2) mRNA, CWP2 protein and abundance of CWP2 localised to encystation 
specific vesicles (Cox and Tovar, unpublished data) which suggests that encystation may be 
regulated by PI3K activity. Conversely, in the control sample, PI3K activity may normally 
be required to prevent Giardia initiating the process of encystation. However, even though 
exposure to LY294002 may initiate the encystation of trophozoites, cyst maturation failed 
to complete (Cox and Tovar, unpublished work). Therefore, encystation could not be 
completed, possibly due to the PI3K activity required for CWP2 processing and/or 
dispersal to form the cyst wall.  
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1.9 Aims and objectives 
Accumulating evidence suggests that PI3K signalling pathways may operate in 
Giardia and that lipid signalling may be important in the regulation of parasite 
differentiation. LY294002 has been shown to inhibit PI3K and different kinases, more 
specifically when Giardia trophozoites are exposed to LY294002, where positive inhibition 
in the cell growth of trophozoites was observed. The study of PI3Ks is important for many 
types of cells; this knowledge together with work on PI3Ks in Giardia may hold the key for 
future discovery in drug targeting approaches.  
This project aims to investigate the range and nature of molecular components 
involved in G. intestinalis intracellular signalling cascade and drug susceptibility. The 
project has the following specific objectives: 
 To identify genes encoding additional proteins that may be involved in lipid 
signalling cascades through Giardia genomic database mining. 
 To determine the effect of specific inhibitors of central signalling proteins (such as 
PI3K and GSK-3β). 
 To develop a reproducible method of quantifying Giardia trophozoites using 
spectrometry. 
 To detect and quantify PI(3,4,5)P3 using a PIP3 Mass ELISA assay for evidence of 
PI3K activity in Giardia. 
 To investigate the effect of PI3K inhibitor LY294002 on G. intestinalis cells by 
using an immunofluorescence labelling technique. 
 To quantify and investigate the morphological differences of PI3K-inhibited G. 
intestinalis cells using scanning and transmission electron microscopy. 
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CHAPTER 2: Materials and Methods 
 
2.1 Bioinformatics 
2.1.1 Giardia intestinalis genome database search with translation BLAST and 
pairwise alignment 
The Giardia intestinalis genome database is available online 
(http://giardiadb.org/giardiadb/) and the National Centre for Biotechnology Information 
(NCBI) website (http://www.ncbi.nlm.nih.gov/). The search for polyphosphoinositide 
kinases and other proteins was performed using the NCBI “BLAST” (Basic Local 
Alignment Search Tool) with G. intestinalis PI3Ks (GiPI3K1 and GiPI3K2). GiPI3K1 and 
GiPI3K2 (GenPept: EAA41385 and EAA40923) were the PI3K proteins encoded by the G. 
intestinalis genome (Cox et al., 2006). To confirm these findings, the protein query 
sequences used were representatives of three classes of polyphosphoinositide kinases: Class 
I Homo sapiens p110α (GenPept: NP_006209), Class II H. sapiens PI3K-C2α (GenPept: 
NP_002636) and Class III Saccharomyces cerevisiae Vps34 (GenPept: NP_013341). Using 
the kinase domains of PI3K for the search translation, BLAST (tBLASTn) was adopted to 
search for common sequences in the G. intestinalis genome. The setting on the tBLASTn 
search was the default setting, showing an expectation value of 10. This means that 10 
sequence matches are expected to be found only by chance and if the statistical significance 
in a match is greater than the expectant threshold, the match will not be reported. Five 
matched sequences of G. intestinalis open reading frames (ORFs) were predicted using 
tBLASTn and these sequences contain detailed information related to translated GenPept 
entries. The Giardia database three best match ORFs were GenPept: GL50803_14855, 
GL50803_17406 and GL50803_16558; these were submitted to tBLASTn and nucleotide-
BLAST searches of non-redundant databases at NCBI to verify the similarity of Giardia 
PI3Ks sequences to the matched PI3K isoforms. The result of the matched PI3K sequences 
were pairwise aligned with default settings on BioEdit (Hall, 1999) against Giardia PI3K 
sequences for percentage identity and similarity values. 
Using the above methods, the identification of other lipid component glycogen synthase 
kinase-3 (GSK-3) in G. intestinalis was achieved with giardial homologue searching and 
sequence alignments were completed.  However, the initial protein query sequences used 
42 
 
were: H. sapiens GSK-3α (GenPept: NP_063937.2) and H. sapiens GSK-3β (GenPept: 
NP_002084.2). Matching sequence results from GSK-3 protein query search were two 
giardial homologs: GSKa (GenPept: GL50803_9116) and GSKb (GenPept: 
GL50803_17625). These two giardial homologs of GSK-3 were pairwise aligned using 
BioEdit (Hall, 1999) with default settings to access the percentage identity and similarity 
values to the similar sequences in non-redundant databases at the NCBI. Alignment was 
visualised using the BioEdit graphic view, which allows the comparison of each sequence 
with one another, therefore showing the similarities and certain identical residues following 
alignment. The pairwise alignments were then exported as rich text file formats and 
annotated manually using Microsoft Word 2010.  
 
2.1.2 Protein analysis and identification of domains 
The domain-prediction program SMART (Simple Modular Architecture Research Tool) 
website (http://smart.embl-heidelberg.de/) (Schultz et al., 1998) was used to predict protein 
domains in giardial PI3K and GSK isoforms. To confirm the identity of the predicted 
domains, the investigated predicted domains of Giardia PI3Ks and GSKs were analysed 
using sequence-similarity searched against a non-redundant database. Using BioEdit (Hall, 
1999), the predicted domains were pairwise aligned in the same way as described in 2.1.1 
and was visualised through Graphic view, where identical and similar residues were 
highlighted after the completion of sequence alignment. The results from Graphic view 
were then exported as rich text file formats and annotated manually using Microsoft Word 
2010. 
 
2.1.3 Protein structure analysis 
The protein prediction program PSIPRED version 3.3 (http://bioinf.cs.ucl.ac.uk/psipred/) 
was used to predict the secondary structure protein with the default settings (McGuffin et 
al., 2000). Constructions of three-dimensional protein structures were carried out using 
Cn3D version 4.3 downloaded from the NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml). Cn3D was opened and run on 
a Microsoft Windows 7 PC. The program initially was used to open the three-dimensional 
structure of H. sapiens GSK-3β (Protein Data Bank identification: 3SAY opened using 
Cn3D through the linked from NCBI). The sequence opened was aligned in the Cn3D 
viewer with the imported Serine/Threonine kinase catalytic domain sequences of either G. 
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intestinalis GSK isoforms GSKa or GSKb. The two H. sapiens sequences and giardial GSK 
sequences were aligned using the BLAST single option in the sequence/alignment viewer. 
The overlay option was chosen and the alignments were carried out on the three-
dimensional visualisation of H. sapiens GSK-3β. The Serine/Threonine kinase catalytic 
domains in Giardia GSKa and GSKb were aligned to H. sapiens GSK-3β; the colour red 
represented identity, while blue corresponded to similarity and grey areas denoted non-
aligned residues. The images obtained were exported as PNG files, arranged using 
Microsoft PowerPoint 2010 and presented in Microsoft Word 2010. 
 
2.1.4 Multiple alignments 
Sequence alignment using the BioEdit program was previously completed using protein 
query sequences obtained from the Giardia DB and NCBI. In order to investigate these 
protein sequences, they were multiple-aligned using the CLUSTALW program with default 
settings. The complete multiple alignment using CLUSTALW was viewed using Graphic 
View, exported as a rich text format and opened in Microsoft Word 2010.   
 
2.1.5 Protein subcellular localisation sites 
Protein sequences were inputted into PSORTII and iPSORT to predict the subcellular 
localisation sites of the giardial GSKs. The PSORTII prediction program 
(http://psort.hgc.jp/) (Nakai and Horton, 1999) is a computer-based program which 
analyses the input sequence and predicts the protein localisation sites in the cells. The 
iPSORT prediction program (http://ipsort.hgc.jp/) (Bannai et al., 2002) is also a computer-
based program that predicts the subcellular localisation site for N-terminal sorting signals. 
Both programs were used with standard settings.   
 
 
2.2 Cell culture 
2.2.1 Trophozoite culture 
G. intestinalis WB trophozoites were subcultured every 3 to 4 days and allowed to 
proliferate at 37°C in axenic filter-sterilised modified YI-S medium as follows: 800 ml YI 
broth (1.24 g K2HPO4, 0.6 g KH2PO4, 1.0 g NaCl, 30.0 g yeast extract (Sigma-Aldrich), 0.5 
g dehydrated bovine bile (Sigma-Aldrich), 10.0 g glucose, 2.0 g L-cysteine HCL (Sigma-
Aldrich), 0.2 g ascorbic acid, 22.8 mg ferric ammonium citrate (Sigma-Aldrich), distilled 
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H2O, to 880 ml, pH 7.0-7.1), 20 ml vitamin mixture 18 (Biofluids Inc.) and 100 ml of (10 
v/v) bovine serum (Sigma-Aldrich) heat inactivated at 56°C for 30 minutes to inactivate 
proteins of the complement pathway (Clark and Diamond, 2002). After 3 to 4 days, fully 
grown trophozoites (estimated population of 1 x 106 cells/ml) were placed in screw-capped 
borosilicate glass culture tubes containing 13 ml of medium, and 50 or 100 µl was 
inoculated. 
 
2.2.2 Induction of Giardia encystation 
After Giardia trophozoites were grown, with populations reaching approximately 1 x 106 
cells/ml, the culture medium was poured away and replaced with encystations medium, as 
described in Kane et al. (1991); this contained the same components as the modified YI-S 
medium but with 10 g/L bile and an increased pH of 7.8. Encystation experiments were 
carried out over 14-168 hours at 37°C; cysts were harvested and counted to determine the 
time course of the appearance of cysts from 24 to 168 hours. 
 
2.2.3 Cell counts 
Cell counts were demonstrated by using a haemocytometer, where the averages were 
calculated, multiplied by dilution factors and multiplied by 104 to account for the volume 
counted; this was to determine the cells/ml and total cells present. Prior to cell counting, 13 
ml tubes containing trophozoites were chilled on ice for 10 minutes and inverted a few 
times to allow trophozoites to detach from the glass surface. Then, 50 µl aliquots of 
trophozoite cultures were taken and mixed with the same volume of 4 w/v 
paraformaldehyde (PFA) for the immobilisation of trophozoites. Once immobilised, 
trophozoites were then pipetted onto a haemocytometer slide and counted using a light 
microscope set to 10 x magnification. 
 
2.2.4 Purification and counting of cysts 
To purify the cyst from trophozoites and encysting cells and to separate each individual 
cyst from cyst “islands”, the culture tubes were allowed to recover for 30 minutes at 37°C. 
The culture tubes were then centrifuged at 500 x g for 5 minutes and the supernatant was 
removed. The pellet was resuspended in 13 ml chilled double-distilled water and stored at 
4°C overnight to lyse encysting cells and trophozoites. The tissue culture tube was then 
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vortexed for 2 minutes to break up the individual cysts. Following the vortex, a 
haemocytometer was use to count cysts, as described in 2.2.3. 
 
2.2.5 Colorimetric quantitation of cell growth 
2.2.5.1 Standard curve for colorimetric assay 
A standardisation experiment was carried out using a known number of trophozoites to 
determine the linear responsive range of the spectrophotometer. Trophozoites that were 
grown for 72 hours were counted to reach a population range 2 x 106 cells/ml. Using table-
top centrifugation, the cultures were centrifuged at 800 x g for 10 minutes at 4°C. The 
pellets were concentrated with trophozoites and the supernatant was discarded. The pellets 
were resuspended with 1.3 ml of Phosphate-Buffered Saline (PBS) to allow cells to be 
concentrated by 10-fold.  The final volume in aach of the 96-well cell flat bottom tissue 
culture plates (Costar 3599) was 300 µl.  The different concentration of cells was calculated 
and pipetted into each well to reach a final volume of 300 µl (Figure 2.1). The blank wells 
contained PBS only. The cells were then fixed (see 2.2.5.3) and the different concentration 
of cells in the 96-well tissue culture plate was measured by using a spectrophotometer with 
an absorbance reading at 655 nm.   
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Figure 2.1: Standard curve for colorimetric assay 
The standard curve of trophozoite number per well was measured by using the average optical 
density at 655 nm. Following 72 hours of incubation of trophozoite culture, cells were counted and 
different concentrations of cells were inoculated into each well, ranging from 4 x 104 cells to 6 x 106 
cells in order to generate a standard curve plotted over a logarithmic scale. 
 
 
2.2.5.2 Standard growth curve 
Fully grown trophozoite cultures were place on ice and counted to reach the population 
range of 1 x 106 cells/ml (2.2.1). Giardia trophozoites were inoculated into 18 borosilicate 
glass tubes with an individual tube containing 13 ml of fresh culture medium. The 
borosilicate glass tube was labelled 0, 24, 48, 72, 96, and 120 hours, and treated with 
inoculums of 0.1 x 106 cells/ml (Figure 2.2). Calculations to inoculate 0.1 x 106 cells/ml 
were completed using the following equation: 
 
Inoculate trophozoites require/Number of fully grown trophozoites = Amount of inocula 
needed. 
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Every 24 hours, the preparation for transferring trophozoite populations into 96 well tissue 
culture plate was as follow. Culture tubes were place on ice for 10 minutes following the 
incubation time. Trophozoites were centrifuged to collect the pellet at 800 x g, 4°C for 10 
minutes. Then, 10 ml of the supernatant was removed without disturbing the pellet and the 
rest was gently mixed and pipetted into 15 ml sterile disposable tubes (Sarstedt). 
Trophozoites were again centrifuged at 800 x g, 4°C for 10 minutes, to collect the pellet 
using a table-top centrifuge. The supernatant was completely removed without disturbing 
the pellet. Trophozoites were fixed by adding 100 µl of PBS and 100 µl of 4 w/v PFA and 
transferring into a 1.5 ml sterile centrifuge tube (Greiner bio-one). The sterile centrifuge 
tube containing trophozoites was centrifuged with the supernatant removed and then 300 µl 
of 1 x PBS was pipetted into each sterile centrifuge tube and vortexed. Cells were then 
fixed and the standard growth curve was determined using absorbance readings at 655 nm 
on the microplate reader (see 2.2.5.3).  
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Figure 2.2: Standard growth curve 
The numbers of trophozoites were measured using average optical density at 655 nm over a period 
of 120 hours. Each data point represents 3 readings from a single culture tube of trophozoites. The 
initial numbers of cells inoculated were 0.1 x 106 cells/ml. The error bars represent standard 
deviation from the average absorbance reading taken in triplicate.  
 
2.2.5.3 Fixation of trophozoites to tissue culture plate 
The tissue culture plate was filled with two-fold dilutions of trophozoites that range from 6 
x 106 to 4 x 104 cells/ml in triplicate. The trophozoites in the tissue culture plate were 
incubated for 2 hours at 37°C. After incubation, the plate was allow to air-dry overnight. 
The plate was first dehydrated by adding 300 µl of 70 v/v ethanol before fixing 
trophozoites with 300 µl of 100 v/v methanol; at each step, the tissue culture plate was 
allowed to dry. The plate was then stained with 0.1 w/v methylene blue for 10 minutes and 
washed twice with distilled H2O. A 300 µl portion of 0.1M hydrochloric acid solution was 
added to each well to release the dye. The dye extracted was determined with optical 
density at 655 nm using a microplate reader (E-max plate reader spectrophotometer, 
Molecular devices, California, USA). The experiments were repeated several times to 
minimise cell loss.  
 
2.2.6 Statistic representation 
The construction of data and graphs through cell counting was first calculated for standard 
deviation and standard errors. The data were then tested for statistical significance using 
normal distribution and a paired Student’s t-test for a confidence level of p < 0.05 (using 
Microsoft Excel 2010). 
 
 
2.3 Chemical inhibition studies 
2.3.1 Inhibitor preparation 
LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one), CT99021 (6-[2-[[4-(2,4-
dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]-
pyridine-3-carbonitrile), LiCl (Lithium chloride), PI-103 (3-[4-(4-morpholinyl)pyrido[3’,
2’:4,5]furo[3,2-d]pyrimidin-2-yl]-phenol), Wortmannin (Sigma-Aldrich) and DRB (5,6-
Dichloro-1-β-D-ribofuranosylbenzimidazole, Calbiochem) were dissolved in different 
volumes of sterile dimethyl sulphoxide (DMSO, Sigma-Aldrich) at room temperature to 
achieve 100 x stock solutions. Inhibitors were prepared for 1/100th of the 13 ml culture 
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volume of 100 x stock solutions of LY294002, CT99021, LiCl, PI-103, Wortmannin and 
DRB. Each inhibitor was diluted as appropriate and added to 13 ml of exponentially 
growing trophozoites to achieve the final concentrations of 25 and 50 µM for LY294002; 
0.5, 1 and 2 µM for CT99021; 5, 10 and 20 mM for LiCl; 0.5, 1 and 2 µM for PI-103; 0.1, 
0.5, 1, 5, 10 and 15 µM for Wortmannin and 100 µM for DRB. Control cultures were 
treated with 130 µl of DMSO (1 v/v). 
 
2.3.2 Inhibitor treatment on trophozoites 
Freshly subcultured trophozoites in 13 ml screw-capped borosilicate glass culture tubes 
were incubated at 37°C and grown for 48-72 hours. Once in the exponential phase of 
growth, the trophozoite culture are ready for the start of treatment. Cultures were chilled on 
ice for 10 minutes and counted as described in 2.2.3. Trophozoites at 0.1 x 106 cells/ml 
were subcultured into 13 ml of fresh medium and cultures were treated with inhibitors 
LY294002, PI-103 and DRB for 48 hours at 37°C. Control cells were treated with equal 
volumes of concentrated DMSO (final concentration of 1 v/v). All experiments were 
carried out in triplicate and 50 µl aliquots of each culture were counted every 8 hours, as 
described in 2.2.3.  
For reversible effects, trophozoites treated with LY294002, DMSO and LiCl for 48 hours 
were prepared in two different ways:  
1. Cells were counted after 48 hours, as described in 2.2.3, and equal numbers of cells 
(0.1 x 106 cells/ml) were inoculated using a pipette to seed treated trophozoites into 
fresh medium borosilicate glass tube; cells were counted over a 72-96 hour period. 
2. Cells were centrifuged at 800 x g for 5 minutes and the supernatant was removed. 
The treated trophozoites were washed in 13 ml of 1 x PBS and centrifugation was 
repeated as before. This was followed by another washing step in 5 ml of 1 x PBS 
and subsequent centrifugation to remove the supernatant. The treated trophozoites 
are then resuspended in fresh culture medium and counted over a 72 hour period.  
 
2.3.3 Inhibitor treatment of encysting cultures 
Giardia intestinalis encysting cultures were prepared, as described in section 2.2.2. The 
inhibitors LY294002 and DRB were prepared as described in section 2.3 and added to 
achieve final concentration of 50 µM and 100 µM, respectively. The treatment of 
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LY294002 and DRB to trophozoites was performed either immediately or 12 hours after 
the addition of encysting culture medium. The control cultures were treated with equal 
volumes of concentrated DMSO. All of the experiments were carried out in triplicate with 
encysting cultures treated with inhibitors for up to 168 hours at 37°C. Once the treatment of 
inhibitors was completed, encysting cells and trophozoites were collected, fixed and 
counted as described in section 2.2.3; cysts were purified, harvested fixed and counted as 
described in section 2.2.4.    
 
2.3.4 Inhibitor treatment of trophozoites 
The colorimetric method in this report was improved from the technique described by 
Hounkong et al. (2011). An aliquot of 1 x 104 trophozoites cells/ml taken from a fully 
grown culture tube, as described in section 2.2, was subcultured into fresh medium. 
Inhibitors (as described in section 2.2) and puromycin to a final concentration of 100 µM 
were added to the fresh medium culture tube containing 1 x 104 trophozoites. The culture 
tubes with inhibitors were incubated for 16 or 48 hours in separate experiments. After 16 or 
48 hours of incubation, the culture tubes were chilled on ice for 10 minutes and trophozoite 
cells were collected by centrifugation at 800 x g for 5 minutes at 4°C. In all of the culture 
tubes, the cells were concentrated to a level of around 4.3 x 106 cells per well in 96-well 
tissue culture plates. After centrifugation, the supernatant was removed, leaving the pellet. 
The culture tube containing the trophozoite pellet was mixed with 1 ml of PBS (pH 7.2) 
and transferred into 1.5 ml centrifuge tubes. An aliquot of 300 µl from each 1.5 ml 
centrifuge tubes was pipetted into a 96 well-tissue culture plate; each concentration was 
assessed in triplicate and repeated at least three times. Trophozoites were first dehydrated 
with 70 v/v ethanol and fixed with methanol; both procedures were allowed to air-dry.  
Trophozoites were then stained with 0.1 w/v methylene blue for 10 minutes. The plate was 
washed twice by immersing the whole plate in distilled H2O. The dye was extracted by 
adding 300 µl of 0.1 M hydrochloric acid solution into each well and read at 655 nm 
(Busatti and Gomes, 2007). The percentage growth inhibition was calculated by 
comparison with the controls grown without treatment. A graph was plotted of 
concentration of trophozoites against the optical density at 655 nm. 
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2.4 Lipids 
2.4.1 Extraction of PI(3,4,5)P3 from Giardia intestinalis, Dictoyostelium discoideum and 
mouse fibroblast cell lines 
Trophozoites were subcultured and grown in 13 ml borosilicate tubes, as described in 
section 2.2.1, and treated with LY294002 and PI-103. Encysting cells were cultured in 13 
ml glass culture tubes, as described in section 2.2.2. NIH 3T3 mouse fibroblast cell lines 
were grown in Dulbecco’s Modified Eagle Media (DMEM). Dictyostelium discoideum 
cells were grown in Axenic medium to reach approximately 3 x 107 cells. D. discoideum 
were harvested and washed with phosphate buffer. Trophozoites and encysting cells were 
counted (as described in section 2.2.3) and a single lipid extraction experiment required 
approximately 5 x 106 total cells. Two 13 ml trophozoite cultures tubes were collected by 
centrifugation at 800 x g for 5 minutes at 4°C to achieve the concentrated trophozoite pellet 
required. The supernatant was removed by gentle aspiration and cell pellet was washed 
twice with 1 x PBS. The PBS/cell mix was centrifuged at 800 x g for 10 minutes at 4°C and 
the supernatant was discarded. The pellet was resuspended in 4 ml cold 0.5 M 
trichloroacetic acid (TCA) and incubated on ice for 5 minutes. The TCA/cell mix was 
centrifuged at 500 x g for 5 minutes at 4°C, the supernatant was discarded and the pellet 
was resuspended in 3 ml cold 5 v/v TCA/1 mM EDTA. The TCA/1 mM EDTA/cell mix 
was vortexed, centrifuged at 500 x g for 5 minutes at 4°C and the supernatant was 
discarded. The pellet was then resuspended in 3 ml cold 5% TCA/1 mM EDTA and 
centrifuged as before. Lipids were extracted by adding 2.25 ml MeOH:CHCl3:12M HCl 
(80:40:1) to the pellet, and vortexing 4 times over 15 minutes at room temperature. The 
mixture was centrifuged at 500 x g for 5 minutes and the supernatant was transferred to a 
new centrifuge tube. The supernatant was phase-split by the addition of 0.75 ml of CHCl3 
and 1.35 ml 0.1 M HCl, vortexed and centrifuged at 500 x g for 5 minutes to separate the 
organic and aqueous phases. The lower organic phase was collected and dried in a vacuum 
dryer. The dried lipid pellet was stored at -20°C. 
 
2.4.2 Detection and quantification of PI(3,4,5)P3  
PI(3,4,5)P3 dried-down extracted sample was resuspended in 65 µl to 185 µl of PBS-T 3 
v/v PS (assay buffer with protein stabiliser provided by PIP3 Mass ELISA Kit K-2500s, 
Echelon Biosciences). The resuspended samples were then vortexed for at least 1 minute 
and centrifuged. Cell extraction samples were then loaded onto an incubation plate 
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(Echelon Biosciences) in triplicate. Each well, except the blank controls, then had 60 
µl/well of diluted PIP3 detector (Echelon Biosciences) added. The incubation plate was 
sealed and placed on a shaker at room temperature for 1 hour; 100 µl from each well was 
transferred to the corresponding wells in the Detection plate (K-1001s, Echelon 
Biosciences). The Detection plate was then sealed and placed on a shaker at room 
temperature for 1 hour. The wells were washed 3 times with 200 µl/well of PBS-T (assay 
buffer, Echelon Biosciences) and 100 µl/well of diluted secondary detector was added. The 
incubation plate was then sealed and place on a shaker as before. The wells were washed 3 
times with 200 µl/well PBS-T. TMB solution (K-TMB1, Echelon Biosciences) was applied 
to each well and the colour was allowed to develop for 5-10 minutes in the dark. Colour 
development was then stopped with 50 µl of 1 N H2SO4 stop solution (K-STOPt, Echelon 
Biosciences). The plate was analysed by absorbance reading at 450 nm on a plate reader. 
The mass of PIP3 present was estimated by comparison to standard curves constructed by 
the addition of known amounts of phosphoinositide to the PIP3 Mass ELISA Kit (Echelon 
Biosciences) (Figure 2.3). 
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Figure 2.3: PIP3 Mass ELISA standard curve 
The Reading value was measured by the absorbance at 450 nm. There are six standard values from 
wells containing PIP3 in a concentration-dose response manner. This standard curve was generated 
using GraphPad prism software using non-linear regression analysis. 
53 
 
2.5 Imaging 
2.5.1 Electron microscopy 
2.5.1.1 Scanning electron microscopy 
G. intestinalis trophozoites and encysting cells treated with LY294002 and DMSO at 
different time periods (12, 24, 48 and 72 hours) were harvested by centrifugation at 500 x g 
for 10 minutes before the pellets were resuspended in 1.5 ml centrifuge tubes. 
Approximately 100 µl of trophozoites was pipetted onto a 24-well cell culture plate 
containing a coated poly-L-lysine 13 mm diameter glass coverslip. The 24-well cell culture 
plate was filled with 2 ml culture medium and placed at 37°C for 60 minutes. Culture 
medium was then carefully removed and the cell culture plate was washed with 2 ml 1 x 
PBS and incubated for 15 minutes at 37°C. Then, 1 x PBS was removed and 1 ml of 2.5 
w/v glutaraldehyde in 0.1 M sodium cacodylate buffer at 37°C was added to each well in a 
cell culture plate followed by incubation at room temperature for 1 hour. Cell culture plates 
were washed twice with 0.2 M cacodylate buffer and stored at 4°C in 0.2 M cacodylate 
buffer. Trophozoites and encysting cells on the coverslip were osmicated for 40 minutes at 
4°C with 1 w/v osmium tetroxide in 0.2 M cacodylate phosphate buffer, followed by a 
dehydration step in ethanol: 2 x 50 v/v ethanol for 10 minutes each, 3 x 70 v/v ethanol for 
10 minutes each, 3 x 95 v/v ethanol for 10 minutes each and 3 x 100 v/v ethanol for 20 
minutes each. The coverslips were then transferred to 100 v/v ethanol in critical point 
drying holders and were critical point-dried using carbon dioxide in a Polaron E3000 
critical point dryer with > 3 flushes over a 45 minute soaking period. The coverslips were 
mounted on stubs (TAAB Laboratories Equipment Ltd) with conductive carbon adhesive 
discs (TAAB Laboratories Equipment Ltd). The samples were sputter-coated with gold in 
an Emitech K550 sputter-coater at 45 mA current for 2 minutes. Samples were examined 
and images collected using an FEI Quanta 200 Field emission scanning electron 
microscope operated at 12 kV in high vacuum mode. 
 
2.5.1.2 Transmission electron microscopy 
Fully grown trophozoites at confluence (approximately 1 x 106 cells/ml) were harvested by 
centrifugation at 500 x g for 10 minutes before the culture medium was gently removed. 
The fully grown trophozoites were resuspended in fresh culture medium treated with 
LY294002 at 50 µM or encystation medium and incubated for different time periods of 24 
and 48 hours. Trophozoites were harvested by centrifugation at 500 x g for 10 minutes, the 
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culture medium was removed and the pellet was washed with 1 x PBS. The centrifugation 
step was repeated to remove 1 x PBS and then 1 ml of 2.5 w/v glutaraldehyde in 0.1 M 
sodium cacodylate buffer (fixative) was added to each tube. The resuspended pellet in 
fixative was transfer to a 1.5 ml centrifuge tube and incubated at room temperature for 3 
hours. The pellets of fixed trophozoites were collected by centrifugation at 500 x g for 5 
minutes at 4°C and the fixative was removed. The pellets were resuspended in sodium 
cacodylate buffer and centrifugation was repeated twice every 10 minutes. Samples were 
post-fixed at 4°C for 1 hour and 30 minutes with 1% osmium tetraoxide in 0.15 M sodium 
cacodylate phosphate buffer. Trophozoites were dehydrated for 10 minutes in 10 v/v 
ethanol, 30 minutes in 70 v/v ethanol and three times for 20 minutes in 100 v/v ethanol at 
room temperature. Samples were exposed twice for 10 minutes in propylene oxide at room 
temperature. Pre-infiltration to the samples for 2 hours and 30 minutes on 1:1 propylene 
oxide and Resin (TAAB Laboratories Equipment Ltd embedding resin, medium) and 
complete infiltration into 100 w/v resin over night at room temperature. Cells were then 
embedded in resin and polymerised for 24 hours at 70°C. Ultrathin sections (70-90 nm) 
were prepared using a Reichert-Jung Ultracut E ultra-microtome and mounted on 150 mesh 
copper grids. Ultrathin sections were contrasted using uranyl acetate and lead citrate and 
observed on an FEI Tecnai 12 transmission microscope operated at 120 kV. Images were 
taken with an AMT 16000 M digital camera. 
 
2.5.2 Light immunomicroscopy 
2.5.2.1 Immunofluorescence analysis 
Giardia intestinalis trophozoites incubated with LY294002, DMSO or Encystation medium 
for 12, 24 and 48 hours or control WB trophozoite cells in normal culture medium for 48 
hours were harvested by centrifugation at 500 x g for 10 minutes; pellets were collected. 
The pellets in each sample were resuspended in approximately 350 μl. Aliquots (100 μl) 
were loaded into each well in the 24-well tissue culture plate containing poly-L-lysine-
coated coverslips per time point in duplicate. Medium (2 ml) was then added to each well 
and the trophozoites were incubated at 37°C for 1 hour to allow adherence to the coverslip. 
Cells were washed with 2 ml warm 1 x PBS for 15 minutes at 37°C. The supernatant was 
gently removed and trophozoites on the coverslip were fixed in 1 ml of 4 w/v PFA in 1 x 
PBS for 30 minutes at room temperature. After 30 minutes, the supernatant was removed 
and the cells on the coverslip were washed with 2 ml 1 x PBS. The cells on the coverslip 
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were permeabilised by adding 1.5 ml of 0.2 v/v Triton-X-100 (Sigma-Aldrich) in 1 x PBS 
(PBS-T) for 15 minutes. This was followed by repeating the washing step with 1 x PBS as 
before, and cells on the coverslip were blocked in blocking solution (1 w/v BSA in 1 x 
PBS) for 1 hour at room temperature with no agitation. This was followed by repeated 
washing with 1 x PBS as before, but with 5 minutes of gentle agitation at room temperature 
to remove the blocking solution. PBS washed cells were then incubated overnight at 4°C 
with primary antibody solution prepared to the following dilutions: 
 1:100 or 1:250 anti-CWP2 mouse monoclonal, fluorescein conjugated 7D2 (kind 
gift from Professor Theodore Nash)  
 1:1000 mouse monoclonal, anti-α tubulin (Sigma-Aldrich). 
 1:100 or 1:250 rabbit monoclonal, anti-IscS (iron sulphur cluster) (kind gift from 
Dr. Jorge Tovar) 
After overnight incubation, the primary antibody solution was discarded and the wells were 
washed thrice in 1 x PBS-T at 5 minute intervals, with a final wash in 1 x PBS. After the 
washes, cells were incubated with 1:500 goat anti-mouse FITC or 1:1000 rabbit anti-mouse 
Cy3 for 1 hour at room temperature. The wells were washed again thrice in 1 x PBS at 5 
minute intervals. The cells on the coverslip were nuclei-stained with DAPI (Sigma-Aldrich) 
at 10 μg/ml for 15 minute. The wells were washed again thrice in 1 x PBS-T at 5 minute 
intervals. These washes were followed by a filter-sterilised 1 x PBS wash for 10 minutes. 
The coverslips were gently tapped to remove excess fluid and were mounted on glass slides 
with a drop of Fluorsave (Calbiochem), before being allowed to air-dry for 1 hour. Slides 
were sealed with nail varnish, covered and stored at 4°C for immunofluorescence 
microscopy (Nikon TE300).  
In co-localisation experiments, trophozoite cells treated with anti-CWP2 antibodies were 
further incubated with rabbit monoclonal, anti-IscS antibodies overnight, washed with 1 x 
PBS and then incubated with secondary anti-rabbit IgG-TRITC conjugated for 1 hour at 
room temperature. Cover slips were washed thrice with 1 x PBS at 5 minute intervals and 
treated with DAPI. The coverslips were washed again thrice in 1 x PBS-T at 5 minute 
intervals and followed by a 10 minute wash using filtered-sterilised 1 x PBS. The cover 
slips were mounted on glass slides using Fluorsave and observed under a confocal 
microscope.  
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2.5.2.2 Confocal microscopy 
The fluorescence images of trophozoites that were labelled using the FITC and TRITC 
secondary antibodies were viewed on a Nikon TE300 inverted fluorescence microscope. 
The microscope had magnification components of 60 x and 100 x oil immersion objectives. 
For FITC, the excitation wavelength was 488 nm with the emission wavelengths of 515-
520 nm; the excitation wavelength for TRITC was 549 nm, with the emission collection 
wavelength of 595-620 nm employed.   
The epifluorescence images were taken using a 60x oil immersion objective lens when the 
dye lists were chosen to either FITC or TRITC. Images were taken using Z stack at 0.42 
µm intervals with 10 slices using the FVI1000 system and collected using the FV10-ASW 
software (version 1.36). The images collected were saved as .tif files and were arranged 
using Adobe Photoshop (version 7). Co-localised images of FITC and TRITC were 
presented using RGB merge tools to display both fluorescences. 
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CHAPTER 3: Bioinformatics sequence analysis of G. intestinalis signalling 
proteins phosphoinositide 3-kinases and glycogen synthase 
kinases 
 
3.1 Introduction  
Giardia genomic resources are an important tool to provide the platform for 
understanding putative lipid signalling cascades and for identifying additional molecular 
components of lipid in this research. Genomic data can have a potential effect on research 
aims and objectives in G. intestinalis sequence. In this research it was considered crucial to 
investigate the identity and confirm the presence of PI3K and GSK gene sequences and the 
amino acid sequence of G. intestinalis. 
The G. intestinalis genome contains 12 million base pairs distributed over five 
chromosomes. G. intestinalis is different to other parasites in that it contains two identical 
nuclei in the trophozoite stage. During the active trophozoite stage of the life cycle, each G. 
intestinalis nuclei cycles between a diploid (2N) and tetraploid (4N) state (Bernander et al., 
2001). The published Giardia genome sequence has enlightened researchers about the 
nuclear genome organisation, the presence of metabolic signalling pathway components 
and the molecules involved in the cellular biology of pathogenicity. Data statistics in the G. 
intestinalis Database (GiardiaDB), which is part of the Eukaryotic pathogen Database 
(EuPathDB), currently show (as of February 2013) that 12.83 mega base pairs of Giardia 
assemblage A isolate WB, clone 6, have been sequenced. The Giardia genome was 
sequenced using whole genome shotgun sequencing where both ends of G. intestinalis 
genomic DNA were sequenced, single reads were assembled into contigs and mapped to 
chromosomes and cloned in a BAC (bacterial artificial chromosome) vector. The genomic 
sequence encoding specific proteins can be found directly on the Giardia database website 
(http://eupathdb.org/eupathdb/) and all single reads are translated and queried against non-
redundant protein databases at NCBI (National Centre for Biotechnology Information). 
The Giardia gene structure has been reported to show certain eukaryotic features 
and other prokaryotic features (Adam et al., 2000). Giardia regularly shows the pattern of 
simplified molecular machinery, cytoskeletal structure and metabolic pathways when it is 
compared to subsequent diverging lineage organisms such as fungi and Entamoeba 
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histolytica (Morrison et al., 2007). This evidence suggests that many specific pathways in 
Giardia are simple in comparison with those of eukaryotic organisms. The similarity in 
Giardia gene structure to yeast and other parasites is shown in Table 3.1. Both G. 
intestinalis nuclei present in trophozoites appear indistinguishable; each has complete 
copies of the genome and are both transcriptionally active (Kabnick and Peattie, 1990, Yu 
et al., 2002, Carranza and Lujan, 2010). 
The availability of the Giardia sequences from the G. intestinalis genome project 
has increased the understanding of protein kinases involved in the intracellular signalling 
pathways in the parasite. This chapter entails the identification of PI3Ks and GSK 
homologues in Giardia and illustrates the protein sequence coding for these kinases 
through bioinformatics. The components of the signalling cascade that will be examined in 
this chapter are PI3K and GSK. In eukaryotic cells, the PI3K signalling cascade has been 
associated with mechanisms to regulate cell growth, intracellular trafficking and cell 
motility (Wymann et al., 2003, Marone et al., 2008). Therefore, it is possible to envisage 
that a failure in PI3K-mediated activity in eukaryotic cells may result in cell cycle arrest 
that will disrupt cell proliferation and cell growth and consequently lead to cell death. It is 
important to understand the signalling cascade and the components involved in the PI3K 
pathway. These components can activate different processes which are important in the 
regulation of cell proliferation, cell growth, and intracellular trafficking and cell motility. 
Reported studies illustrate that G. intestinalis encodes and expresses two putative PI3Ks 
(Cox et al., 2006). Once PI3K is activated in the signalling cascade, PI3K phosphorylates 
PI to generate PIP. An additional phosphorylation reaction adding phosphate to PIP by 
PI3K generates PIP2, and then PIP3 is produced by Class I PI3Ks and recruits proteins with 
a pleckstrin homology (PH) domain to the plasma membrane; an example of one of these 
proteins is protein kinase B (PKB). The phosphate from PIP3 is then transformed to PKB, 
thereby activating PKB through phosphorylation of the PH domain at the membrane. Once 
activated, PKB activates or inactivates a series of downstream effector proteins. Thus, PKB 
acts as a key regulator of important cell processes such as cell survival. PKB has been 
extensively studied in mammalian cells as a regulator of cell growth, proliferation and 
survival. Furthermore, PKB has been identified in Dictyostelium discoideum (Haribabu and 
Dottin, 1991), Trypanosoma cruzi (Pascuccelli et al., 1999) and Entamoeba histolytica 
(Que et al., 1993). Work by Kim, et al. (2005) showed the identification and 
characterisation of PKB in G. intestinalis (GenPept: AAF06671). Another important 
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component associated with PPIn is the PPIn-metabolising phosphatase. Below is a list of 
the protein phosphatases in G. intestinalis that have been identified to date: serine/threonine 
protein phosphatase 2A-2 (PP2A-2) catalytic subunit (GenPept: EDO79971), 
serine/threonine protein phosphatase 5 (GenPept: EDO77915), serine/threonine protein 
phosphatase 4 (GenPept: EDO76443.1) and serine/threonine protein phosphatase (GenPept: 
EDO80051.1); all of these may act to dephosphorylate the products of GiPI3K1 (Lauwaet 
et al., 2007, Morrison et al., 2007). Furthermore, Giardia PP2A is needed during the 
parasite differentiation, as knockdown of Giardia PP2A RNA by the expression of 
antisense RNA under a strong constitutive promoter results in the inhibition of  encystation 
and excystation (Lauwaet et al., 2007). 
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Table 3.1: G. 
lamblia genome 
contents in 
comparison to other 
eukaryotic species.  
A comparison of 
genome content and 
organization of 
common eukaryotic 
species to G. 
lamblia.  
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3.2 Experimental Results 
3.2.1 Identification of putative phosphoinositol-3 kinase and glycogen synthase kinase 
in G. intestinalis 
 G. intestinalis genome searches were executed by using translation BLAST 
(tBLASTn) to identify genes encoding putative PI3Ks and GSK. First, we searched for 
validated PI3K and GSK sequences from other organisms representing the three 
homologues of class I, II and III PI3Ks and homologues of GSK. The protein query 
sequences chosen for PI3Ks were; 1) Homo sapiens p110α representing class I PI3K 
(GenPept: NP_006209); 2) H. sapiens PI3K-C2α representing class II PI3K (GenPept: 
NP_002636); 3) Saccharomyces cerevisiae Vsp34 representing class III PI3K 
(NP_013341). For GSK, the chosen protein query sequences were; 1) H. sapiens GSK-3α 
(Genpept: NP_063937.2) 2) H. sapiens GSK-3β (GenPept: NP_002084.2). 
Using the catalytic domain of PI3Ks and GSK isoforms as query sequences, 
tBLASTn was performed with query sequences against the Giardia genome. The translated 
sequences of five PI3K and two GSK open reading frames (ORFs) from G. intestinalis 
were identified. The matches of query sequence to G. intestinalis probability show 
significant low E-values in both PI3K and GSK kinase domains (E values refer to the 
probability of the query sequence getting a matching return from the genome it was 
compared to; the lower the E values, the higher the number of matched sequences). Also 
the percentage identity values were moderately high by the kinase domain of PI3K and 
GSK; this is shown in Tables 3.2 and 3.3. 
G. intestinalis PI3K matched sequences in Table 3.2 were analysed and two 
sequences were removed from the list. The bottom two amino acid sequences excluded 
from further analysis are GL50803_35180 and GL50803_16805; the former sequence name 
is GTOR and it is predicted to be involved in the targeting of Rapamycin-related protein 
kinase, while the latter is predicted to be a hypothetical protein (Morrison et al., 2007). The 
remaining three matching sequences of PI3K are made up of long sequences: 
GL50803_14855 is 6,467 bases on chromosome 5, GL50803_17406 is 4,916 bases on 
chromosome 2 and GL50803_16558 is 6,779 bases on chromosome 4.  Furthermore, when 
these three PI3K sequences are translated into amino acid protein sequences, the molecular 
weights are 242 kDa, 183 kDa and 254 kDa for GL50803_14885, GL50803_17406 and 
GL50803_16558, respectively. The two matching GSK sequences from G. intestinalis 
contain 1,112 bases and 1,052 for GL50803_9116 on chromosome 5 and GL50803_17625 
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on chromosome 3, respectively. Giardia GSK protein sequences have a molecular weight 
of 42.24 kDa and 39.98 kDa and are similar to the putative Leishmania major GSK 
sequence (accession: XP_001682433), which contains 355 amino acid residues and has a 
molecular weight of 40.72 kDa (Aslett, 2005). 
 
Table 3.2: Percentage identity and probability values of putative G. intestinalis PI3K 
sequences.  
Amino acids of PI3K class I, II and III from H. sapiens were chosen as query sequences for 
translational blast to determine the PI3K homologues in G. intestinalis genome. Here are the five 
Giardia match sequences with low E-values and moderately high percentage identity. Each 
sequence identification code can be referred to the Giardia Genome Database.   
 
  Query sequences 
Giardia match  H. sapiens 
p110α 
H. sapiens  
PI3K-C2α 
S. cerevisiae  
Vps 34p 
GL50803_14855 E-value 4.0 x 10-60 6.5 x 10-46 1.2 x 10-36 
% 
identity 
44% 33% 31% 
GL50803_17406 E-value 5.7 x 10-17 3.1 x 10-19 1.1 x 10-32 
% 
identity 
27% 26% 31% 
GL50803_16558 E-value 2.5 x 10-15 3.9 x 10-12 6.7 x 10-19 
% 
identity 
27% 25% 23% 
GL50803_35180 E-value 8.7 x 10-3 3.5 x 10-4 1.1 x 10-08 
% 
identity 
34% 36% 25% 
GL50803_16805 E-value 1.4 x 10-3 - 4.2 x 10-01 
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% 
identity 
34% - 24% 
 
Table 3.3: Percentage identity and probability values of putative G. intestinalis GSK-3 
sequences. 
Amino acid sequences of GSKs from H. sapiens have been chosen as query sequences for 
translational blast to determine the GSK homologues in the G. intestinalis genome. Here are a 
couple of Giardia match sequences with very low E-values and quite high percentage identity. 
Again, each sequence given below can be referred to the Giardia Genome Database. 
 
  Query sequences 
Giardia match  H. sapiens GSK-3α H. sapiens GSK-3β 
GL50803_9116 E-value 2.7 x 10-81 6.8 x 10-83 
% identity 46% 48% 
GL50803_17625 E-value 2.2 x 10-72 1.7 x 10-72 
% identity 41% 45% 
 
 
Three remaining sequences of G. intestinalis PI3K and two G. intestinalis GSK 
sequences were translated and were used to search with tBLASTn for similar sequences in 
a non-redundant database. The top three matches for PI3K in Giardia are listed in Table 3.4 
and for Giardia GSK matches are listed in Table 3.5. Non-redundant database searches for 
Giardia PI3Ks returned matches showing similarity and identity to class IB p110 PI3K, 
class III PI3K and PI4K kinases. It was decided that further analysis should focus on the 
putative giardial PI3K enzymes rather than the putative PI4K. PI3K based research has 
rapidly accelerated in many different cell types together with the knowledge of PI3K 
structure and cellular function; it was reasoned that there was more to gain in terms of 
applying known PI3K principles by focusing on the giardial PI3Ks.   
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Table 3.4: 
Probability and 
percentage 
identity values of 
matches from 
the non-
redundant 
database of 
nucleotide 
sequences at 
NCBI to all three 
G. intestinalis 
ORF following 
tBLASTn. 
Percentage 
identity and 
probability result 
from three 
Giardia PI3Ks 
(GiPI3K1, 
GiPI3K2 and 
GiPI4K) that 
were used to 
search for similar 
sequences in the 
non-redundant 
sequence in NCBI 
non-redundant 
database using 
tBLASTn tool. E-
values are the 
expected values 
for the sequence 
to show up; they 
are in brackets 
below.  
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The search for Giardia GSKs against non-redundant proteins returned matches to 
GSK3 and the GSK3-beta isoforms. The sequences given in the search will now be referred 
to as GiPI3K1 (GL50803_14855), GiPI3K2 (GL50803_17406) and GiPI4K 
(GL50803_16558); for GSK sequences, two different isoforms will be referred to as 
GiGSKa (GL50803_9116) and GiGSKb (GL50803_17625). The term “Gi” represents G. 
intestinalis.   
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Table 3.5: 
Analysis of 
the putative 
G. 
intestinalis  
GSK 
sequences 
following 
tBLASTn. 
Percentage 
identity and 
probability 
result from 
two Giardia 
GSKs 
(GiGSKa and 
GiGSKb) that 
were used to 
search for 
similar 
sequences in 
the non-
redundant 
sequence in 
NCBI non-
redundant 
database 
using 
tBLASTn 
tool. E-values 
are in 
brackets 
below. 
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3.2.2 Analysis of the domains in PI3Ks and GSKs in G. intestinalis 
The domains characteristic of PI3Ks and GSKs in G. intestinalis were analysed 
through the domain-prediction programs SMART (Schultz et al., 1998). G. intestinalis 
GiPI3K1, GiPI3K2 and GiPI4K sequences were entered into SMART and predicted to 
contain a Ras-binding domain, a C2 domain, a PIK and kinase catalytic domains with a 
high E-value. The domain predictions were similar to the other PI3Ks which also show Ras 
binding, C2-like and catalytic domain. Upon activation by external stimuli to cell 
membrane receptors, the Ras binding domain interacts specifically to effector-proteins, 
thereby initiating protein-protein interactions. The resulting effector protein activation for 
example in PI3K, therefore leads to the increased PI3K activity due to translocation of the 
enzyme to the plasma membrane. C2-like domains have been reported to be important for 
membrane interaction and binding (Walker et al., 1999). Work reported by Cox et al. 
(2006) illustrated that GiPI3K1 and GiPI3K2 appear to have long insertions in the PIK 
domains, whereas other well-studied organisms do not. Giardia PI3K domains were 
analysed using sequence-similarity searches where the predicted domains of GiPI3K1 and 
GiPI3K2 were queried against a non-redundant database, thus confirming the identity of the 
predicted domains and providing further evidence of the similarity of Giardia PI3Ks to 
class I and III PI3K isoforms (Table 3.6). GiPI4K was also queried and a kinase domain 
was reported in the region of amino acids 1955-2257. Several matches were reported, with 
the highest being 12% sequence identity to the H. sapiens PI4K kinase domain. 
 Giardia GSK isoforms were also queried through sequence similarity using the 
sequence of predicted Serine/Threonine protein kinases, catalytic domain (S_Tkc), against 
a non-redundant database. S_Tkc was chosen as the query to search for GSK isoforms in 
Giardia because GSK protein sequences in other organisms contain S_Tkc domains. The 
S_Tkc domain is one of the three main classes of protein kinases that are able to catalyse 
the transfer of phosphate groups, which result in a conformational change affecting the 
protein function. The results illustrate that there are several matches to S_Tkc domain in 
both GiGSKa and GiGSKb; the highest percentage score was 53% to Caenorhabditis 
remanei GSK-3 and 47% to H. sapiens GSK-3β (Table 3.7). In general, GSK-3 
homologues in well-studied organisms share significant degrees of homology, especially in 
the kinase domain; therefore, to further support this, pairwise alignment of the giardial 
GSK domain S_Tkc was performed against the GSKs sequence, which share the greatest 
similarity with giardial GSKs.  
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Research in PI3K cellular signalling has rapidly progressed beyond PI4K-based 
research. Moreover, the knowledge of PI3K structure and intracellular function in many 
different cell types is more advanced. Therefore, it was to gain in terms of applying known 
PI3K principles by focusing on the giardial PI3Ks and GSK.   
 
Table 3.6: Investigation of giardial PI3K domains. 
This table shows sequence identity values as a percentage of GiPI3K1, GiPI3K2 and GiPI4K in 
comparison to other well-studied isoforms of PI3K.   
 
 GiPI3K1 GiPI3K2 GiPI4K 
RBD 41% to H. sapiens class 
IB PI3K 
- - 
PIK 29% to H. sapiens PI3K 
catalytic p110α 
31% to C. elegans 
Vps34-like PI3K 
- 
Kinase 39% to D. discoideum 34% to G. max PI3K 12% to H. sapiens PI4K 
C2 
domain 
12% to D. discoideum 13% to G. max PI3K - 
     
Table 3.7: Investigation of giardial GSK proteins. 
Serine/Threonine protein kinase, catalytic domain sequences were used for sequence-similarity 
search and the percentage identity value of the similar domain sequences were shown following 
sequence alignment. 
 
 GiGSKa GiGSKb 
S_Tkc 53% to C. remanei GSK-3 
protein 
47% to H. sapiens GSK-3β 
 
Giardia PI3K sequence alignments by Cox et al. (2006), showed similarities in the 
domain sequence and provided structural analysis of important domains, such as the Ras 
binding domain, the C2 domain and the PIK domain. Here, Giardia GSK pairwise 
alignments were carried out (Figure 3.1) for alignment of GiGSKa and GiGSKb against 
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kinase domains of GSKs from C. elegans and G. max, respectively. The domain sequences 
used in the comparison were chosen based on the highest percentage matches in similarity 
and identity. 
Glycogen synthase kinase is from a family that includes cyclin-dependent kinase 
(CDK), mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) 
and CDC-like kinase (CMGC). Two isoforms are typically found: GSK-3α and GSK-3β. In 
the primitive eukaryote, GSK or GSK-3 has one isoform, GSK-3α, while an invertebrate 
would normally have two isoforms of GSK-3. Comparison of the amino acid sequences of 
the two open reading frames reveals identity of up to 98% in the region containing motifs 
that are common to all protein kinases (Woodgett, 1990). The differences between the two 
genes are found in the N-terminal and C-terminal, where the latter share only 36% identity 
in the last 76 residues.  
Structural analysis of the kinase domain S_Tkc, in the well-studied organism Rattus 
norvegicus, has revealed conserved residues that have important features within this 
domain. For example, key serine residues (Ser-21 in GSK-3α and Ser-9 in GSK-3β) have 
been implicated in phosphorylation and, therefore, play a role in a variety of signalling 
pathways such as the insulin signalling cascade, cyclic AMP activation and the epidermal 
growth factor. Two conserved lysine residues, Lys-148/149 in GSK-3α and Lys-85/86 in 
GSK-3β, are important for ATP binding and stabilising γ-phosphate during transfer to the 
substrate. Initially, the substrate undergoes priming via a phosphorylation mechanism; this 
is when pre-phosphorylation of the substrate occurs by another kinase at a site four amino 
acids towards the C-terminal to the GSK-3 phosphorylation site, where the optimal site for 
GSK-3 is Ser/Thr-x-x-x-Ser/Thr-P (Martinez et al., 2002). In H. sapiens, GSK-3β activity 
is negatively regulated by phosphorylation of Ser-9 and positively regulated by 
phosphorylation on Tyr-216. The putative kinase domain sequences of Giardia GSKs 
(GiGSKa and GiGSKb) were analysed using a protein structure prediction server from 
University College London (program PSIPRED) to reveal their secondary protein structure 
(Bryson et al., 2005; McGuffin et al., 2000). The S_Tkc domains of GiGSKa and GiGSKb 
are predicted to fold into 8 and 9 beta strands, respectively (Figure 3.2). The alpha helix of 
the two sequences analysed show 9 and 8 α-helices from GiGSKa and GiGSKb, 
respectively. Both the number of alpha helixes and beta strands in the S_Tkc domain of 
Giardia GSKa and GSKb are similar to the secondary structure arrangement in Rattus 
norvegicus (Woodgett, 1990). 
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 In addition to the study above, the structure of Giardia GSK domain S_TKc was 
further analysed using the crystal structure of human GSK-3β as a model (Cheng et al., 
2011). The structure of GiGSKa and GiGSKb kinase domains was imported into the Cn3D 
macromolecular structure viewer and aligned to H. sapiens GSK-3β. The kinase domain 
from GiGSKa and GiGSKb was blast-searched against the sequence of GSK-3β and 
aligned to GSK-3β (see Figure 3.3). This showed the 3D-structural homology. The 
structural analysis of the kinase domains revealed that GiGSKa and GiGSKb share similar 
S_Tkc domains, as illustrated in the alignment with mammalian GSK-3β. This could be due 
to the high similarity and conservation of the functional kinase domain reported across the 
species (see Figure 3.5). 
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a) 
b) 
72 
 
Figure 3.1: GSK domain pairwise alignments for GiGSKa and GiGSKb sequences. 
Pairwise sequence alignments of GiGSKa (a) and GiGSKb (b) Serine/Threonine protein kinase, 
catalytic domain (S_Tkc) using CLUSTAL W multiple alignment (Thompson et al., 1994).  
Sequences with identical residues are highlighted in black shading and the conserved residues are 
shaded in grey according to PAM250 matrix (Schwartz and Dayhoff, 1978). Identity and similarity 
percentages for the sequence alignments of GiGSKa are 53% and 73% with CeGSK3 (Accession: 
NP_493243), and 49% and 72% with DdGSK3 (Accession: XP_645156). The identity and 
similarity percentages for sequence alignments of GiGSKb are 47% and 73% with GmGSK 
(Accession: ACQ91102), 45% and 73% with CrGSK3 (Accession: XP_001690881).   , ATP 
binding and active sites;   , phosphorylation site; Solid line under the residues indicates an 
activation loop. 
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Figure 3.2: Secondary structure prediction of Serine/Threonine protein kinase, catalytic 
domains in Giardia GSKa and GSKb. 
The Serine/Threonine protein kinase catalytic domains of GiGSKa and GiGSKb were input to the 
PSIPRED protein sequence analysis at Bioinformatic group, University College London (Jones, 
1999). The PSIPRED show the secondary structure prediction of the input sequence. Legend: Conf, 
confidence of prediction (the higher the bars, the higher confidence values); (1) Pred, predicted 
secondary structure in a diagrammatic form; (2) Pred, series of coil (C), helix (H) and strand (E); 
AA, target sequence (S_Tkc from GiGSKa and GiGSKb); α helix, ; β strand,               and 
coil,  fefsefk. 
 
 
 
 
 
Figure 3.3: GiGSKa and GiGSKb Serine/Threonine kinase catalytic domain alignment on 
crystal structure of Homo sapiens glycogen synthase kinase-3 beta (HsGSK-3β). 
Giardia GiGSKs sequences were aligned onto the three-dimensional crystal structure of Human 
glycogen synthase kinase beta (Cheng et al., 2011). Cn3D (version 4.1) was used to produce the 
three-dimensional structures of GSK-3β and the overlaying alignments were red for identity and 
blue for similarity. The grey areas are non-aligned residues; the structure is presented in the 
secondary structure model, and thus consists of: alpha helices, pink cylinder arrows; beta pleated 
sheets, flat arrows; and coils, intervening loops. The N-terminal and C-terminal are labelled N and 
C, respectively.       
 
3.2.3 Functional analysis of GiPI3Ks and GiGSKs 
It is important to mention the function of the kinases and highlight the residues 
required to carry out the specific activity. Firstly, the GiPI3K1 and GiPI3K2 kinase domain 
has been determined against the structurally characterised kinase domain of PI3Kγ from S. 
scrofa by Cox et al. (2006). The residues required for ATP binding site in S. scrofa PI3Kγ 
GiGSKa GiGSKb 
N N 
C C 
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are Ser-806 binding to β-phosphate of substrate ATP and Lys-833 binding to α-phosphate 
of ATP and the PI3K inhibitor wortmannin. Other important residues that feature in S. 
scrofa PI3γ are metal binding residues (Asp-836, Asn-951 and Asp-964) and the 
phospholipid substrate binding site that includes Lys-807, Lys-808 and Lys-973. Residues 
Lys-807 and Lys-808 function as a ligand for the I-phosphate of the substrate; GiPI3K1 
shares these residues with S. scrofa PI3 PI3Kγ, whereas GiPI3K2 shares only Lys-808. 
Residues Lys-973 acts as a ligand of the 5-phosphate and only GiPI3K1 shares 
phospholipid binding residues (Walker et al., 1999).  
Moreover, the activation loop of GiPI3K2 appears to be shorter than that found in 
GiPI3K1. GiPI3K2 lacks Lys-807, an important residue that is thought to provide I-
phosphate of phospholipid substrate binding, and lacks Lys-973, which is another important 
residue that acts as a ligand for 5-phosphate of PI(4,5)P2, as reported in the S. scrofa 
sequence. This suggests that GiPI3K2 belongs to the class III isoforms. Also, due to the 
similarity between GiPI3K and S. scrofa PI3Kγ in lysine residues and a similar length in 
the activation loop, this strongly suggests that GiPI3K1 belongs to class I.  
The structural functionality of Giardia GSKa and GSKb was also investigated here 
with comparison to the well-known R. norvegicus GSK-3α structure. The region of the 
functional kinase domain reveals 72% and 74% similarity when R. norvegicus GSK-3α is 
aligned to the GiGSKa and GiGSKb sequences, respectively. The residues required for 
ATP binding and kinase activity in H. sapiens and R. norvegicus are 88% and 90% 
conserved in GiGSKa and GiGSKb (Figure 3.4). The conserved residue responsible for 
tyrosine phosphorylation at Tyr-279 in R. norvegicus and the H. sapiens kinase domain are 
also found in GiGSKa and GiGSKb sequences. Moreover, the conserved GSK-3 primed 
substrate recognition site residues Arg-159, Arg-243 and Lys-268, which are present in H. 
sapiens and R. norvegicus kinase domains, are conserved in both GiGSKa and GiGSKb. 
Priming is important as it involves hierarchical pre-phosphorylation of the substrate by 
another kinase at a site downstream, towards the C terminus of the GSK-3 phosphorylation 
site, thus forming the GSK-3 recognition motif Ser/Thr-x-x-x-Ser/Thr-P. The conserved 
residues mentioned suggest that GiGSKa and GiGSKb are both functional kinase domains, 
meaning that it is possible to hypothesise that they would operate in the same manner as the 
well characterised GSK-3.         
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Figure 3.4: Detailed sequence investigation of Serine/Threonine kinase catalytic domain of 
GiGSKa and GiGSKb. 
ClustalW multiple alignments of the kinase domain S_TKc of GiGSKa and GiGSKb with the well 
characterised GSK-3α S_TKc domain from H. sapiens (HsGSK3A) [Accession: NP_063937.2] and 
Rattus norvegicus (RnGSK3A) [Accession: P18265]. The alignment highlights the similarity of the 
sequences, and also reveals conserved functional residues. Solid line under the residues indicates an 
activation loop using the ClustalW multiple alignment between well characterised sequence and 
GiGSKa and GiGSKb.    , substrate binding sites;    , ATP binding and active sites;    , primed 
substrate recognition site binding sites;    , possible proton acceptor site;   , phosphorylation site. 
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Figure 3.5: Multiple alignment of Serine/Threonine kinase catalytic domain (S_TKc). 
The S_TKc domain of several sequences was aligned using ClustalW (Thompson et al., 1994) with 
GiGSKa and GiGSKb. The accession numbers of the following GSKs sequences are: L. major 
GSK-3, LmGSK3 [Accession: CAJ03501.1], S. pombe GSK-3, SpGSK3 [Accession: NP_593134], 
Plasmodium falciparum GSK-3, PfGSK3 [Accession: XP_001351197], C. elegans GSK-3, 
CeGSK3 [Accession: NP_493243], G. max GSK, GmGSK [Accession: ACQ91102], C. reinhardtii 
GSK-3, CrGSK3 [Accession: XP_001690881], D. discoideum GSK-3, DdGSK3 [Accession: 
XP_645156], D. melanogaster GSK-3, DmGSK3 [Accession: P83101], A. thaliana GSK-3, 
AtGSK3 [Accession: AAG50665], H. sapiens GSK-3α, HsGSK3A [Accession: NP_063937.2], S. 
scrofa GSK-3α and GSK-3β, SsGSK3A/SsGSK3B [Accession: NP_063937 and NP_001121915, 
respectively], R. norvegicus GSK-3α and GSK-3β, RnGSK3A/RnGSK3B [Accession: P18265 and 
P18266, respectively] and D. rerio GSK-3α, DrGSK3A [Accession: NP_571465]. The shading 
threshold was set at 70%, where grey shading refers to similar residues and black shading refers to 
identical residues. The underline in blue represents ATP binding sites and underline in red 
represents the activation loop. 
 
3.2.4 Prediction of GiPI3Ks and GiGSKs protein localisation sites in cell through 
bioinformatics learning algorithms 
PSORTII (Nakai, 1999) and iPSORT (Bannai et al., 2002) are bioinformatics 
programs that were used to predict the subcellular localisation sites of the query protein in 
the cell. Although the program PSORTII has massive potential, it assumes that all proteins 
are localised in a single subcellular compartment within the systems; thus, it should not be 
assumed that all query proteins are assigned to one of the known compartments. Both 
GiPI3K1 and GiPI3K2 with their kinase domains sequences removed were predicted by 
PSORTII to localise to the nucleus (see Table 3.8). However, if the GiPI3K1 sequence is 
entered without the removal of the kinase domain, the protein is predicted to localise to the 
plasma membrane. This shows that the kinase domain influences the overall prediction, 
possibly due to bias in the training data used by PSORTII; alternatively, it is possible that 
GiPI3K1 may localise to multiple known compartments. There were no signal peptides or 
any mitochondrial targeting signal sequences identified in either of GiPI3K1 or GiPI3K2 
using iPSORT prediction. 
G. intestinalis GiGSKa and GiGSKb were also submitted for PSORTII prediction 
as a full sequence and sequences without the serine/threonine kinase catalytic domain 
(S_Tkc). The exclusion of the S_Tkc domain was performed to ensure that the domain did 
not have any influence on the entire PSORTII sequence prediction. In GiGSKb, the 
prediction of full length sequence was cytoplasmic; however, upon removal of the kinase 
domain, the result of the prediction was nuclear (see Table 3.9). In mammalian cells, GSK-
3 is constitutively active in resting conditions. However, GSK-3 becomes inactivated 
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through phosphorylation on the N-terminal residue Ser-21 for GSK-3α and Ser-3, for GSK-
3β, respectively. Wakefield et al. (2003) observed accumulation of phospho-GSK-3 at the 
centrosomes upon entry into mitosis, and further reported that PKB is responsible for 
phosphorylating and inactivating GSK-3 at the centrosome during mitosis. Therefore, the 
prediction that GiGSKb would localise in the nucleus seems appropriate to this example. 
Moreover, the results from PSORTII for GiGSKb show a predicted nuclear localisation of 
69.6%, which may be due to the nuclear localisation signals (NLS). NLS sequences are rich 
in either arginines or lysines. These two residues are required for transporting proteins 
through the nuclear pore complex into the nucleus (Boulikas, 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
Table 3.8: The subcellular localisation of GiPI3K1 and GiPI3K2 prediction using the internet 
program PSORTII. 
PSORTII is a computer-based program that compiles a list of different subprograms which use 
mathematical algorithms to calculate the probability of the localisation of query sequences. These 
subprograms identify query sequences for specific localisation; for example, signal sequence 
recognition, ER retention motif, and peroxisomal targeting signals. The PSORTII program uses the 
k-nearest neighbour algorithm to predict the probability of the subcellular localisation of the query 
sequence through values of the subprograms and training data. The values of k-nearest neighbour 
predictions are in percentages, where a higher percentage is used for the final prediction. 
 
Protein PSORTII prediction 
GiPI3K1 
34.8% plasma membrane; 17.4% nuclear; 17.4% endoplasmic 
reticulum; 13.0% vacuolar; 4.3% cytoskeletal; 4.3% Golgi; 4.3% 
mitochondrial; 4.3% cytoplasmic. 
No significant signal peptides / motifs identified 
 
Prediction for sequence is Plasma membrane 
GiPI3K1 
without kinase 
domain 
56.5% nuclear; 21.7% cytoplasmic; 8.7% cytoskeletal; 8.7% 
mitochondrial; 4.3% Golgi 
No significant signal peptides / motifs identified 
 
Prediction for sequence is Nuclear 
GiPI3K2 
69.6% nuclear; 13.0% cytoplasmic; 8.7% mitochondrial; 4.3% vesicles 
of secretory system; 4.3% endoplasmic reticulum 
Nuclear localisation signals KKKR at 632; RHRR at 1003; PMRHRRI 
at 1001 
ER retention motif signal KKXX-like motif in the C-terminus QGFK 
2nd peroxisomal targeting signal RLDMLYVHL at 1145 
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Prediction for sequence is Nuclear 
GiPI3K2 
without kinase 
domain 
73.9% nuclear; 17.4% cytoplasmic; 4.3% cytoskeletal; 4.3% plasma 
membrane 
Nuclear localisation signals KKKR at 632; RHRR at 1003; PMRHRRI 
at 1001 
 
Prediction for sequence is Nuclear 
 
Table 3.9: The subcellular localisation of GiGSKa and GiGSKb prediction using the internet 
program PSORTII. 
PSORTII is a computer-based program that compiles a list of different subprograms which use 
mathematical algorithms to calculate probability of the localisation of query sequences. These 
subprograms identify query sequences for specific localisation; for example, signal sequence 
recognition, ER retention motif, and peroxisomal targeting signals. The PSORTII program uses the 
k-nearest neighbour algorithm to predict the probability of subcellular localisation of the query 
sequence through values of the subprograms and training data. The values of k-nearest neighbour 
predictions are in percentages, where the higher the percentage is used for the final prediction. 
 
 
Protein PSORTII prediction 
GiGSKa 
69.6% cytoplasmic; 17.4% nuclear; 13.0% mitochondrial 
No significant signal peptides or protein motifs 
 
Prediction for sequence is Cytoplasmic 
GiGSKa 
without Kinase 
domain 
43.5% cytoplasmic; 30.4% nuclear; 17.4% mitochondrial; 4.3% vesicles 
of secretory system; 4.3% cytoskeletal 
No significant signal peptides or protein motifs. 
 
Prediction for sequence is Cytoplasmic 
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GiGSKb 
60.9% cytoplasmic; 30.4% nuclear; 4.3% vacuole; 4.3% mitochondrial 
ER membrane retention signal KKXX-like motif in the C-terminus KIRP 
 
Prediction for sequence is Cytoplasmic 
GiGSKb 
without kinase 
domain 
69.6% nuclear; 13% cytoplasmic; 13% mitochondrial; 4.3% cytoskeletal 
ER membrane retention signal KKXX-like motif in the C-terminus KIRP 
 
Prediction for sequence is Nuclear 
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3.3 Discussion 
The availability of various bioinformatics tools has paved the way for scientists to 
identify sequence of interest within the model organism. These analysis tools such as 
sequence BLAST, ClustalW, secondary protein structure model, three-dimensional 
structural display through sequence alignment and domain prediction programs have 
provided relevant information and a platform for experimental work. G. intestinalis PI3K 
isoforms (GiPI3K1 and GiPI3K2) can be found within the giardial genome and it has been 
shown that the closest class that these isoforms represent is class IB and class III for 
GiPI3K1 and GiPI3K2, respectively. Indeed, a class II PI3K sequence search did not reveal 
any homologues of class II PI3K in G. intestinalis. However, the reason why there may 
only be two isoforms of PI3K homologues in G. intestinalis could be due to reductive 
evolution as a result of the parasitic way of life. Mammalian cells may have as many as 
eight PI3K isoforms (Fry, 2001). 
The large insertion in the PI3Ks kinase domain means that GiPI3K1 and GiPI3K2 
are much larger than in other organisms containing homologues of PI3K. The study by Cox 
et al. (2006) concluded that the functional significance of the insertion sequence in the 
kinase domain region of PI3K is still unknown. However, it has been observed that the long 
insertions in the kinase domain did not interfere with substrate binding and formation of the 
active site using three dimensional mapping alignments in GiPI3K1. On the other hand, the 
kinase insertion of GiPI3K2 has the potential to inhibit substrate entry because the insertion 
residues may fold at its amino and carboxy-terminal, thus affecting the active site of the 
enzyme.  
The bioinformatics analysis indicates that the G. intestinalis genome encodes two 
GSKs from the CMGC group. Initially GSK was described to be a regulator of glycogen 
metabolism; however, GSK-3 (where the ‘three’ in GSK-3 derived from is currently 
unknown) is also an important component of the Wnt pathway in many organisms, 
including humans and D. melanogaster (Komiya et al., 2008). Therefore, the name GSK is 
somewhat of a misnomer because GSK-3 has a variety of other functions, as described in 
the introduction (Ojo et al., 2011). Sequence analysis in similarity and identity searches 
within the S_Tkc catalytic domain has shown the presence of highly conserved residues in 
both GiGSKa and GiGSKb. Although it has been mentioned that the kinase domain 
between GSK-3α and GSK-3β is 98% identical in mammalian cells, between GiGSKa and 
GiGSKb it is 71%. This indicates that there are two homologues of GSK in G. intestinalis 
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that contain the S_Tkc domain. It has been identified that the GSK-3α homologue does 
have a longer N-terminus, with the H. sapiens and GSK-3α having 483 residues compared 
to the 420 residues in GSK-3β. GiGSKa contains 370 amino acids, whereas GiGSKb 
contains 350 amino acids; this means that the difference in the size of GSKs within G. 
intestinalis and mammalian cells is up to one hundred amino acid residues. However, the 
alignment of the kinase domain sequence using ClustalW has shown that important amino 
acid residues are highly conserved within the kinase domain of Giardia and mammalian 
cells (Figure 3.4). Identification of threonine phosphorylated proteins was highlighted in 
the alignment and abundant phosphoserine and phosphothreonine presence within the 
Giardia trophozoites lysate has been detected using western blot (Manning et al., 2011).  
The program PSORTII, predicting the localisation of GSKs in Giardia, has 
calculated that GiGSKa is in the cytoplasm whereas GiGSKb may be in the nucleus or 
cytoplasmic through specialised learning algorithms. Given the background of GSK-3 
signalling in mammalian cells, the predicted subcellular localisation of the giardial GSKs 
matches other GSK-3 proteins in mammalian cells. Therefore, GiGSKa may be 
phosphorylated by PKB leading to the inactivation of cyclin D and the initiation of 
proteolytic degradation. On the other hand, nuclear localised GiGSKb may play a role in 
cell cycle regulation.              
    In summary, detailed analysis of the Giardia genome has revealed the gene 
sequence that encodes PI3Ks and GSKs. However, due to the divergent nature of G. 
intestinalis as a parasitic organism that is undergoing reductive evolution, kinases in 
Giardia may have lost many of their basic cellular functions. Research presented in the 
next chapter involving these protein kinases will attempt to understand the cellular 
functions of PI3Ks and GSKs in Giardia trophozoites.   
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CHAPTER 4:  Investigating the effect of PI3K and GSK inhibition on  
aaaaaaaaaaaaG. intestinalis  
 
4.1 Introduction 
In this Chapter, a panel of inhibitors has been utilised to study the effect of PI3K 
and GSK-3 signalling in Giardia trophozoites. Previous studies mentioned earlier in the 
introduction chapter have demonstrated that exposure of trophozoites to LY294002 
appeared to initiate the process of encystation (Cox and Tovar, unpublished data). With this 
in mind, in order to try and understand the molecular basis of this observation, we carried 
out the work described in this chapter. There were three PI3K inhibitors that used: 
LY294002, wortmannin and a novel inhibitor PI-103. LY294002 and wortmannin are both 
commonly used inhibitors of PI3K. Although wortmannin had been shown in the literature 
to be more potent and specific inhibitor of PI3K than LY294002 (Bain et al., 2007), it was 
recommended that both of these inhibitors may cause a similar phenotypic effect to inhibit 
the activity of PI3K (Davies et al., 2000). 
LY294002 is a PI3K inhibitor of p110α, p110β and p110δ and was synthesised 
from the flavonoid quercetin. Quercetin is a PI3K inhibitor marketed by Calbiochem. It can 
inhibit a number of protein serine/threonine kinases such as AMPK, CKII, MAPKAP-
K1/RSK2 and S6K1 with similar concentrations to PI3K. LY294002 has been reported to 
inhibit the PI3K family and other kinases through competitive inhibition at the ATP 
binding site (Davies et al., 2000). Moreover, it has been described that LY294002 used at 
microMolar (µM) concentrations is effective against protein kinases from humans. Also, 
LY294002 has been shown to inhibit other kinases such as mTOR, DNA-PK (DNA-
dependent protein kinase), GSK-3, CKII and Pim-1 (proto-oncogene serine/threonine-
protein kinase) (Bain et al., 2007, Gharbi et al., 2007).  
Wortmannin is a commonly used PI3K inhibitor, it has a steroid metabolite 
structure derived from the fungi Penicillium funiculosum and Talaromyces wortmanni 
(Brian et al., 1957). The mode of action of wortmannin is that it inhibits members of PI3K 
family through irreversible inhibition at nanoMolar (nM) concentrations reported in the 
mammalian cells study. To interact with the substrate, wortmannin forms a covalent link to 
a lysine residue in the ATP-binding pocket of PI3K (Lys802 in p110α and Lys833 in 
PI3Kγ). However, at higher concentrations, wortmannin has been shown to target other 
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kinases in mammalian cells such as PI4Kα/β, mTOR and DNA-PK (Stein and Waterfield, 
2000).  
PI-103 is a novel synthetic small molecule of the pyridofuropyrimidine class, which 
has been reported to be both a potent and selective inhibitor of class I PI3K (Raynaud et al., 
2007, Westhoff et al., 2009). PI-103 is an ATP-competitive PI3K inhibitor that can also 
inhibit several other protein kinases such as DNA-PK, mTORC1 and mTORC2, with an 
IC50 value of 2nM, 20 nM and 83 nM, respectively (Raynaud et al., 2007). PI-103 inhibits 
mTOR through its morpholine ring, which binds to the adenine pocket, forming two 
hydrogen bonds; the phenol group binds to the inner pocket to form another two hydrogen 
bonds. These hydrogen bonds are likely to be important for the affinity of PI-103 for 
mTOR (Yang et al., 2013). In vitro studies have shown that PI-103 inhibits human cancer 
cell growth and has been observed in vivo to have anti-tumour activity in several human 
tumour xenograft models (Raynaud et al., 2007). Recent studies have reported that PI-103 
binds with class I PI3K of the human PI3Kα by forming a new hydrogen bond with Lysine 
residue 802 (Lys802), which is adjacent to the ATP catalytic site, in order to increase 
binding affinity (Zhao et al., 2013). 
The application of LY294002 and wortmannin inhibitors in mammalian cells has 
contributed toward our understanding of the PI3K signalling pathways. Many researchers 
have linked LY294002 and wortmannin to cell growth inhibition, apoptosis and cellular 
proliferation. Since these inhibitors of PI3K were discovered, steps have been taken by 
scientists to understand the complex cellular signalling pathways that involve the 
phosphoinositide family and PI3K activity. Early research showed that wortmannin, a 
known inhibitor of respiratory-burst activity, acts on PI3Ks by inhibiting PIP3 production at 
concentrations between 10 and 100 nM (Arcaro and Wymann, 1993). LY294002 was 
synthesised using the bioflavinoid quercetin as a model compound (Vlahos et al., 1994). 
Quercetin has been demonstrated to inhibit kinases, including PI3K, other tyrosine and 
serine/threonine kinases (Matter et al., 1992). Moreover, LY294002 was found to be a 
selective inhibitor of PI3K with an approximately three-fold greater potency than quercetin 
(Vlahos et al., 1994). Vps 34 (vacuolar protein sorting 34) was first described to be the sole 
PI3K in yeast. Vps 34 belongs in class III of the PI3K family, and is the only PI3K that is 
expressed in all eukaryotic cells. Previous works have indicated that Vps 34 in yeast is 
relatively resistant to wortmannin with protein structural studies highlighting key 
differences in residues between human class I PI3K and Vps 34. This may explain the 
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reason for inhibitor resistance (Backer et al., 2008). The pyridofuropyrimidine PI-103, a 
novel inhibitor of PI3K, was pharmacologically characterised in 2007 (Hayakawa et al., 
2007). This inhibitor of PI3K has been reported not only to be a highly potent inhibitor 
(IC50 values of 3 nmol/L) but also a selective inhibitor of class I PI3K (Bain et al., 2007, 
Raynaud et al., 2007). 
There are different methods that may be carried out to study the inhibition effect of 
PI3K in vivo and in vitro. Experimental designs to detect the activity of PI3K usually start 
with purified protein (Bain et al., 2007). During in vivo testing, cells are labelled directly 
with radioactive 32[P]; they are then harvested and the lipid is extracted for radioactive 
activity after treatment with inhibitors. Comparison between the control cells (cells with 
32[P] but without PI3K treatment) and sample cells (with PI3K inhibitors) were completed 
using thin layer chromatography (TLC) to measure the level of phosphate in PIP3 products 
of PI3K (Zhou et al., 1998). 
Downstream of PI3K signalling, protein kinase B acts as the direct effector of PI3K 
signalling and plays an important role in cell survival, cell proliferation and cell 
differentiation. Activated PKB will phosphorylate downstream protein effectors which will 
stimulate cell survival signals, thus preventing the cells from undergoing cell death 
(Frankeret al., 1995). An experiment using anti-phosphorylated PKB was able to reveal the 
effect of wortmannin and LY294002 on the inhibition of PI3K, as the results show that 
PI3K inhibition effectively blocks the phosphorylation of PKB (Cheatham et al., 1994). 
Inhibitors of PI3K, such as LY294002, wortmannin and PI-103, have contributed 
towards our understanding of the PI3K pathway. Extensive works in this field have been 
reported in many different types of cells, most of which are from mammalian cells. In 
addition, work in G. intestinalis by Hernandez et al. (2007) reported inhibition of the PI3K 
signalling pathway by both LY294002 and wortmannin. This contradicts previous findings 
from this laboratory suggesting that wortmannin did not affect trophozoite growth while 
LY294002 did (Cox et al., unpublished data). With this in mind, the effects of PI3K 
inhibition were further investigated in this work. The inhibition of GSK, a downstream 
effector of PI3K signalling, was also studied. 
 
 
 
88 
 
4.2 Experimental Results 
Experiments in this Chapter were demonstrated by utilising two different methods. 
One approach uses the method of counting the number of cells in each of the subcultured 
samples. Trophozoites in the sample tube were directly counted visually using a 
haemocytometer under a light microscope and calculated to give cells per ml (see section 
2.2.3). An average number of cells in three counts was collected, standard deviation of the 
data was calculated and graphs were plotted showing the number of trophozoites per 
millilitre against either concentration of an inhibitor or time (hours). The second approach 
demonstrates the use of methylene blue staining of trophozoite cells. The rationale for using 
this technique is that the methylene blue assay allows a higher throughput of samples under 
different treatments. Moreover, this quantitative method provides an efficient and effective 
means of calculating the total number of cells. The absorbance reading was measured on 
each sample, which correlates to the number of cells in the individual population. The 
methylene blue staining cannot penetrate viable cells; therefore, cells were initially fixed, 
and stained with methylene blue, consequently allowing the membrane of the cell to turn 
deep blue. After the cells were stained, hydrochloric acid was use to de-stain the cells and 
absorbance was taken in order to quantify how many cells were in each sample. Both of the 
approaches described above were carried out to monitor the effect of the inhibitor under 
two different conditions. 
 
4.2.1 Effect of PI3K inhibitor LY294002 on G. intestinalis 
Here, inhibitors of PI3K are tested to determine the roles of PI3K activity on 
trophozoite proliferation. Prior to the inhibition experiments, trophozoite growth curves 
were determined to establish the normal course of vegetative growth. A number of G. 
intestinalis trophozoite log growth curves were found to be reproducible, showing a period 
of exponential growth following subculture. After the exponential growth, trophozoites 
enter the stationary phase, displaying constant numbers of cells (Figure 4.1). The 
concentrations of LY294002 used were reported at 10 - 50 µM to inhibit class I PI3Ks in 
cell-based assays (Bain et al. 2007). Therefore, in this experimental work, trophozoites 
were treated with LY294002 to a final concentration of 10, 25, 30, 50 and 75 µM. 
LY294002 was added to exponentially-growing trophozoites to observe any inhibition of 
growth. If trophozoites were treated with LY294002 at a late exponential or even stationary 
89 
 
phase, the observation of a decrease in cell number could be due to the shortage of nutrients 
and over-populated cultures (Figure 4.1). 
In Figure 4.2, the exponential growing trophozoite cells were treated with the PI3K 
inhibitor LY294002 for 48 hours. The rate of trophozoite cell proliferation at the end of 48 
hours was measured by the average optical density reading at 655 nm following treatment 
using methylene blue staining (Hounkong et al., 2011). The effect of LY294002 on 
trophozoites was dose-dependent because cell proliferation decreased significantly with the 
increasing concentration of LY294002. At concentrations of 25-30 µM, we were able to 
observe approximately 50% inhibition of growth in trophozoite cell cultures. Toward 
higher concentrations of 50 and 75 µM of LY294002, a decrease in trophozoite 
proliferation of approximately 75% was observed compared to control cells exposed to 
equal volume of DMSO. The control background absorbance in each experiment was 
observed by measuring the well containing culture medium with no cells. Any background 
absorbance was subtracted from both the drug-treated values and the control values. 
 
 
Figure 4.1: Giardia intestinalis growth curve over a 168-hour period. 
Exponential growth 
Stationary phase 
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Giardia intestinalis trophozoites were subculture into fresh culture medium and counted over 168 
hours. Exponential growth and stationary phases are indicated and the error bars on each time point 
show the standard deviation of the mean of 3 counts per time point. The solid and dotted lines 
indicate two individual growth curves by trophozoites; at time zero, solid line starting inoculum: 8.2 
x 103 cells/ml and dotted line starting inoculum: 4 x 103 cells/ml.  
 
 
Figure 4.2: Inhibition of trophozoites proliferation by PI3K inhibitor LY294002. 
Trophozoites with starting inoculums of 1 x 105 cells/ml were treated with PI3K inhibitor 
LY294002 to a final concentrations of 0 (DMSO-solvent control), 10 µM, 25 µM, 30 µM, 50 µM 
and 75 µM. Following 48 hours of incubation, trophozoites were harvested, pipetted into a 
microplate, fixed, stained with methylene blue, and quantified by measuring absorbance at 655 nm. 
The data show the average number of cells of three samples measured by absorbance at 655 nm and 
the error bars represent the standard deviation of the data. 
 
These data suggest that cell growth was reduced due to the effect of LY294002 on 
PI3Ks intracellular signalling in Giardia trophozoites. Another important PI3K inhibitor, 
wortmannin, was tested to verify this hypothesis. The concentrations of wortmannin 
experimental work reported by Bain et al. (2007) found that wortmannin inhibits class I and 
II PI3Ks activities at 50-100 nM. Wortmannin can enter Giardia trophozoites through the 
parasite biological membrane. Research by Cox et al. (unpublished) tested the inhibitory 
action of wortmannin against human embryonic kidney-293 cells which resulted in 
decreased levels of phosphorylated PKB compared to the untreated control. This result 
91 
 
revealed that wortmannin solution was capable of effectively inhibiting the HEK-293 
PI3Ks to reduce PKB activation by phosphorylation. Hernandez et al. (2007) reported 
wortmannin to inhibit trophozoite cell growth with IC50 ~11 µM. Therefore, the 
concentration gradients in the chosen experiment were 0.1, 0.5, 1, 5, 10 and 15 µM. The 
rationale behind these concentration ranges with the highest concentration being 15 µM 
was because there was no effect of growth inhibition observed at 1 µM; therefore, the 
concentration of 15 µM wortmannin was set to determine whether this excessive 
concentration showed any effect on PI3K inhibition. The results of the wortmannin 
experiment are shown in Figure 4.3; here, the number of trophozoites is represented 
through average optical density at 655 nm against different concentrations of wortmannin 
and the DMSO control. Compared with the control, no significant different in cell number 
was observed across the chosen concentrations. The results were found to be reproducible 
for a further two separate experiments. It may be useful to compare the giardial PI3Ks with 
wortmannin-insensitive PI3Ks; an example of this is in yeast. Yeast Vps 34 is ~1000x less 
susceptible to wortmannin inhibition than its human homologue (Stack and Emr, 1994), 
possibly because of differences in key ATP/wortmannin-binding regions of the respective 
class III isoforms (Walker et al., 2000). Human Vps 34 compared with yeast Vps 34 differs 
at Ile-831 and Gly-868 in the S. scrofa PI3K sequences (Cox and Tovar, unpublished). 
Studies of giardial PI3Ks reveal that its residues also differ at the same position described 
for yeast Vps 34. Therefore, the differences in residue might explain the apparent 
insensitivity of Giardia to wortmannin. Another possible explanation for the lack of a 
significant difference in the number of cells observed in the result may be due to the 
inhibitor wortmannin. Previous findings suggest that wortmannin is unstable in cell culture 
medium (Woscholski et al., 1994). The results of these two experiments have raised 
questions: 1. was the inhibition of trophozoite proliferation by LY294002 the result of 
blocking PI3K activity? 2. Could LY294002 affect other intracellular signalling kinases, 
thus resulting in the inhibition of trophozoite cell growth?  
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Figure 4.3: Effect of wortmannin on trophozoite proliferation. 
Trophozoites at exponential growth were treated with wortmannin at various concentrations: 0 
(DMSO-solvent control), 0.1 µM, 0.5 µM, 1 µM, 5 µM, 10 µM and 15 µM. The average bar charts 
from three samples were measured by absorbance readings at 655 nm after 48 hours of treatment. 
The error bars represent the standard deviation of the data. 
 
To find out a possible answer to the first question, a novel PI3Ks inhibitor PI-103 
was introduced. PI-103 is a potent inhibitor of class I PI3Ks reported by Raynaud et al. 
(2007). PI-103 was selected for this experiment because it can inhibit the PI3K pathway 
and the proliferation of cancer cells in vitro. The concentrations chosen for the inhibitor 
were based on previous studies by Bain et al. (2007).  Figure 4.4 shows the absorbance 
reading at 655 nm over a period of 48-hours for the average trophozoite cell proliferation 
after treatment with different concentrations of PI-103. The optimal concentration of PI-103 
required for PI3K inhibition in mammalian AML cells is 1 µM (Park et al., 2008). When 1 
µM PI-103 was applied to Giardia trophozoites, however, no significant difference in cell 
number was observed. At a higher concentration of 2 - 5 µM PI-103, the cell number 
decreases by about 20-25% compared to the control DMSO cells. However, between the 
three concentrations of 2, 3 and 5 µM, there was no significant difference in the cell 
number observed. The range of PI-103 concentrations employed only increased up to 5 µM 
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because higher PI-103 concentrations that may have an effect on trophozoite proliferation 
will not be due to the inhibition of PI3K.    
 
Figure 4.4: Effect of PI-103 treatment on trophozoites proliferation. 
Trophozoites with starting inoculums of 1 x 105 cells/ml were treated with PI3K inhibitor PI-103 
with various concentrations: 0 (DMSO-solvent control), 0.2 µM, 0.5 µM, 1 µM, 2 µM, 3 µM and 5 
µM. Following 48 hours of incubation, trophozoites were harvested, pipetted onto a microplate, 
fixed, stained, and quantified using a spectrophotometer at 655 nm. The data show the average 
number of cells of three samples measured by absorbance at 655 nm and the error bars represent the 
standard deviation of the data. 
 
 
4.2.2 Effect of known PI3Ks inhibitors LY294002, wortmannin and PI-103 on 
trophozoite proliferation over time 
The predicted outcome of LY294002 inhibition on Giardia trophozoites would be 
the decrease in the overall population of Giardia to a certain number of cells per ml through 
inhibition of the PI3K pathway. When Giardia culture is treated with LY294002 at a 
concentration of 50 µM, the trophozoite number remains constant for 48 hours under the 
cell counting approach. The result in Figure 4.5 illustrates that the growth of trophozoites 
was inhibited in a concentration-dependent manner, because at 25 µM LY294002, the rate 
of trophozoites proliferation decreased by approximately 50%. This suggests that there was 
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an effect of LY294002 on the proliferation of the exponentially growing trophozoites over 
a period of 48 hours. Therefore, based on these results, one can hypothesise that LY294002 
may have an effect on the trophozoite replication pathway, as PI3K plays a major role in 
the cell proliferation and cell growth. If PI3K is inhibited in the signalling pathway, we 
predicted that this will cause cell cycle arrest, as trophozoite numbers remain constant, 
rather than cell death. 
 
 
Figure 4.5: Effect of LY294002 inhibition on trophozoites population over a 48-hour period. 
The exposure of LY294002 at different concentrations: 25 μM (blue line) and 50 μM (red line) on 
exponentially growing trophozoites. This was monitored by cell counting every 8 hours over a 48 
hour period. The error bars indicate the standard deviation of 3 counts. Standard deviation shows 
how much variation or, “dispersion” exists from the average. A paired Student’s t-Test calculated to 
0.007 showed a significant difference between control DMSO and 50 μM LY294002, where p < 
0.05 for normalised data.  
 
To test this possibility, we investigated whether the effect of LY294002 treatment 
could be reversed upon the removal of LY294002 from the culture medium. After 48 hours 
of treatment with LY294002 (25 µM and 50 µM), trophozoite cells in each sample were 
used to seed new cultures in fresh culture medium without an inhibitor. The growth of 
subcultured cells was monitored for 96 hours. Figure 4.6 shows subcultured trophozoite 
cells prior to treatment with LY294002 (25 µM and 50 µM) and DMSO (untreated). 
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Trophozoite cells show that upon removal of LY294002 inhibitor, they are capable of 
proliferating to increase the population equal to that of the untreated control cells. 
Trophozoites in this experiment (Figure 4.6) were no longer resting in culture medium 
containing different concentration of LY294002 inhibitor; therefore, cell proliferation 
continued to increase and reached a similar cell density as the control DMSO (untreated 
sample) upon the removal of PI3K inhibition. 
 
 
Figure 4.6: The effect of LY294002 inhibitor can be reversed by subculturing in inhibitor-free 
medium. 
Exponentially growing trophozoites treated for 48 hours with DMSO (control) and LY294002 at 
two concentrations 25 μM and 50 μM were counted and equal numbers (0.1 x 106 cells/ml) were 
inoculated to seed new cultures. This graph shows the average cell count of 3 samples that are the 
result of treated samples over a 96 hour period. The bars represent the standard deviation of three 
counts. Statistical analysis using the paired Student’s t-Test calculated show no significant 
difference between the tested samples. 
 
The specificity of the inhibitor LY294002 has been argued to inhibit the activity of 
other protein kinases. The reported study on protein inhibitors by Davies et al. (2000) 
demonstrated in vitro, using purified proteins in a cell-based assay, that the inhibitor 
LY294002 also inhibits other protein kinases such as CKII at concentrations similar to 
those that inhibit PI3Ks. The IC50 for CKII is 6.9 μM and IC50 for PI3K is 10 μM (Davies et 
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al., 2000). CKII is present in the G. intestinalis genomic database (McArthur et al., 2000) 
under the accession numbers XP_766966 (for alpha subunit) and EAA39338 (for the beta 
subunit). CKII is a serine/threonine selective protein kinase that phosphorylates a range of 
enzymes and transcriptional factors implicated in cell cycle control, DNA repair, regulation 
of the circadian rhythm and other cellular processes (Litchfield, 2003). The disruption of 
genes encoding for CKII catalytic subunits could lead to cell cycle arrest and even 
apoptosis. For example, CKII has been shown in D. discoideum and S. cerevisiae to be 
essential for cell growth and viability, respectively (Kikkawa et al., 1992, Glover, 1998). 
Therefore, it is reasonable to hypothesise that because the LY294002 inhibitor has an effect 
on CKII in Giardia, the cell cycle arrest of trophozoites when treated with LY294002 
inhibitor could be due to the inhibition of Giardia CKII and not PI3K. To test this 
possibility, a specific CKII inhibitor DRB (5,6-Dichloro-1-β-D-
ribofuranosylbenzimidazole) (Zandomeni et al., 1986) was examined on trophozoites to 
compare the growth of LY294002-treated cells against DRB-treated cells.  
In this experiment, LY294002 inhibitor concentrations were kept the same at 25 µM 
and 50 µM. DRB was prepared at a final concentration of 100 µM, which is the standard 
concentration of DRB used in mammalian studies (Dirac-Svejstrup et al., 2000; Yang and 
Sale, 2000). It is important to take into account that the LY294002 inhibitor IC50 value for 
CKII is 6.9 µM whilst that for DRB is 6 µM. Therefore, if a putative CKII was being 
targeted by LY294002, using DRB at 100 µM should be sufficient to inhibit this enzyme 
(Cox et al., 2006). Exponentially growing trophozoite samples were counted over 48 hours 
to determine the effect of DRB and LY294002 inhibitors with a control being DMSO. 
Figure 4.7 demonstrates that DRB-treated cells continue to grow exponentially compared to 
LY294002-treated cells for the duration of 48 hours. However, at the 48 hour cell count, the 
population of LY294002-treated cells at 50 µM was less than 50% of the population of the 
control DMSO cells. These data demonstrate that LY294002 does not have an inhibitory 
effect on Giardia CKII, because trophozoites exposed to DRB do not show positive growth 
inhibition. Furthermore, LY294002 also inhibits a number of other kinases such as GSK-3β 
and Polo-like kinase 1 (Gene id: GL50803_104150), which are present in G. intestinalis. 
The experimental works have been designed and carried out later in this chapter to 
determine whether LY294002 has an effect on Giardia GSK. 
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Figure 4.7: The effect of LY294002 and DRB exposure over a 48-hour period. 
To test LY294002 specificity, the experiment was repeated with the same concentration of 
LY294002 in treated cells (25 μM and 50 μM) and DMSO in untreated cells from experiments in 
Figure 4.5. The addition of DRB at a final concentration of 100 μM aimed to establish whether 
LY294002 was able to inhibit CKII in trophozoites. Trophozoites were monitored by cell counting 
over a 48-hour period. The average number of cells in three counts was plotted and the error bar 
plots show the standard deviation of the data.  
  
The effect of PI-103 was also tested to determine whether its reported specific 
inhibitions of PI3K activity will have a positive effect on trophozoite growth inhibition. PI-
103 is a novel potent PI3K, PKB and mTOR inhibitor (Raynaud et al., 2007, McNamara 
and Degterev, 2011). Recent work on PI-103 in cell-based assays illustrates that PI-103 
blocks Class I PI3Ks completely at only 0.5 μM (Bain, et al. 2007). However, Bains et al. 
(2003) reported that at 1 μM PI-103 inhibits very few of the 70 purified protein kinases 
tested and no more than 30-40% even when assayed in vitro at 1 μM (Bains, et al. 2003). 
Therefore, two experiments were designed and completed to expose Giardia trophozoites 
to PI-103 at a final concentration of 0.5, 1 and 2 μM, in triplicate. In Figure 4.8, trophozoite 
samples were treated with various concentrations of PI-103 (0.5, 1 and 2 μM). The results 
show trophozoite proliferation at a rate similar to that in the untreated sample over the 
period of forty-eight hours for all treatments. The results in Figure 4.8 can be interpreted to 
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show that the PI-103 inhibitor does not inhibit Giardia trophozoite proliferation at any 
concentration; Student’s t-Test showed no significant difference in the data between the 
DMSO control and PI-103-treated samples (P > 0.05). One could argue that because PI-103 
was tested on a purified protein sample by Bains et al. (2007), and once it is added into 
Giardia culture medium, the capability for the inhibitor may have failed to enhance any 
effect on growth inhibition of trophozoite cells. PI-103 functions as a competitive inhibitor 
of ATP binding, although it is unknown which amino acid residues are important for PI-
103 binding and inhibition in giardial PI3Ks. Therefore, one could not rule out the 
possibility that LY294002 inhibits giardial PI3Ks. In light of this result, it was important to 
explore other kinases that LY294002 was reported to inhibit, therefore resulting in 
inhibition of the cell cycle.  
 
Figure 4.8: Exposure of trophozoites to different concentrations of PI-103. 
Trophozoites were counted every 8 hours over a 48 hour period with an initial inoculum of 1 x 105 
cells/ml at time zero. The error bars represent the standard deviation of the data. Using a paired 
student’s t-test, there was no significant difference (p > 0.05). The experiment was conducted in 
triplicate on at least two different occasions. 
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4.2.3 Effect of puromycin on Giardia trophozoites 
 To establish whether the inhibition of PI3K activity in LY94002-treated 
trophozoites was due to cell death or inhibition of cell proliferation, puromycin was 
introduced into this experimental study as a positive control of cell death. Puromycin is an 
aminonucleoside antibiotic, which originates from Streptomyces alboniger. Puromycin is 
known to be continuously used as a selective marker in G. intestinalis transfection 
experiments (Yu et al., 2002) and inhibits protein synthesis by binding to RNA, therefore 
causing premature chain termination during the translation process that takes place in the 
ribosome. Exponentially growing trophozoites were subcultured and treated with 
puromycin to a final concentration of 100 µM at time zero. The samples were collected at 
48, 96 and 144 hours for quantitative analysis. The evidence clearly showed that 
puromycin-treated trophozoite cells under the light microscope appear to be stationary 
compared to control cells. Furthermore, in Figure 4.9, the number of puromycin-treated 
trophozoites remained constant from the addition of puromycin (time zero) to 144 hours. 
Quantitative studies showed a significant increase in the number of trophozoites in the 
control (untreated) sample measured by the average optical density at 655 nm where cells 
would reach the absorbance of 4 at 48 hours, which is equivalent to approximately 6 x 106 
cells. Moreover with the quantitative analysis technique, Figure 4.10 illustrates cells treated 
with puromycin and LY294002 to the final concentration of 100 µM and 50 µM, 
respectively. The untreated control trophozoite proliferation over 48 hours was significantly 
different over three average optimal density readings (where p ≤ 0.005). After 24 hours, the 
quantitative analysis detected less than 50% of the cells treated with LY294002 compared 
to untreated control. On the other hand, puromycin-treated cells were unable to proliferate 
(see Figure 4.10), resulting in the same number of cells following treatment at time zero to 
48 hours. 
Furthermore, to determine whether puromycin-treated cells were still functional and 
to show that the inhibition was temporary, as evidenced by the LY294002-treated cells, 
puromycin-treated trophozoites had the medium containing puromycin removed and 
replaced with fresh culture medium. After 48 hours of incubation, Figure 4.11 shows the 
remaining number of trophozoites that were pre-treated with puromycin through 
quantitative analysis with the control cultures. The result suggests that pre-treated 
puromycin cells were non-responsive after changing the medium. Indeed, this also meant 
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that cells were not moving. However, the inability of puromycin-treated cells to recover 
upon the removal of puromycin strongly suggests that this is the characteristic of cell death.    
 
 
Figure 4.9: The effect of puromycin on Giardia trophozoite proliferation over 144 hours. 
Spectrophotometric quantification of Giardia trophozoites after the addition of 100 µM of 
puromycin was applied to exponentially growing trophozoites over 144 hours. The average optical 
density at 655 nm for the triplicate sample was plotted and the error bars represent the standard 
deviation of the data. 
 
 
Figure 4.10: The effect of puromycin and LY294002 inhibition over 48 hours. 
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Inhibitory effect of puromycin (100 µM) and LY294002 (50 µM) on Giardia trophozoites was 
monitored by using a spectrophotometric quantification method over a period of 48 hours compared 
to the control (distilled water). The triplicate samples were measured by absorbance readings at 655 
nm and data were plotted. The error bars represent the standard deviation of the data. 
 
 
 
Figure 4.11: Pre-treated with puromycin trophozoite cell proliferation observed after 
subculturing. 
Exponentially growing trophozoites treated for 48 hours with puromycin (100 µM) and control 
(distilled water); these were washed and 0.1 x 106 cells of the control cells were used to seed new 
cultures, while puromycin-treated cell cultures were replaced with fresh medium. The graph shows 
the average triplicate absorbance reading at 655 nm over a 48-hour period. The error bars represent 
the standard deviation of the data. 
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4.2.4 Inhibition of Glycogen synthase kinase-3 
Glycogen synthase kinase is a well-known downstream effector of PI3K signalling. 
To determine whether Giardia GSK-3 homologues are involved in the regulation of cell 
proliferation and cell cycle arrest in G. intestinalis, two different types of GSK-3 inhibitors 
reported to inhibit GSK-3 activity were examined: i) CT99021, a highly potent and specific 
inhibitor of GSK-3, and ii) LiCl, which inhibits GSK-3β activity more strongly than other 
protein kinases tested (Bain et al., 2007). 
 Figure 4.12 (A) shows that CT99021 at final concentrations of 0.5 μM, 1 μM, 2 
μM, 5 μM and 10 μM had no significant effect on exponentially growing trophozoites. The 
average optical density measured in the control compared to the average optical density of 
the samples treated with CT99021 indicated no significant change in cell density. Under 
normal conditions in mammalian cells, GSK-3 are inactivated (Doble et al., 2003); thus cell 
growth continues as normal, and we can hypothesise that trophozoites treated with 
CT99021 will not be inhibited with regard to cell proliferation because the inhibition of 
GSK-3 by PKB inactivates GSK-3 by inducing phosphorylation (Doble et al., 2003). 
Therefore, to confirm that CT99021 shows no positive effect in reducing trophozoite 
proliferation, in Figure 4.12 (B), CT99021 was applied to trophozoites during the 
exponential phase (trophozoite subculture after 48 hours, see Figure 4.1) to final 
concentrations of 0.5 μM, 1 μM and 2 μM with control DMSO. Figure 4.12 (B) 
demonstrates that for the duration of the time course, cell numbers that were counted over a 
48 hour period show that CT99021 treated cells continue to grow exponentially and, in 
comparison to the control DMSO treated cells, no significant difference in trophozoite cell 
number was observed. This suggests that CT99021 does not have a positive effect on 
trophozoites growth and supports the hypothesis that GSK-3 may be normally inhibited by 
PKB phosphorylation, thus maintaining substrate dephosphorylation, allowing the 
continuation of trophozoite proliferation. In mammalian cells, active GSK-3 would activate 
phosphorylated cyclin D and deactivate eukaryotic protein synthesis initiation factor -2B 
(elF2B), which would lead to cell cycle arrest (Diehl et al., 1998, Quintayo et al., 2012). 
Another experiment was carried out using an inhibitor of GSK-3, lithium chloride 
(LiCl), to monitor trophozoite growth. The lithium cation (Li+) has been shown to inhibit 
GSK-3β with an IC50 concentration of 2 mM. Moreover, in mammalian cells, Li+ has also 
been implicated to inhibit other kinases such as: polyphosphate 1-phosphatase, inositol 
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monophosphatased, casein kinase-II (CKII), MAP kinase-activated protein kinase-2 and 
p38-regulated/activated kinase (Bhat et al., 2008). 
Trophozoite cell numbers of LiCl-treated cultures over a 48-hour period were 
measured using a spectrophotometer with an optical density of 655 nm to test the effect of 
LiCl, which is represented in Figure 4.13. Figure 4.13 illustrates that trophozoites treated 
with LiCl at final concentrations of 1 mM, 2 mM, 5 mM and 10 mM for 48 hours show no 
significant changes when compared to the control DMSO culture. However, trophozoites 
treated with LiCl at 20 mM show growth inhibition when compared to control DMSO. This 
suggests that LiCl treatment at a final concentration of 20 mM may have an effect on 
trophozoite proliferation. However, using statistical calculations, the results show no 
significant differences between trophozoites treated with LiCl at 20 mM against the control 
DMSO and other concentrations employed. Bain et al. (2007) reported using a 10 mM 
concentration of LiCl to inhibit the activity of purified GSK-3β in vitro and describes that, 
after treatment, only 30% activity remained compared with the control. Figure 4.13 
describes trophozoites treated with different concentrations of LiCl (5 mM, 10 mM and 20 
mM) and control DMSO. The numbers of cells from different cultures were counted over a 
48-hour period to determine the effect of LiCl on trophozoite cultures when different 
concentrations of LiCl were used. At 8 to 32 hours, the population of LiCl- and the control-
treated cells are not significantly different from one another when calculated using a paired 
Student’s t-Test. However, at 40 hours and 48 hours, LiCl-treated trophozoites at 20 mM 
demonstrated the same number of trophozoites when compared to a previous time point at 
32 hours. LiCl is reported to inhibit GSK-3β activity more strongly than any of the protein 
kinases tested in vitro by Bain et al. (2007); at higher concentrations of 20 mM, it may also 
inhibit other protein kinases in trophozoites (as mentioned above). This is because the 
inhibition of GSK-3 leads to inactive/phosphorylated GSK-3; therefore, downstream 
signalling would permit the cell cycle to continue.      
The concentration ranges of CT99021 and LiCl suggested in the literature were used 
in the experimental work on purified proteins (Jope, 2003, Bain et al., 2007). Therefore, it 
is important when working with Giardia as the model organism to determine the 
concentrations of these two inhibitors of GSK. 
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Figure 4.12: Effect of CT99021 over a 48-hour period. 
CT99021, inhibitor of GSK3 was applied to trophozoites (at exponential growth). A, Trophozoites 
with starting inoculums of 1 x 105 cells/ml were treated with various concentrations: 0 (DMSO-
solvent control), 0.5 µM, 1 µM, 2 µM, 5 µM and 10 µM. The trophozoites were quantified using 
spectrophotometer at 655 nm, where the bars show the average number of cells of three samples. B, 
CT99021-treated trophozoites at concentrations of 0.5 μM, 1 μM and 2 μM were observed by cell 
counting over a 48-hour time period. The samples exposed to each concentration of CT99021 are 
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the average number of cells in triplicate samples. The error bars represent the standard deviation of 
the data. Using a paired Student’s t-Test, no significance was detected between each concentration.  
 
Figure 4.13: Effect of Lithium chloride over 48-hour period. 
Lithium chloride, a common inhibitor of GSK-3β, was applied to exponentially growing 
trophozoites. Trophozoites with starting inoculums of 1 x 105 cells/ml were treated with LiCl at 
various concentrations: 0 (DMSO-solvent control), 1 mM, 2 mM, 5 mM, 10 mM and 20 mM. 
Following 48 hours of incubation, trophozoites were harvested, pipetted onto a microplate, fixed, 
stained, and quantified using a spectrophotometer at 655 nm. The data show the average number of 
cells of three samples measured by absorbance at 655 nm. The error bars represent the standard 
deviation of the data. 
 
A summary of all of the inhibition studies performed so far is shown in Figure 4.14. 
Here, trophozoites were treated with a range of inhibitors at time zero: LY294002 to a final 
concentration of 25 and 50 µM; PI-103 to a final concentration of 0.5, 1 and 2 µM; 
CT99021 to a final concentration of 0.5, 1 and 2 µM; LiCl to a final concentration of 5, 10 
and 20 mM; and DRB to a final concentration of 100 µM. These concentrations have been 
reported to be within the range as being effective for most mammalian cell types (Cohen, 
2003). Positive controls of the experiment were wild type cells and DMSO-treated 
trophozoites. Alternatively, the negative control in this experiment was three wells in a 96-
well tissue culture plate with no wild type trophozoite.  
Figure 4.14 illustrates trophozoites that were treated and untreated with inhibitors at 
two different time intervals (16 and 40 hours) following subculture and treatment with 
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inhibitors. The number of trophozoites was quantified through the quantitative method; at 
16 hours the DMSO-treated control and wild type trophozoite cells had average optical 
density (at 655 nm) readings of 1.25 and 1.1, respectively. When the controls were 
compared to trophozoite-treated samples at 16 hours, the data showed no significant 
difference. However, LY294002-treated trophozoites (50 µM) at 40 hours highlighted the 
effect on Giardia proliferation, as it reported that approximately 50% of the population was 
reduced compared to the DMSO-treated and wild type control. Moreover, it is worth noting 
that trophozoites treated with 25 µM LY294002 also showed positive inhibition of cell 
proliferation and the cell number was reduced by approximately 40% compared to the 
controls. LiCl-treated trophozoites at 20 mM also showed an approximately 25% decrease 
in the number of cells when compared to controls. It is unclear as to why this occurs, 
because there were no changes in cell number observed across LiCl-treated sample after 16 
hours. Only when Giardia trophozoites were incubated with LiCl (20 mM) for over 40 
hours was a decrease in the number of cells observed compared to the controls.  
It is unlikely that a reduction in the number of trophozoite demonstrated in the LiCl-
treated sample was due to the inhibition of GSK-3 or the inhibition of PI3K, as PI3K-
inhibited trophozoite cell cultures would demonstrate a decrease in cellular proliferation at 
a concentration dose-dependent manner. It is important to distinguish in an experiment 
whether the inhibition of PI3K activity by LY294002 hampered growth due to cell death or 
a block in the cell cycle. This experimental study will be re-visited later on in this Chapter.   
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4.2.5 Effect of co-exposure to PI3K and GSK-3 inhibitor on Giardia trophozoites 
Experiments were carried out with two inhibitors to investigate the downstream 
signalling pathway of PI3K and GSK-3. The mammalian intracellular signalling pathways 
involving PI3K and GSK-3 show that when GSK-3 is phosphorylated it is inactive under 
normal growth conditions allowing the cell cycle to progress. The effect of blocking PI3K 
from phosphorylating phosphatidylinositol will result in no phosphorylated PKB; thus, 
downstream GSK-3 will not be phosphorylated. GSK-3 will become active and therefore 
lead to blocking of the cell cycle. The inhibition experiment used purified protein in a cell-
based assay, which showed that LY294002 can partially inhibit GSK-3 activity directly 
(Bain et al., 2007). The rationale for these experiments is that although theoretically one 
does not expect the GSK-3 inhibitor to affect the cell cycle due to the inactive state of 
GSK-3 under normal growth, given what had been published, it was important to 
demonstrate this using an inhibitor of GSK-3 on trophozoite culture (Bain et al., 2007). 
One possibility is that the inhibition of trophozoite growth caused by LY294002 may not 
be the result of PI3K activity inhibition but rather of LY294002-mediated GSK-3 
inactivation. If this was the case, based on the GSK-3 inhibition studies reported above 
(section 4.2.4), the prediction would be that the cell cycle should continue unimpeded (as 
GSK-3 is normally kept inactivated by PKB-mediated phosphorylation during normal cell 
growth) and parasite culture growth would be observed.  
To investigate this hypothesis, two inhibitors, LY294002 and CT99021, were used 
for the double inhibitor experiments. The first experiment (Figure 4.15) demonstrated the 
double inhibitor experiment initially with constant CT99021 at a final concentration of 2 
µM and in addition, an increasing concentration of LY294002 at a final concentration of 10 
µM, 25 µM or 50 µM. Inhibitors were added at the same time, each treatment was 
completed in triplicate and trophozoites in the treated cultures were counted over a 48-hour 
period. The control culture samples contained a single inhibitor of CT99021 with a final 
concentration of 2 µM. The observation of trophozoites through cell counting showed that 
control culture CT99021-treated samples proliferate as seen in previous experiments (see 
Figure 4.12). On the other hand, cultures treated with CT99021 and LY294002 begin to 
affect cell numbers 16 hours into treatment. The experiment showed that increasing the 
concentration of LY294002 in a constant CT99021 concentration (2 µM) affected cell 
number in a concentration-dependent manner. This has been shown previously in 
LY294002-treated cells (see Figure 4.5). For the duration of the time course in LY294002-
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treated cultures at 50 µM with CT99021 (2 µM), cell numbers remained constant from time 
zero. This evidence strongly suggests that LY294002 is likely to inhibit PI3K and not GSK-
3. LY294002 might not affect GiGSKs, possibly because GSK-3 in Giardia does not 
contain specific residues required to bind to the inhibitor. Furthermore, the missing serine 
residues in the GiGSK N-terminus may affect the binding of an inhibitor complex, because 
in mammalian cells, Serine 21 on GSK-3α and Serine 9 on GSK-3β have been shown to be 
essential residues for the phosphorylation of GSK-3 (Zhang et al., 2010).  
The second double inhibitor experiment examined the hypothesis that if LY294002 
was inhibiting PI3K, we would not expect to see a reversal of the mutant growth phenotype 
upon addition of increasing concentrations of GSK inhibitor. Alternatively, if LY294002 
was inhibiting GSK, then further inhibition with CT might possibly exacerbate the growth 
phenotype. However, because there is no abnormal growth phenotype in CT99021-treated 
trophozoites (see Figure 4.12 and Figure 4.14), then no change in growth phenotype would 
be expected. Exponentially growing trophozoites were treated with two inhibitors, 
LY294002 and CT99021. Trophozoite cell cultures were set up with an increasing 
CT99021 at a final concentration of 0.2 µM, 1 µM and 3 µM, with the second inhibitor 
LY294002 added at 50 µM added to all of the samples. The controls for this experiment 
LY294002 and CT99021 were applied to trophozoites to a final concentration of 50 µM 
and 1 µM, respectively. The former represent a control for positive growth inhibition, 
whereas the latter was a control for positive trophozoite cell proliferation. Figure 4.16 
shows cell numbers of CT99021-treated control cultures grown exponentially from time 
zero to 48 hours. In contrast, the number of LY294002-treated trophozoite cell cultures 
appeared to be constant for the duration of the time-course. The effect of LY294002 on 
trophozoite number was observed 8 hours into the treatment. Furthermore, from 16 hours to 
the final count of trophozoites at 48 hours, there were no significant changes in cell number 
from all double inhibitor treated samples. These data strongly suggest that LY294002 
inhibits PI3K and that the inhibition of PI3K activity indirectly leads to the activation of 
GSK through a lack of PKB-mediated phosphorylation. This leads to cell cycle arrest.     
The results of two double inhibitor experiments were as expected. LY294002 
inhibits PI3K, which leads to a lack of downstream phosphorylation of PKB and GSK-3, 
leading to cell cycle arrest.  
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Figure 4.15: Effect of double inhibitor treatment on trophozoite proliferation. 
Inhibitor CT99021 and LY294002 was applied to exponentially growing trophozoite culture 
starting at 0.1 x 106 cells/ml, where the CT99021 concentration remained constant with increasing 
LY294002 concentrations (10 µM, 25 µM and 50 µM). Control samples were individually treated 
with CT99021 and DMSO to a final concentration of 2 µM and 100 µM, respectively. Trophozoites 
were counted over a period of 48 hours following the treatment. This graph shows the average 
number of cells from three counts and the error bars represent the standard deviation of the data. 
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Figure 4.16: Effect of double inhibitor treatment to monitor trophozoite proliferation. 
Exponentially growing trophozoites were treated in the presence of LY294002 at a concentration of 
50 µM together with increasing CT99201 concentrations (0.2 µM, 1 µM and 3 µM). Control 
samples were individually treated with LY294002, CT99021 and DMSO to a final concentration of 
50 µM, 1 µM and 100 µM, respectively. Trophozoites were harvested every 8 hours over a 48-hour 
period and counted. The line plotted shows the average number of cells from three counts and the 
error bars represent the standard deviation of the data. 
 
4.2.6 The importance of PI3K activity during encystation process  
The relevance of PI3K activity during G. intestinalis trophozoite vegetative growth 
is described above. Giardia encystation is an important mechanism that allows the parasite 
to differentiate from trophozoite cells into resistant cysts. During trophozoite replication 
within the host intestinal surface, the initiation of encystation occurs in the jejunum after 
exposure to biliary secretions (Adam, 2001). Giardia relies on the formation of 
environmentally-resistant cysts for transmission to a new host, thus ensuring the survival of 
the parasite. With this in mind, it is important to further investigate the impact of the PI3K 
inhibitor LY294002 on trophozoites under the process of encystation.  
Here, we determined whether the inhibitor LY294002 would affect the Giardia 
encystation process. The differences between the normal culture and encysting culture 
medium are in the concentration of bile. Normal trophozoite culture medium contains low-
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bile content, whereas the encysting medium contains high-bile content in the complex 
medium. Giardia trophozoites, in the presence of high-bile culture medium, will initiate the 
process of encystation (Gillin et al., 1987 and Lujan et al., 1997). The process of 
encystation was described in the introduction chapter as an adaptive process where an 
extracellular signal is perceived (for example changes in the concentration of bile), which 
activates the processes of parasite encystation. Within approximately 10 hours, the first 
phase of encystation begins in response to the change in environment. This includes the 
expression of encystation-specific genes (such as cyst wall proteins) and the complete 
synthesis of these cyst wall proteins together with packaging and intracellular 
transportation in encystation-specific vesicles (ESVs) to the target site. Subsequently, the 
second phase, referring to the cyst wall being assembled by exocytosis of ESVs, is 
complete after 16 hours, with zero hour being the time at which the encystation medium is 
added (Lujan et al., 1997, Adam, 2001).  
 Before the start of encystation experiments, it is vital to distinguish the differences 
between trophozoite, encysting cell and cyst cell morphology. Initially, cysts may be the 
obvious candidate to discriminate from trophozoites and encysting cells. Cysts are ovoid in 
shape and rounder than trophozoites and encysting cells. A cyst is approximately 8 – 10 
µM in diameter with the composition of cyst wall proteins that may appear like a fibrous 
coat on the outer layer. Once the formation of cysts is complete, the disappearance of 
trophozoite flagella has been suggested to be because they were disassembled during the 
encystation process (Roxstrom-Lindquist et al., 2006). In addition, a previous study 
illustrated images of flagella internalisation during encystation process, thus rendering them 
immotile (Midlej and Benchimol, 2009). Trophozoites are pear-shaped cells with four pairs 
of flagella; these are known as the anterior flagella, caudal flagella, posterior lateral flagella 
and ventral flagella. Each trophozoite cell contains two nuclei that can be found on the 
dorsal side at the anterior lobe. The length of a trophozoite cell is approximately 10 – 15 
µM; this is also approximately the same as an encysting cell. The morphology of encysting 
cells appears rounder than trophozoites, but with shorter posterior. Not every trophozoite 
undergoes the encystation process at the same time; therefore, encystation is divided into 
two phases: early and late. In the early phase, encysting cells contain two nuclei, similar to 
trophozoites. The flagella on encysting cells appear shorter in length and disappear 
completely at the completion of encystation. Adhesive discs become dysfunctional and can 
no longer be detected; thus, encysting cells are not able to attach to a surface (Adam, 2001). 
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The early phase of encysting cells may display ESVs carrying cyst wall material proteins; 
these are apparent on the body of encysting cells as granulated structures.             
It is important to investigate PI3K signalling activity for trophozoites at the 
beginning of encystation, because trophozoites will need to respond quickly to changes in 
the surrounding environment by modifying the extracellular morphological structures. PI3K 
signalling might play an important role during the whole period of Giardia encystation 
process because PI3K activity was demonstrated to be crucial for the proliferation of 
vegetative trophozoites. Therefore, one can expect that PI3K activity may be essential in 
the differentiation of trophozoite cells. The inoculated exponentially growing trophozoites 
are transferred to fresh encystation medium supplemented with LY294002 to a final 
concentration of 100 µM. This meant that trophozoite exposure to LY294002 was at time 
zero, during which trophozoites were also under the chemical signal in the encystation 
medium. The number of trophozoites, encysting cells and cysts were then counted. 
Trophozoite cells were treated instantly with LY294002 after the changes in trophozoite 
conditions under encysting culture medium. Previously in this chapter, the concentration of 
LY294002 was kept at 50 µM; however, it has been suggested that inhibitor degradation for 
120 to 168 hours may affect the result. Therefore LY294002 at a final concentration of 100 
µM was adopted to maintain the potency of the inhibitor.  Equally, PI3K activity may not 
only be important at the beginning of encystation; to test this hypothesis, trophozoites were 
treated with LY294002 to a final concentration of 100 µM and incubated in encysting 
medium for 12 hours. This was to allow the parasite to perceive and respond to the 
chemical signals in the encystation medium for 12 hours before exposing them to an 
inhibitor of PI3K (LY294002). 
The total numbers of Giardia cells were counted in Figure 4.17 under encysting 
medium.  The treated cultures show decreases in the total number of cells in all of the 
samples under encysting medium (inhibitor added immediately and 12 hours later). The 
encysting cultures that were treated immediately in Figure 4.17 (A) illustrate that the cell 
number of the control-DMSO and DRB-treated cells decreased by 40% and 50%, 
respectively, from the start to 168 hours. LY294002 treated cell population also decreased 
by 72%. Cells treated 12 hours after exposure to encysting medium showed decreases in the 
number of cells of the controls DMSO- and DRB-treated cells by approximately 16% and 
23%, respectively, when compared with the population at time zero. LY294002-treated 
cells had a 68% decrease in the cell population, as shown in Figure 4.17 (B). A reason for 
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this overall decline in cell numbers could be due to the effect of the DMSO solvent in each 
of the samples. The studies by Trubiani et al. (1996) have shown that a DMSO 
concentration above 0.5% may cause G1 cell cycle arrest in cell types such as human 
lymphoid cells. At higher concentrations, DMSO can reduce cell viability in human 
hepatoblastoma cells and cause apoptosis in the developing mouse brain cells (Vesey et al., 
1991, Hanslick et al., 2009). Generally, an increase in the number of cells between 48 to 72 
hours was followed by a marked decrease in the number of cells under all conditions. 
However, the number of cells was always lower in LY294002-treated than in DRB-treated 
and control trophozoites. The reason for the overall decrease in the number of cells could 
be because of the effect of DMSO solvent that is present in all of the inhibitors added at a 
concentration of 1%.  
DMSO is widely use in cell biology and its mode of action employed at low 
concentration is to induce membrane thinning, which results in increasing permeability of 
the membrane. However, at higher concentrations, DMSO may induce transient water pores 
into the membrane and can disintegrate the bilayer structure of the cell (Gurtovenko and 
Anwar, 2007). Cox and Tovar (unpublished work) showed that at a concentration of 1%, 
after two days, DMSO can decrease the cell number of trophozoite in normal culture 
medium by approximately 50%. 
Observations in the experimental work earlier with LY294002 suggest that this 
PI3K inhibitor has a cytostatic effect on trophozoite cells suggesting that a block in the cell 
cycle for up to 48 hours was responsible (see Figure 4.5). During the encystation process, 
however, LY294002-treated trophozoite cultures demonstrated a decrease in the number of 
cells that was significantly higher (P < 0.05) than that observed for the control-DMSO and 
DRB-treated cells (see Figure 4.17). This trend of decline in cell number suggests that it is 
not only due to the effect of DMSO solvent or the cytostatic effect on trophozoite cells by 
LY294002. A possible explanation is that LY294002 not only has a cytostatic effect on 
trophozoite cells, but may also trigger the encystation process upon the treated cells. 
However, this does not explain why the total number of cells suddenly declines but what if 
LY294002-treated cells do not complete encystation process, due to the inhibition of PI3K 
activity therefore resulting in a halt the cell cycle. Additionally, during encystation, 
trophozoites that were treated after 12 hours with LY294002, DRB and control (DMSO), 
all to a final concentration of 100 µM, revealed an increase in total cells in DRB- and 
control-treated cells. However, at 48 hours, LY294002 retains approximately the same 
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number of cells that it had started with (see Figure 4.17 (B)). In Figure 4.17 (A), the 
number of LY294002-treated cells could be seen to decrease by 50% at 48 hours and 42% 
at 72 hours. This result illustrates that trophozoite cells under encysting medium for 12 
hours prior to the treatment may influence cells to enter encystation under normal 
conditions, thus initiating an early phase of the encystation process. In comparison to 
Figure 4.17 (A), the addition of treatment 12 hours following encysting medium in Figure 
4.17 (B) may allow cells to adjust to the encysting medium giving cells the advantage of 
initiating the process of encystation that may aid in protection from LY294002 inhibitor. 
It was challenging to accurately measure the number of encysting cells and cysts 
because of the morphology and the positioning of individual cells. Therefore, using a 
vortex after the hypotonic lysis of cysts, “island” allows better distinction between each 
cell. These limitations could be the reason for errors, therefore cysts and encysting cells 
were placed in the same category. The number of cysts and encysting cells were calculated 
through total cell count subtracting trophozoite cell count in each of the treated and 
untreated samples. 
In the process of encystation, one may expect trophozoites to stop cell proliferation; 
however, because of the nature of Giardia trophozoites, each individual cell does not divide 
and replicate at the same time in the cell cycle. Besides, not every trophozoite enters 
encystation and differentiates into a cyst. In reality, some trophozoites will continue to 
proliferate under encysting medium. Therefore, to ensure that the results under these 
circumstances are reliable, the number of trophozoites, encysting cells and cysts were 
represented as a percentage of the total number of cells in Figures 4.18 and 4.19. Figure 
4.18 shows that in the cultures treated immediately following the onset of encystation, the 
number of trophozoites is significantly higher than the number of encysting/cyst cells in 
LY294002-treated samples at 24, 72 and 120 hours. At 168 hours, LY294002 treated 
samples display similar numbers of trophozoites and encysting/cysts cells. When this is 
compared to the other sample treated at 168 hours, the pattern shows a very high number of 
encysting/cyst cells against trophozoites. Compared with the control-treated cultures, the 
significant differences in trophozoites and encysting/cysts cells observed in the LY294002-
treated sample could be because inhibitor LY294002 compromises PI3K cell signalling; 
thus, the process of encystation in LY294002-treated samples is interrupted. Furthermore, 
Figure 4.19 with the addition of treatment 12 hours after the beginning of encystation with 
DMSO, DRB or LY294002 illustrate that LY294002-treated cells were able to reach a 
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similar pattern compared to other treated samples towards 168 hours. Again, the result may 
suggest that once trophozoites initiate encystation, changes in morphology can reduce the 
effect of LY294002, thus allowing a normal encystation process. Finally, the similarity 
between the number of cells treated with DRB and DMSO in encysting cultures exposed to 
inhibitors immediately and after 12 hours across the timeline indicates that the effect by the 
LY294002 inhibitor may be PI3K-mediated. 
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Figure 4.17: Total cell number under encystation. 
Encysting cultures were treated immediately (A) or 12 hours later (B) with LY294002 or DRB or 
DMSO control, all at a final concentration of 100 µM. The total number of cells per ml was counted 
over 168 hour period following the initiation of encystation. The total number of cells of three 
counts was averaged and plotted. The bars represent the standard errors of the data. 
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Figure 4.18: Effect of PI3K inhibition in encysting cultures. 
Trophozoites were induced to encyst and immediately treated with LY294002 (100 µM final 
concentration), DRB (100 µM final concentration) or DMSO (control). A. Untreated 
trophozoites in encystation medium were labelled wild type (WT). Trophozoites (T), 
encysting cells (En) and cysts (C) were then counted over a 168-hour period. The average 
number of cells from three counts was calculated and the counts are shown as a percentage 
of the total number of cells at a given time point. The bars represent the standard error of 
mean of the data. Paired Student’s t-Test calculated to determine significance at p < 0.05 in 
the average cell counts (asterisks) B. Trophozoites (T) with encysting cells and cysts 
(En/C). B. Presented in this Figure to facilitate the viewing of the data, it represents the 
same data as shown in A. 
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Figure 4.19: Effect of PI3K inhibition in encysting cultures. 
Trophozoites were induced to encyst and treated with LY294002 (100 µM final concentration), 
DRB (100 µM final concentration) or DMSO (control) twelve hours following the addition of 
encystation medium (at 0 hour). A. Untreated trophozoites in encystation medium were labelled 
wild type (WT). Trophozoites (T), encysting cells (En) and cysts (C) were then counted over 168-
hour period. The average number of cells from three counts was calculated and the counts are 
shown as a percentage of the total number of cells at a given time point. The bars represent the 
standard error of the mean of the data. Paired Student’s t-Test was calculated to determine 
significance at p < 0.05 in the average cell counts (asterisks). B. Trophozoites (T) with encysting 
cells and cysts (En/C). B. Presented in this Figure to facilitate the viewing of the data; it represents 
the same data as shown in A.     
 
4.2.7 Detection and quantitation of phosphatidylinositol (3,4,5)-trisphosphate in cell 
cultures 
To determine the presence of PI3K activity in G. intestinalis, the product of class I 
PI3K, phosphatidylinositol (3,4,5)-trisphosphate (PIP3), was quantified using PIP3 Mass 
ELISA assay. It has been widely accepted that PIP3 is the product of class I PI3Ks; 
therefore, the detection of PIP3 may provide evidence of class I PI3K activity in Giardia 
trophozoites and encysting cell cultures. Experiments were carried out to detect PIP3 in G. 
intestinalis, NIH-3T3 mouse fibroblast cells and D. discoideum. Lipid samples were 
extracted from cell cultures and incubated with a PIP3 detector protein. Individual samples 
were then added to the PIP3-coated plate for competitive binding. A peroxidase-linked 
secondary detection reagent and colorimetric substrate were applied to detect the level of 
PIP3 which corresponds to the detector protein bound to the plate. The colorimetric 
absorbance was read at 450 nm in which the absorbance reading is inversely proportional to 
the amount of PIP3 extracted from cell samples. The PIP3 standards were pre-applied to the 
assay and used as a comparison to allow one to determine the signal of PIP3 in the cell 
extract. The amount of PIP3 quantified in trophozoites is 0.355 picomoles per 1 x 10
7 cells, 
which is lower than the amount detected in mammalian mouse fibroblast cells, of 2.324 
pmol per 1 x 107 cells (Table 4.1). This observation was consistent over two independent 
repeat experiments. Giardia trophozoite cells were collected after 48 hours incubation in 
normal culture medium following initial subculture, it is possible that a higher 
concentration of growth factors in Giardia culture medium may lead to an increased 
amount of PIP3 extracted from the trophozoite cells. Nevertheless, the outcome of this 
result adds further evidence for the presence of functional PI3K activity in G. intestinalis; 
because PIP3 is the product of class I PI3Ks, it is possible to hypothesise that class I PI3Ks 
is present within the intracellular signalling activity of G. intestinalis. 
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 Given that PIP3 is the product of class I PI3Ks and class I PI3K isoforms have been 
identified in G. intestinalis (Cox et al., 2006), it was hypothesised that the level of PIP3 in 
trophozoite cells would reduce if trophozoite cells were treated with PI3K inhibitor. 
However, trophozoite cultures exposed to specific PI3K inhibitor PI-103 (Figure 4.8) did 
not show growth inhibition in trophozoite cell cultures. Therefore, it was not expected to be 
able to see a reduction in the level of PIP3 in trophozoite cell cultures exposed to PI-103. 
The level of PIP3 in Giardia cells exposed to encystation medium over 48 hours was 
established here to examine whether there were any changes in the level of extracted PIP3 
in trophozoites under encystation medium. The level of PIP3 detected using an ELISA 
assay in normal trophozoite cell cultures, encysting cell cultures, PI-103-treated 
trophozoites and LY294002-treated trophozoites is presented in Figure 4.20. The level of 
PIP3 in trophozoites under normal culture medium was used as a control. The three 
samples, PI-103-treated cells, LY294002-treated cells and encysting cells, were normalised 
against the control to obtain the percentage PIP3 level across the graph plotted (Figure 
4.20). The control PIP3 level and cells under encystation medium show no significant 
difference in the amount of PIP3 detected. This was also true in the PI-103 treated 
trophozoites, as statistical analysis using ANOVA indicated no significant difference in the 
amount of PIP3 between PI-103-treated trophozoites and the control and encysting cell 
cultures. On the other hand, the PI3K inhibited trophozoite cells treated with LY294002 
illustrated an approximately 60% decrease in the level of PIP3 when compared to the level 
of PIP3 in the control cells. These data support the evidence that Class I PI3Ks activity is 
present in G. intestinalis and that LY294002 inhibits PI3K activity in trophozoites, leading 
to a significantly reduced level of PIP3 in trophozoite cells. 
Table 4.1: Quantification table showing amount of PIP3 detected in different species. 
PIP3 level quantified in three different species are presented here per 1 x 107 cells. These values 
were obtained using a lipid extraction method and applied to a competitive ELISA assay where the 
signal given is inversely proportional to the amount of PIP3 produced. The experiment was repeated 
in triplicate, where the PIP3 value is an average ± standard deviation. 
 
Species PIP3 level in 1 x 10
7 cells (pmol) 
NIH-3T3 mouse fibroblast  2.324 ± 0.194 
D. discoideum 0.410 ± 0.097 
G. intestinalis (trophozoite) 0.355 ± 0.131 
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Figure 4.20: Investigation on phosphatidylinositol (3,4,5)-triphosphate (PIP3) level in G. 
intestinalis. 
Giardia trophozoites were treated with PI-103 and LY294002 (48 hours following initial 
subculture) to a final concentration of 2 µM and 50 µM, respectively. Encysting medium was 
exposed to trophozoite culture 48 hours after the initial subculture. The control of this experiment 
was a non-treated trophozoite culture. Forty-eight hours following treatment, treated trophozoites 
and encysting cells were collected, PIP3 was extracted and analysed by direct PIP3 ELISA mass 
assay. The graph shows normalised PIP3 level in triplicate sample and the error bar represents the 
SEM. Statistical analysis was performed by post-hoc Tukey test, following ANOVA (*p < 0.001). 
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4.3 Discussion 
Different inhibitors targeting kinases of the lipid signalling pathway have been 
tested in this chapter to observe the effect on G. intestinalis cells proliferation. The 
importance of the PI3K activity in the lipid signalling pathway of trophozoites has been 
reported here. The potent inhibitor of PI3K, LY294002, has been commonly used for over 
20 years to investigate the mechanisms in the intracellular pathways involving PI3K. In 
order to confirm that putative PI3Ks in G. intestinalis cells are involved in many cellular 
processes, trophozoite cultures were treated with several PI3K inhibitors. The compound 
LY294002 was shown to inhibit trophozoite cell proliferation in a concentration-dependent 
manner. At a final concentration of 25 µM, the trophozoite population was reduced by 
approximately 50%, while LY294002 at a final concentration of 50 µM lowered the 
number of trophozoite cells by 65% compared to the control. In contrast, wortmannin and 
PI-103 did not show any effect on trophozoite population as compared to the control. 
Wortmannin and PI-103 experiments were completed using a range of concentrations; 
wortmannin was reported to inhibit PI3K with an IC50 of 1 µM (Davies et al., 2000). 
However, the highest concentration that was experimented in this study was 15 µM. PI-103 
was reported to inhibit PI3K with an IC50 of 1 µM in the purified protein sample (Bain et 
al., 2007). Here, various concentrations of PI-103 were examined (0.2 – 5 µM) on 
trophozoite cells with no effect. The result of the PI-103 experiment did not show any 
significant effect on growth inhibition. Wortmannin has been known to inhibit PI3K for 
many years; however, the inhibitory effect seems to not function towards Giardia 
trophozoites. There are a few suggestions as to why wortmannin may not have a positive 
inhibition effect on trophozoite proliferation. First of all, structural differences between 
wortmannin and LY294002 suggest that GiPI3Ks may be missing key lysine residues or 
sequences required for ATP binding (Ward et al., 2003). Additionally, wortmannin 
insensitivity in class III isoforms in GiPI3Ks could suggest the difficulty in binding through 
covalent modification as an irreversible inhibitor (Walker et al., 2000). Previous work on 
PI-103, a novel inhibitor of PI3Ks that target class IA PI3Ks and mTOR, also does not 
demonstrate positive trophozoite growth inhibition in Giardia cell cultures (Workman et 
al., 2006). To demonstrate that the effect of LY294002 on trophozoite cell proliferation was 
not CKII-mediated, an inhibitor of CKII was used to treat trophozoite cells. Interestingly, 
the phenotypes reported from the experimental work using CKII inhibitor showed that 
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trophozoite cultures behave in the same pattern of proliferation to the untreated control. In 
light of this result it was concluded that LY294002 is unlikely to affect giardial CKII but 
does not rule out the possibility that other kinases downstream of PI3K may be affected by 
the inhibitor (see Table 4.2). 
 
Table 4.2: A brief summary showing specificities of PI3Ks inhibitors. 
Values shown represent the percentage of catalytic activity remaining when the corresponding 
purified kinases were incubated in the presence of PI3K inhibitors as compared with control 
incubations. The experiment was repeated in triplicate to obtain results with each value as an 
average ± standard deviation. The concentrations of each compound were determined by carrying 
out the experiment at ten different concentrations. Figure summarised from Bain et al. (2007). 
 
Kinase LY294002 
(10 µM) 
Wortmannin 
(1 µM) 
PI-103 
(1 µM) 
GSK-3β 37 ± 3 65 ± 1 84 ± 11 
CKII 23 ± 5 96 ± 7 83 ± 6 
PLK1 26 ± 1 64 ± 1 79 ± 10 
PI3K 13 ± 0 0 ± 0 0 ± 0 
 
Due to the highly specific and potent ability of wortmannin and PI-103 to inhibit 
PI3Ks in mammalian cells, it was important to verify whether the effect of LY294002 on 
trophozoites proliferation was indeed because of the downstream inhibition of other kinases 
(such as GSK-3β or PLK1). This creates a hypothesis that LY294002 may be inhibiting 
other kinases thus causing a block in the cell cycle. Glycogen synthase kinase-3 is another 
essential protein kinase involved in signal transduction, cell survival and protein synthesis. 
To ascertain this hypothesis, trophozoites were treated with GSK-3 inhibitors LiCl and 
CT99021. The results show that CT99021-treated trophozoites at various concentrations 
(Figure 4.9) do not show a positive growth inhibition effect on Giardia cells, after 
observing that the number of treated cells was similar to the untreated control. Following 
CT99021 treatment, trophozoites with LiCl at the recommended concentration also did not 
demonstrate the inhibition of growth with five different concentrations treated and 
compared with the control. Under normal growth, one can hypothesise the two GSK-3 
inhibitors applied to trophozoites may facilitate in the phosphorylation of GSK-3; therefore, 
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the cell cycle would continue, leading to an increase in the number of cells. However, this 
assumes that these inhibitors actually work in Giardia as in other organisms.  
  
The level of PLK1 activity in mammalian cell is regulated during the cell cycle and 
involves in multiple functions during mitosis (Liu et al., 2005). Small-molecule inhibitors 
developed to target this kinase have reported that PLK1 inhibitor has a cytotoxic effect on 
mammalian cancer cells (Sanhaji et al., 2013). This may rule out the possibility of PLK1 
being an LY294002 target in Giardia, as LY294002 demonstrates a cytostatic effect on 
trophozoites. However, it is important to note that a specific inhibitor of PLK1 should be 
investigated on the exponentially growing trophozoite culture to observe any effect on 
trophozoite cell proliferation.     
 The result of using double inhibitor treatment on Giardia trophozoites showed that 
LY294002-treated cultures with the addition of GSK-3 inhibitor continues to show growth 
inhibition. Moreover, increasing the concentration of LY294002 treatment in CT99021-
treated trophozoites at a constant concentration affects trophozoite cell number in a 
concentration-dependent manner. Based on this evidence, this strongly suggests that 
LY294002 does not inhibit GiGSKs. An explanation could be that GiGSKs lack crucial 
residues needed for binding to form phosphorylated GSK (inactive form). The second 
double inhibitor experiment result found that increasing the concentration of CT99021 
together with trophozoites treated with fixed levels of LY294002 did not demonstrate an 
increase in the number of trophozoite cells. Therefore, it was concluded that the effect of 
LY294002 was due to PI3K inhibition. 
 LY294002-treated cells inhibit trophozoite proliferation through blocking the 
activity of PI3K, alleviating this effect with the removal of this compound from cultures; 
consequently, trophozoites are able to proliferate. To confirm that LY294002 treatment has 
a cytostatic effect on trophozoites, experiments using puromycin were carried out. The 
results illustrated that puromycin has a cytotoxic effect on trophozoites. This was 
confirmed by attempt to reverse the condition through removing the culture medium 
containing puromycin and replaced with fresh culture medium. Trophozoites pre-treated 
with puromycin did not show a reversible effect upon removal of puromycin, unlike 
trophozoites pre-treated with LY294002. This strongly suggests that puromycin kills cells, 
whereas LY294002 treatment reversibly blocked cell proliferation. 
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Evidence from previous studies suggests that LY294002-treated trophozoites 
initiate the process of encystation. Inhibition of PI3K activity may cause trophozoites to 
initiate expression and translation of CWP2 and package into ESV-like vesicles reminiscent 
of early encystation cells. This evidence has been shown by Cox and Tovar (unpublished). 
Therefore, this outcome suggests that trophozoites treated with PI3K inhibitor promote 
cells to enter cell differentiation, similar to an encystation process. 
Experimental work on LY294002-treated cells following encystation induction 
discovered that it could yield reduced numbers of cysts. However, this may raise an 
important question that trophozoite cells following encystation induction treated with 
LY294002 could initiate the process of encystation, but these cells resulted in incomplete 
cyst formation. Under normal conditions, the percentage of encysting cells and cysts in cell 
culture should reach approximately 45% within 24 hours (Figure 4.18 and Figure 4.19). In 
this work, however, approximately 82% of the LY294002-treated cells in encysting 
medium in the first 24 hours were still showing trophozoite morphology, with the 
remaining appearing as encysting cells and cysts. This evidence supports the hypothesis 
that PI3K inhibition at the early phase of encystation delays the differentiation of 
trophozoites to encysting cells and cysts; as a result, this may lead to cell death (see Figure 
4.18). An experiment to increase the accuracy of detecting initiation of the encystation 
process could use markers of encystation. Encystation markers such as monoclonal 
antibodies against ESV-specific calcium binding proteins of G. intestinalis can detect the 
changes from trophozoite to encysting cell as it is only present in secretory vesicles of 
encysting trophozoite (Touz et al., 2002). These findings may be interpreted further by 
taking a closer look at the Giardia cell cycle in relation to the parasite’s ability to 
differentiate into cysts, the PI3K signalling cascade in mammalian cells and initiation of the 
encystation process involving ESVs and the production of CWPs.    
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Figure 4.21: Mammalian class IA PI3K signalling pathway impacts on cell growth, survival 
and metabolism. 
Arrows represent activation, while bars reflect inhibition. A negative feedback loop has been 
described from the downstream target S6 kinase (S6K) to the adaptor protein IRS-1. RTK, receptor 
tyrosine kinase; GPCR, G-protein coupled receptor; P, phosphate; G, G protein; PTEN, phosphatase 
and tensin homolog; IRS-1, insulin receptor substrate 1; eIF4E, eukaryotic initiation factor 4E; S6, 
ribosomal S6 protein; PIP2, phosphatidylinositol 4,5-bisphosphate; mTORC2, rapamycin (mTOR) –
containing protein complex 2. (*) p110 alpha, beta, or delta. Figure taken from Courtney et al. 
(2010).  
 
The PI3K signalling cascade is an important regulator of cell growth and cell 
survival. Many studies have highlighted the crucial roles that PI3K activity has in 
mammalian intracellular signalling pathways (Figure 4.21). A central component of this 
signalling cascade is PKB. While PI3K phosphorylates PIP2 to PIP3, this anchoring PIP3 
migrate the two PH domain containing component PDK1 and PKB. PDK1 activates PKB 
through phosphorylation at threonine 308, thus promoting cell growth and several 
mechanisms that are involved in cell survival such as GSK-3, Forkhead transcription 
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factors (FOXO), Bcl-XL-antagonist, casing cell death (BAD), mouse double minute 2 
(MDM2) and tuberous sclerosis complex 2 (TSC2). However, a vital component in the 
regulation of cell growth in the PI3K signalling cascade is mammalian target of rapamycin 
(mTOR). Phosphorylation of TSC2 by PKB inhibits Rheb (ras homolog enriched in brain) 
GTPase, therefore activating Rheb. The Rheb component stimulates mTOR which initiates 
translation by activating ribosomal S6 protein and eukaryotic initiation factor 4E (eIF4E). 
Activation of the ribosomal S6 protein promotes translation of the ribosome and 
components of the translation mechanism. Conversely, mTOR also controls cell growth via 
negative feedback through its protein complex mTORC1 to reduce PI3K activation (Hresko 
et al., 2005).  
Cell growth in Giardia during an infection in vivo is currently not fully understood; 
however, in vitro studies from cultivation using the extremely versatile TYI-S-33 medium 
were able to sustain Giardia growth. A reversible inhibitor of eukaryotic nuclear DNA 
replication, aphidicolin, blocks the cell cycle at the S-phase. Flow cytometric analysis was 
then used to determine the length of time in each of the cell cycle phases and duration in 
Giardia cell cycle (Reiner et al., 2008). G. intestinalis cell division involves an unusual 
number of two nuclei. During vegetative growth, each trophozoite nucleus cycles between a 
diploid (2N) or tetraploid (4N) genome, therefore resulting in the cellular ploidy of 4N or 
8N (Bernander et al., 2001). The starting point of Giardia trophozoite cell division begins 
at G1 stage of the cell cycle, when two nuclei with a total of 4N undergo DNA replication 
to produce trophozoites with two nuclei, making a total of 8N. Progressing to G2 phase, 
trophozoites with two nuclei and 8N undergo nuclear division to form trophozoites with 
four nuclei (8N; 4N x 2 = 8N). Following nuclear division, trophozoites containing four 
nuclei (8N) reach the M phase (mitosis phase), and two trophozoite daughter cells emerge 
from a single trophozoite parent cell, with each daughter cell possessing two nuclei (4N) 
(Svard et al., 2003). At what point in the cell cycle the inhibition of PI3K activity could 
have an effect on Giardia cell cycling is currently unknown. However, one would assume 
that PI3K activity is required in both G1 and G2 stages of the cell cycle. As PI3K-inhibited 
trophozoites were unable to proliferate and failed to complete cell division, the inhibition of 
cell growth cause by LY294002 may block cell cycle at G1 or G2. Upon removal of 
LY294002, if the inhibitory effect does take place in the G1 phase, this may result in a 
slight delay in the recovery of the trophozoites growth, but should eventually reach the 
same number of cells as the control. Alternatively, if the inhibitory effect takes place at G2 
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phase, upon removal of the inhibitor LY294002, the expected outcome would be that there 
should be no delay in the recovery of the trophozoite growth. Furthermore, an increase in 
trophozoite number should occur compared to the control because G2 arrest cells are 
already prepared for the M phase with each trophozoite having four nuclei 8N. However, 
the results in Figure 4.6 illustrate that there was no significant difference between the 
number of trophozoites between the treated and control cells at 96 hours upon removal of 
the PI3K inhibitor. Therefore, it is likely that LY294002 stimulates G1 arrest in 
trophozoites. Having concluded that, it would be ideal to follow the different stages of cell 
replication which will pinpoint the specific stage at which PI3K activity is no longer 
functional. Fluorescence-activated cell sorting (FACS) techniques can provide a tool for 
identifying Giardia differentiation or a stop in cell growth (Bernander et al., 2001). A 
complication of this could be the fact that Giardia trophozoites in cell culture are not 
synchronised and do not all go through the same stages of the cell cycle at any one time 
(Bernander et al., 2001). 
Given that inhibition of PI3K activity affects trophozoites under normal conditions 
at the G1 stage, therefore causing cell cycle arrest, under normal conditions, Giardia during 
the encystation process would differentiate from the G2 stage (Bernander et al., 2001). The 
cyst wall material (CWP) would be transported by ESVs and deposited to the outer cell 
membrane of Giardia. The Giardia nuclei then divide, giving a single encysting cell 
composed of four nuclei (8N). Continuation of cell replication takes place and a mature 
cyst will have complete 16N cellular ploidy with four nuclei. However, during initiation of 
the encystation process, trophozoites are likely to differentiate from G2 stage of the cell 
cycle. Addition of a PI3K inhibitor at this stage may interrupt the encystation signalling 
pathway, therefore inhibiting cell differentiation. One way of detecting cell differentiation 
is the use of an antibody to label CWPs carried by encystation-specific secretory vesicles 
(ESVs) that are made from ER, which may be an important tool in identifying the process 
of encystation (see Figure 4.22). Further observation of the impact of PI3K inhibition in 
Giardia, the morphology of Giardia within cells and the overall ultrastructure will be 
presented in the next chapter using scanning and transmission electron microscopy.   
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Figure 4.22: Encystation process images at 4 hours and 8 hours. 
The two different encystation protocols at time points 4 and 8 hours with insets images of bright-
field. Protocol A proceeds with two-step encystation; the first step is pre-encysting medium (bile-
free medium) to incubate trophozoite for 44 hours. The second step is using pre-warmed encystation 
medium with a pH to 7.85 and the addition of porcine bile together with lactic acid. Protocol B 
initiate lipid starvation using bile-free medium containing delipidated foetal calf serum at a pH of 
7.85 to induce differentiation of cells grown in standard trophozoite medium. Scale bars 3 µm, red 
indicates CWP-labelled cells and blue shows two nuclei labelled by DAPI. Images are taken 
directly from Morf et al. (2010). 
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CHAPTER 5: Using scanning and transmission electron microscopy to   
eeeeeeeeeeeeeinvestigate the effect of LY294002 on G. intestinalis  
 
5.1 Introduction 
The research so far has suggested that components of PI3K intracellular signalling 
pathway and downstream GSK signalling pathways do exist in G. intestinalis. The previous 
chapter reported the use of PI3Ks and GSK inhibitors on Giardia trophozoites to examine 
the impact that these have on parasite intracellular signalling pathways. The research 
presented in this chapter was carried out in an attempt to study the ultrastructure of 
vegetative trophozoites, to investigate the ultrastructural modifications of trophozoites 
treated with the PI3K inhibitor LY294002 and to examine differentiation of trophozoites 
into cysts, in a process known as encystation. The different techniques and tools required to 
address this work lie within the field of electron microscopy.    
The first scanning electron microscope (SEM) was introduced by Manfred Von 
Ardenne in 1937; however, one of the first articles on G. intestinalis using SEM was 
published in 1964 by Cheissin. The exterior morphology of Giardia trophozoites are 
approximately 12-15 µm in length and 5-9 µm wide, and Giardia cysts measure about 8-12 
µm in length and 7-10 µm in width (Adam, 2001). There are many advantages of using 
SEM to study the morphology of Giardia. Previous SEM studies reported the detailed 
ultrastructure of the cell and presented high magnification images of the morphology of the 
cell. Powerful magnification combined with the high resolution of SEM means that each 
individual flagellum in Giardia, the ventral disk used for adherence and the lateral flange 
that surrounds the whole cell can be clearly examined (Lanfredi-Rangel et al., 1999).  
Transmission electron microscopy (TEM), in contrast to ordinary light microscopy, 
uses electron beams instead of light beams. A beam of electrons is transmitted through the 
ultra-thin sample that has been cut following resin embedment. The first TEM was built in 
1931 by Max Knoll and Ernst Ruska, but this type of microscopy continues to be further 
developed to the present day. The developments in TEM led to one of the first publications 
in 1980 using this equipment to investigate G. intestinalis cysts (Luchtel et al., 1980). The 
nature of TEM allows observation of the ultrastructure of the inner layers of trophozoite 
and cyst cells; together with its high magnification and resolution capability, TEM has been 
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a useful technique to study the impact of cellular signalling in Giardia cells. For example, 
encystation in G. intestinalis has been examined and images of trophozoites differentiating 
into cysts were presented using electron microscopy (Adam, 2001, Midlej and Benchimol, 
2009, Hausen et al., 2009, Castillo-Romero et al., 2009). All of the knowledge of 
encystation at present could not have been accomplished without the visual aid of TEM. 
Furthermore, immunolocalisation of cyst wall protein 1 (CWP1) in Giardia under TEM 
clearly shows evidence of the ESVs within encysting cells through electron-dense vesicles 
(Midlej et al., 2012).   
In the present study, SEM and TEM were selected to study G. intestinalis cells from 
the outer layer structural pear-shaped trophozoites to the internal cytoplasmic structures of 
Giardia cells. The aim of this chapter was to utilise SEM and TEM to further explore the 
suggestion that LY294002-treated trophozoites initiate an encystation-like processes. Taken 
together our data suggest that trophozoites treated with the PI3K inhibitor LY294002 halt 
trophozoite proliferation in the G1 phase of the cell cycle in normal growth medium. 
Inhibition of GiPI3K1 and/or GiPI3K2 under encystation medium also halts in the G2 stage 
of the cell cycle, preventing the formation of cysts in the encystation process. 
 
 
5.2 Experimental Results 
5.2.1 Scanning electron microscopy images of G. intestinalis trophozoites 
Using SEM to view exponentially growing Giardia trophozoites was crucial to the 
understanding of trophozoite ultrastructure and cell morphology. Initially, trophozoite 
exponential growth was reached after 48 hours and the cells were allowed to attach to a 
coverslip and taken for SEM viewing. It was important to establish these normal untreated 
pear-shaped trophozoites (Figure 5.1, panel a) showing four pairs of flagella; the anterior 
flagella (shown closest to the scale bar), posterior lateral flagella, ventral flagella (on the 
ventral side) and caudal flagella (tail section). The flagella are essential for trophozoite 
motility and their functional role was reviewed by Elmendorf et al. (2003). Here, 
trophozoites were measured and found to be approximately 15 µm in length and 7 µm in 
width (Figure 5.1). A general view (see Figure 5.1, panel b) displays single random fields 
of view that demonstrate the distribution of trophozoites in untreated culture. The anterior 
side of trophozoites (see Figure 5.1, panel a) shows a smooth surface surrounded by the cell 
plasma membrane.  
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Figure 5.1: Giardia intestinalis trophozoites morphology. 
SEM images of control trophozoites showing a, pear-shape-like cell morphology and b, overview 
of one random field of view under normal conditions. Scale bars, 10 µm. 
 
The results in Chapter 4 show that the PI3K inhibitor LY294002 inhibits 
exponentially growing Giardia trophozoite proliferation in a concentration-dependent 
manner. Upon removal of the inhibitor LY294002, trophozoite cell cultures recovered back 
to normal. Therefore, it is important to investigate what had occurred to trophozoite 
ultrastructure under the PI3K inhibitor that enabled this reversible effect on its growth. 
Exponentially growing trophozoites were treated with LY294002 at a final concentration of 
either 15 µM or 50 µM. The selected concentrations were the lowest effected potency and 
the IC50 value for LY294002 concentrations, respectively (Chapter 4).  Figure 5.2 illustrates 
exponentially growing trophozoites treated with LY294002 at 50 µM. After forty-eight 
hours of incubation, trophozoites were fixed and prepared for SEM. The resulting 
micrographs detected several differences between the DMSO-control trophozoites and 
LY294002-treated cells. The general view in a random field shows differences in the 
number of cells present (later quantify). More importantly, almost all of the cells had 
altered shapes (Figure 5.2, panel b) and the appearance of vesicular protrusion spots on the 
body of the trophozoites (Figure 5.2, panel d) compared to the smooth surface of the 
DMSO-control trophozoite (Figure 5.2, panel c).        
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Figure 5.2: Trophozoites cells treated with LY294002 cell morphology. 
SEM images showing a and c control trophozoites treated with DMSO in a random field of view 
and a single DMSO-control trophozoite cell morphology, respectively. b and d, trophozoites treated 
with LY294002 in a single random field of view and morphological changes to a trophozoite 
structure under the treatment of a PI3K-inhibitor. Scale bars, 10 µm. 
 
To further characterise the morphological changes during LY294002 treatment to 
trophozoites at concentration of 15 µM and 50 µM, Figure 5.3 shows a general observation 
in a single field of view where treated and untreated cultures were incubated for 24 hours 
and 48 hours (left panel and right panel, respectively). Trophozoites exposed to 15 µM of 
LY294002 over 24 hours display lower numbers of trophozoites in a single random field of 
view where some Giardia cells exhibit unusual morphology compared to the control 
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trophozoites (see Figure 5.3, panel c). The morphological changes to trophozoites can be 
categorised into shortened cells, vesicular spots, elongated cells, doublet cells (dividing 
cells) and membrane blebs. This is also observed in Figure 5.3, panel e; however, at higher 
concentrations of LY294002, the number of abnormally-shaped trophozoites increases. At 
48 hours incubation in Figure 5.3, panel d and f, almost all of the cells show remarkable 
alterations in cell morphology, cells become more elongated, the cell plasma membranes 
display thin blebs and the appearance of small vesicular features on the surface of the 
trophozoite can be observed. 
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Figure 5.3: Comparison of Giardia trophozoite cells treated with LY294002 over 24 hours and 
48 hours. 
SEM images showing 24 hours (left panel) and 48 hours (right panel) incubation of a and b control 
DMSO-treated trophozoites. c and d, trophozoites treated with LY294002 at 15 µM. e and f, 
trophozoites treated with LY294002 at 50 µM. Scale bars, 10 µM. 
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Figure 5.4: Proportion of morphologically-altered trophozoite cells in groups of PI3K-
inhibited cells treated with LY294002 and control-treated trophozoites. 
SEM was used to view disfigured trophozoites which can be divided into six categories: normal 
cells, shortened cells, vesicular spots, elongated cells, doublet cells (dividing cells) and membrane 
blebs. A shows the group of cells incubated for 24 hours and B shows trophozoites that were 
incubated for 48 hours. This data are from a single experimental treatment. Data presented as 
percentages of the total cells counted in a maximum of seven random fields of view in each 
incubation period. The minimum number of cells counted per treatment was 100 cells.  
A 
B 
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Total cell numbers of LY294002-treated cultures at final concentrations of 15 µM 
and 50 µM were counted using micrographs taken from SEM. Figure 5.4 shows a 
comparison of the treated-trophozoites at different concentrations of LY294002 and the 
control DMSO-treated cells. The number of morphological changes was calculated by 
counting the number of cells exhibiting abnormal characteristics and determines the 
percentage given to each of the categories. The percentage of normal cells in LY294002-
treated cells was 52.6% and 42.3% in the first 24 hours with concentrations of 15 µM and 
50 µM, respectively. The highest percentage of abnormal characteristics over 24 hours 
appears to be accounted for by the vesicular spots and plasma membrane blebs. Vesicular 
spots are irregular protrusions of the cell surface membrane. At 48 hours incubation with 
LY294002, almost all of the trophozoites appear to become totally distorted; this was 
evident in Figure 5.4, where LY294002-treated trophozoites at 15 µM and 50 µM indicate 
11.1% and 7.6% of normal cells, respectively. There were no major changes in the number 
of vesicular spots cells or the number of plasma membrane blebs; however, the number of 
elongated cells in LY294002-treated cells increased. Elongated trophozoites are seen as 
thinner, ‘torpedo-like’ in shape, and the area between the median body to caudal flagella is 
lengthened (Figure 5.5, panel h and i). Figure 5.4 indicates that LY294002-treated cells at 
50 µM show an increase in the average percentage of elongated cells from 11.3% after 24 
hours incubation to 33.7% in 48 hours exposure to a PI3K-inhibitor. Furthermore, the 
average percentage of doublet cells has also increased in LY294002-treated cells, where it 
shows that 10.4% and 12.1% of cells are doublet cells (Figure 5.5, panel d) in cells exposed 
to LY294002 at 15 µM and 50 µM, respectively. These observations suggest that 
LY294002 affects trophozoite cell growth and may stimulate G1 cell cycle arrest, thus 
leading to incomplete cell division of the trophozoites. 
Close observation of individual trophozoites following exposure to different 
concentrations of LY294002 for 24 and 48 hours were completed using SEM. Images taken 
in Figure 5.5 show abnormal cells that were counted and presented in Figure 5.4. These 
cells are examples of the morphology of trophozoites that were under the treatment of 
LY294002. Some trophozoites change morphology from a pear-shaped-like cell (Figure 
5.5, panel b) into round shapes with the length of the cell shortened (Figure 5.5, panel c) 
and doublet cells with a heart-shape-like appearance suggest incomplete cell division 
(Figure 5.5, panel d). Cell adhesive disks bleb when attached to the coverslip (Figure 5.5, 
panel e to i), protrusion of vesicles on the cell dorsal surface (Figure 5.5, panel c, d and j), 
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elongated, torpedo-like cells (Figure 5.5, panel h and i) and flattened cells with loss of 
normal morphology shown in Figure 5.5, panel k, were also observed. 
 
Figure 5.5: Giardia intestinalis trophozoites under LY294002 treatment. 
SEM images of a and b control trophozoite cells untreated with a pear-shape appearance. c and d 
trophozoites treated with LY294002 at 50 µM after 24 hours. e – h, trophozoites treated with 
LY294002 at 15 µM after 48 hours. i – k, trophozoites treated with LY294002 at 50 µM after 48 
hours. Scale bar 10 µm. 
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5.2.2 SEM images of G. intestinalis encysting cells  
The observation of Giardia trophozoites under SEM was continued to monitor the 
organism as the encystation process is stimulated through the introduction of encysting 
medium. Experiments were carried out to study changes in the morphology of Giardia 
during encystation and to examine cell modifications under the exposure of LY294002. 
Under normal encystation, the introduction of encysting medium will trigger the process of 
encystation in vitro. It was mentioned in Chapter 4 that encystation can be divided into two 
phases: the earlier phase and the late phase. More importantly, not all Giardia trophozoites 
differentiate into cysts; also, cells within a population do not all enter encystation at the 
same time (Adam, 2001).      
To establish the standard wild type Giardia cell morphology during encystation, 
Figure 5.6 shows Giardia cells incubated in encysting medium for 48 hours with SEM 
images taken every 12 hours after the initial introduction of the medium. Initially, the 
earlier phase of encystation should complete within the first 10 hours of the introduction of 
encysting medium. The earlier phase mentioned before in Chapter 4 includes the 
intracellular synthesis of cyst wall component proteins required for encystation (Reiner et 
al., 1990). ESVs become visible to allow transportation of the cyst wall components to the 
outer layer of the cell (Adam, 2001). In Figure 5.6, the left panel a, c, e and i show the 
general view of Giardia in a single random field of view, where the organism was under 
encysting medium for 12, 24, 36 and 48 hours, respectively. The result highlights that the 
number of trophozoites, encysting cells or cysts decreases the longer they are under 
encysting medium. This observation was supported by the percentage of normal cells, 
which decreases from 61.3% in the first 12 hours to 37.3% at the end of the 48 hour 
incubation period. Therefore, stimulation of the encystation process may effectively 
become a stressful environment for the growth of trophozoites. Upon closer inspection, 
there were signs of morphological change that indicate the initiation of encystation; for 
example, shortening cells increased from 0.7% in the first 12 hours to 7.5% by 48 hours 
(see Figure 5.6). Other morphological changes were observed by TEM; these will be 
discussed later on in this chapter.     
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Figure 5.6: Giardia intestinalis under encysting medium over 48 hours. 
SEM images of a and b Giardia under encysting medium after 12 hours. c and d, Giardia under 
encysting medium after 24 hours. e and f, Giardia under encysting medium after 36 hours. i and j, 
Giardia under encysting medium after 48 hours. a, c, e and i represent the general view of Giardia. 
b, d, f and j display the detailed morphology appearance of the cell. Scale bars a, c, e and i, 10 µm; 
b, d, f and j, 1 µm. 
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Figure 5.7: Encystation experiment with G. intestinalis over a period of 48 hours. 
Using SEM images showing the general view of wild type cells exposure to encysting medium, the 
total number of cells were counted and placed in to different categories of different cell 
morphology; normal cells, vesicular spotted cells, doublet cells and shortening cells. Data are 
presented as the number of cells counted in different categories/the total number of cells counted in 
the group. Percentages are also given and represent the proportion of cells in that category within 
each time period. These data were from a single experimental work with a minimum of 100 cells 
analysed per treatment.  
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To determine the effect of LY294002 on Giardia cell morphology using SEM 
during encystation, encysting cultures were treated with LY294002. Giardia cultures were 
incubated for 24, 48, 72 and 96 hours. The positive control of the experiment was encysting 
cultures treated with DMSO. Referring back to Chapter 4 during encystation, the total cell 
number decreases under both control-DMSO- and LY294002-treated encysting cultures 
over a period of 168 hours. However, the number of cells in control-DMSO encysting 
cultures did not decrease until after 72 hours. Therefore, this suggests that in the general 
view, similar numbers of cells are expected at 24 hours and 48 hours.       
Observation of SEM images illustrates that the loss of normal morphology 
continues under encystation conditions when exponentially growing trophozoites were 
under encysting medium and immediately treated with DMSO (control) and LY294002 
(Figure 5.8). Interestingly, Figure 5.8 illustrates that both LY294002-treated samples and 
the control-DMSO show Giardia cells with abnormal morphological changes. In the first 
24 hours, the appearance of vesicular protrusions on the cell surface membrane were 
common to both LY294002-treated and control-DMSO Giardia cells. The proportion of 
vesicular protrusions on an average percentage count was 21.2% and 25.6% in control-
DMSO and LY294002-treated cultures, respectively. At 48 hours, the effect of LY294002 
treatment showed a significant increase by an average of 60.2% in the number of cells with 
vesicular protrusions, with the control-DMSO reaching 39.3% (Figure 5.9 A and B). 
Moreover, flagella were positioned at irregular locations in both conditions and after 
incubation times of both 24 and 48 hours (Figure 5.8). The SEM images used for analysis 
show a total decrease in the average percentage of normal cells in both LY294002-treated 
and control-DMSO treated cells over the course of 72 hours. Initially, LY294002-treated 
cultures at 24 hours show an average of 49.6% of normal pear-shaped cells, similar to 
control-DMSO, with an average of 50%. However, after 48 hours of incubation, the 
proportion of normal cells in the control-DMSO decreased to 32% while, LY294002-
treated samples averaged only 12% (Figure 5.9 B). The abnormal appearances of 
LY294002-treated cells were predominately due to a large number of protrusions 
distributed on the cell surface membrane. These protrusions can be seen following closer 
inspection in Figure 5.10, panel b and c; on average, the proportion of cells with vesicular 
spots appearance was as high as 67.6%. Previous studies have suggested that these 
protrusions on the encysting cell surface membrane may represent the increasing number of 
encystation vesicles below the surface of the cell differentiating plasma membrane, as 
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previously characterised in replicas of freeze-fractured encysted cells (Lanfredi-Rangel et 
al., 2003 and Bittencourt-Silvestre et al., 2010). 
The other important changes in cell morphology were doublet and shortened cells. 
In LY294002-treated cells, an increase of doublet cells from 11.2% to 15% was observed 
after 24 hours and 48 hours, respectively. In the control-DMSO-treated culture, doublet 
cells decreased from approximately 9.7% after 24 hours to 4.5% after 48 hours. This 
suggests that some of the LY294002-treated cells were not able to complete the process of 
cell division. Accumulating results lead to the direction that cell cycle is blocked due to 
inhibition of the PI3K signalling pathway by LY294002. On the other hand, Giardia with 
characteristic shortened cells in both LY294002 and control-DMSO treated cultures under 
encysting medium shows that both treatments resulted in increased shortened morphology 
after 24 hours and 48 hours, with LY294002-treated cultures reaching 12.7% and the 
control-DMSO cultures reaching 24.2%. However, both cultures displayed decreases in 
shortened cell morphology after a 72 hour incubation period.     
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Figure 5.8: General view of Giardia under encysting medium and LY294002 treatment. 
SEM images of a and c, control Giardia cells with DMSO treatment after 24 and 48 hours, 
respectively. b and d, Giardia cells under LY294002 at 50 µM after 24 and 48 hours, respectively. 
Scale bar 10 µm. 
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Figure 5.9: Encystation experiment with LY294002 and DMSO treatment. 
The general view of Giardia cells exposed to encysting medium treated with LY294002 and DMSO 
(control) was observed under SEM. The total number of cells was counted and they were placed in 
to different categories of different cell morphology; normal cells, vesicular spotted cells, doublet 
cells and shortening cells. A shows the cells that were incubated for 24 hours, B represents the 
incubation time of 48 hours and C show cells that were incubated for 72 hours. Data are presented 
as the number of cells counted in different categories/the total number of cells counted in the group. 
Percentages are also given and represent the proportion of cells in that category within each time 
period. 
A 
C 
B 
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Encystation in G. intestinalis has been well-recorded in previous investigations 
using light microscopy and electron microscopy (Lujan et al., 1997, Lanfredi-Rangel et al., 
2003, Benchimol, 2004, Midlej and Benchimol, 2009, Bittencourt-Silvestre et al., 2010). 
Although it was not possible to pinpoint the exact time at which each stage of encystation 
occur in trophozoites under encysting medium in vitro in the first 10 hours, trophozoites 
remained predominately pear-shaped (Midlej and Benchimol, 2009). After 12 hours some 
trophozoites begin to show alterations in their structure, and the emergence of small 
protrusions on the cell plasma membrane can be seen. Further transformation of the 
trophozoite outline takes place from a flattened pear-shaped structure into a rounded form, 
with an increasing flange size and shortening of the flagella (Bittencourt-Silvestre et al., 
2010). The small protrusions were observed again at 18 hours, and after 24 hours they were 
larger but lower in number on the plasma membrane of the organism. Within the final hours 
of encystation, Bittencourt-Silvestre et al. (2010) reported no surface protrusions and the 
mature cyst surfaces were demonstrating a homogeneous rough appearance. Under 
LY294002 treatment, a substantial proportion of cells with protrusions on the surface 
plasma membrane were observed between 24 and 48 hours, as mentioned earlier. At closer 
examination in Figure 5.10, the appearance of a large number of protrusions was seen in 
control-DMSO after 48 hours of incubation (Figure 5.10, panel a). Interestingly, 
LY294002-treated samples in encysting medium after 72 hours continued to show 
protrusions distributed throughout the surface of the plasma membrane of the cell (Figure 
5.10, panel b and c). This suggests that LY294002-treated cells were held at the stage of 
encystation. Further investigation into the protrusions in LY294002 treated cells was 
required in order to confirm these findings in view of the accumulation of encystation 
vesicles below the surface membrane after 72 hours in LY294002-treated cells.   
It was necessary to analyse the work completed by other research groups on Giardia 
under the encystation process. This was because in the wild type encystation experiment, it 
was not possible to locate any mature cysts images under SEM. Attempts were carried out 
with Giardia trophozoites grown to 72 hours with approximately 1 x 106 cells/ml, and the 
growth medium was replaced with encysting medium, as described in Kane et al. (1991). 
After the addition of encysting medium, Giardia trophozoites were incubated for a further 
48 hours. Parasites were washed and, in order to obtain cysts alone, distilled water was 
added to remove trophozoites through hypotonic lysis overnight. This was completed to 
increase the efficiency of mature cyst production. However, after processing the cells for 
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electron microscopy, Figure 5.11 shows images of wild type cells after attempts to obtain 
cysts. Although in Figure 5.11, panels a and b show characteristics of round and oval-shape 
encysting cells, it was noticeable that the cells were damaged and distorted. While under 
the light microscope, more rounded cells and oval cyst shapes were detected contrary to 
images under SEM. Utilising the SEM high resolution, closer examination of this 
experiment shows round cells that may look like cysts (Figure 5.11 panel e and f), but they 
were remnants of the incomplete formation of cysts. An example of non-encysting 
trophozoites in distilled water can be seen in Figure 5.11, panel c and d. The plasma 
membrane was removed, allowing observation of the Giardia cytoskeleton. An important 
feature such as the spiral disc is shown in Figure 5.11, panel c and d. This is one of the 
features observed in the early stages of encystation reported by Midlej et al. (2009). At the 
latter stage of encystation, the spiral disc structure changes into a horse-shaped structure 
observed on SEM and then a fragmented structure shown by TEM images in the mature 
cysts (Midlej et al., 2009).       
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Figure 5.10: Giardia intestinalis cells in encysting medium under LY294002 treatment at 
different concentration. 
SEM images of a control Giardia cell with DMSO treatment after 48 hours. b and c, Giardia cells 
under LY294002 at 50 µM treatment after 72 hours. d and e, Giardia cells under LY294002 at 50 
µM treatment after 96 hours. Scale bars 5 µm. 
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Figure 5.11: Encystation experiment to harvest cysts after 48 hours of trophozoites incubation 
in encysting medium. 
SEM images of a ovoid appearance encysting cell with shortened flagella. b, round encysting cells. 
c and d, trophozoites that did not initiate encystation process. e and f, round-shape cells that may be 
misinterpreted as cysts under the light microscope. Scale bars 2µm. 
154 
 
5.2.3 Transmission electron microscopy images of G. intestinalis trophozoites  
The first set of trophozoite images under TEM were cells under normal growth 
medium incubated over 48 hours at 37oC. The ultrastructure of Giardia infective 
trophozoites in Figure 5.12, panel a, shows a transverse section of the cytoskeleton that 
includes two nuclei, flagellar axonemes, median body, endoplasmic reticulum, peripheral 
vacuoles and flagella. The two oval nuclei revealed by TEM images show nearly identical 
ultrastructure appearance. Peripheral vesicles are located below the cell plasma membrane 
and are present in both trophozoites and cysts.  
A coronal section in Figure 5.12, panel b, highlighted other structures such as the 
ventral adhesive disk, which allow trophozoites to attach to the intestinal wall of their hosts 
in vivo, and also to the surface of the borosilicate glass culture tubes in vitro. The concave 
ventral disk structure is essential for the survival of trophozoites because it allows 
adherence to the host and combats against peristalsis (Elmendorf et al., 2003). The median 
body is located in the midline and dorsal to the caudal flagella. It is made up of a group of 
microtubules in a tight bundle (Adam, 2001). It has been suggested that the median body is 
the site responsible for the assembly of microtubules to be incorporated into the ventral disk 
(Meng et al., 1993 and Adam, 2001). The endoplasmic reticulum (ER) within the 
cytoplasm of the cell plays an important role in protein folding and translocation. The 
confirmation of the ER existence in Giardia came about through the cloning and 
characterisation of signal recognition particle receptor α (SRα) and the identification of an 
extensive membrane system labelled with antibody to the HSP70 homologue found in the 
ER (BiP). BiP is a chaperonin that aids in folding and the further transport of SRα and SRβ 
(Soltys et al., 1996 and Adam, 2001). Figure 5.12, panel c, displays the general view of 
ultrathin sections on a gold grid where different slices were taken to allow quantitative 
studies of the ultrastructure of G. intestinalis.  
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Figure 5.12: Giardia intestinalis trophozoite cells. 
An untreated control TEM images of a cross section of a trophozoite cell with two eye-like nuclei 
(N), flagella (F), flagellar axonemes (A), median body (MB), surrounded by peripheral vesicles 
(PV). b, A coronal section of trophozoites with visible ventral disk (VD). c, A general view 
showing one random field of view. Scale bars a 3 µm; b and c 2 µm.  
 
5.2.4 TEM images of G. intestinalis encysting cells 
The process of encystation in G. intestinalis has been investigated by TEM and 
documented in the literature. Here, trophozoites were induced to encyst in vitro following 
the protocol established by Kane et al. (1991). Increasing pH and bile in encystation 
medium stimulates Giardia trophozoites to initiate encystation. One possible approach to 
identify trophozoites that may have initiated encystation is the development of ESVs that 
cannot be observed in normal non-encysting trophozoites (Benchimol, 2004). Initiation of 
the encystation process begins with external stimulation leading to encystation-specific 
gene expression. ESV appearances in encysting trophozoites were often detected after 6-12 
hours filled with an amorphous and electron-dense material in the matrix. These ESVs are 
responsible for transporting CWPs to the cell membrane where the CWPs will be released 
at the assembly site of the cell wall (Lujan et al., 1997, Lanfredi-Rangel et al., 2003). In 
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accordance with previous research, four structural CWPs have been identified: CWP1, 
CWP2, CWP3 and a high cysteine non-variant cyst protein (HCNCp) (Davids et al., 2006).  
Experiments were carried out to investigate the ultrastructure of trophozoites under 
encystation medium. Trophozoite cultures were grown to approximately 1 x 106 cells/ml 
confluence and had the growth medium replaced with encystation medium as described in 
Kane et al. (1991). After 24, 48 and 72 hours of incubation in the encystation medium, 
Giardia cells were harvested and prepared for TEM (Figure 5.13). An example of a single 
random field of view was taken from trophozoite cell culture following a 24 hour 
incubation period (Figure 5.13, panel a) and a closer image of doublet cells during the 
process of cell division (Figure 5.13, panel b). It was possible to identify the doublet cells 
due to double ventral discs; the presence of three nuclei suggested that this was not a single 
Giardia cell but a cell undergoing cell division. Moreover, the peripheral vesicles also 
surrounded the doublet cell, which displays characteristics of a single cell during the early 
stages of cell division. After 48 hours of incubation, Figure 5.13, panel c and d, show a 
general picture at low magnification of Giardia TEM sections during encystation and a 
higher magnification image of two individual cells, respectively. In the general view of the 
TEM image (Figure 5.13, panel c), normal visible organelles were present and many were 
labelled such as nuclei, adhesive disk, peripheral vesicles and flagella. Upon closer 
inspection, unfamiliar vesicular structures in a parasite were observed using TEM. These 
unknown vesicular structures are labelled with an arrowhead (Figure 5.13, panel d) and 
they are identical to cleft structure reported by Lanfredi-Rangel et al. (2003). These cleft 
structures can be considered nascent ESVs because they eventually get completely filled 
with the amorphous electron-dense material and these mature ESVs transport CWPs to 
peripheral regions of the cell (Lanfredi-Rangel et al., 2003). Cleft structures derived from 
the dilation of some regions of the cisternae of the rough ER in the early stages of 
encystation; at this point, these dilations area were empty. This cleft structure appeared as 
an electron-lucent area within the ER cisternae (Lanfredi-Rangel et al., 2003). 
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 Figure 5.13: Giardia intestinalis under encystation medium for a period of 72 hours. 
TEM image of a and b Giardia cells incubated in encystation medium for 24 hours. c and d, cells 
were incubated in encystation medium for 48 hours. e and f, cells were incubated in encystation 
medium for 72 hours. The left panel shows a general view of one random field of view and the right 
panel shows a cross-section or a coronal section of Giardia cells. These panels show that Giardia 
cells have surrounding the inner membrane the peripheral vesicles (PV), ventral disk (VD), nascent 
ESVs (arrowhead), flagella (F) and typically two nuclei (N) per cell. Scale bars 2 µm.   
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Recent studies using TEM to investigate vesicle structures in encysting Giardia 
have identified the cleft structure as electron lucent vesicles (ELVs) (Midlej et al., 2012). 
These ELVs were distinct from other vesicles and organelles in the ultrastructure of 
encysting Giardia. They were shown to contain a different composition from ESV through 
a monoclonal antibody, anti-CWP1 labelling experiment, which resulted in only ESVs 
being labelled. Interestingly, both ESVs and the ELVs were found budding from ER 
membranous profile (Midlej et al., 2012). Upon closer inspection, Figure 5.14 illustrates 
Giardia cells under encysting medium after 24 and 48 hours in Figure 5.14, panel a, b and 
c, d, respectively. Arrowheads depict cleft structure and electron-lucent vesicles in Giardia 
under encystation medium after 24 and 48 hours (Figure 5.14). Two different structures 
were identified (labelled with arrowheads): elongated cleft structural features that may be 
associated with ER cisternae (Figure 5.14, panel a) and the other structure showed a more 
round enlargement vesicle with an electron lucent area (inset, Figure 5.14, panel b and 
Figure 5.14, panel d). It was important to analyse the changes in the ultrastructure of 
Giardia cells during transformation under encysting medium, as this may improve our 
understanding of specific details of this encystation process and act as a control experiment 
to investigate the effect of LY294002 on G. intestinalis. Figure 5.15 shows analysis of each 
individual Giardia population harvested from encystation media; the emergence of a 
significant ultrastructure that was not present in the non-encysting cells are analysed here in 
cells fixed at different time of encystation. A rapid was observed increase in the number of 
Giardia cells containing clefts and ELVs in both categories from time zero to the first 24 
hours during encystation. The percentage of cells containing these clefts and ESV 
morphologies was quantified by counting; approximately 82.3% of the cells fixed at 24 
hours had the appearance of clefts or ELV structures. The dilated region of the ER (clefts) 
and round electron-lucent vesicles are approximately 1 to 2.2 µm and 1 to 1.4 µm, 
respectively. The reported size of the average ELVs in a recent study is 1.02 µm, this 
measurement is in agreement with this findings. The structures are found throughout the 
cytoplasm (Midlej et al., 2012). After 48 and 72 hours of encystation, the number of cells 
containing these clefts and ELVs decreased to 53.8% and 51.7%, respectively, in the 
population of cells observed. It is important to mention that the ELVs observed (inset, 
Figure 5.14, panel b) were different from the peripheral vesicles surrounding Giardia cells. 
The peripheral vesicles are smaller, ovoid in shape with measuring approximately 300 nm 
(inset, Figure 5.14, panel b) and are present throughout the life cycle of G. intestinalis.              
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Figure 5.14: Giardia cells incubated in encystation medium for 24 and 48 hours. 
TEM images of a and b encysting cells after 24 hours; a shows a general view of one random field 
of view displaying nuclei (N), ventral disk (VD), elongated ‘cleft’ (arrowhead). The large granules 
in b (arrowhead) inset is the size of normal encystation specific vesicles. c and d, Encysting cell 
after 48 hour incubation; c, general view of one random field of view; the peripheral vesicles (PV) 
are located surrounding the cell; d, cross-section area highlighting a granule (arrowhead) adjacent to 
the median body (MB). Scale bars a – d 2µm; inset b and d 500 nm. 
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Figure 5.15: Ultrastructure studies of G. intestinalis under encystation process. 
Analysis of morphological changes in the appearance of clefts or ELVs in Giardia cells exposed to 
encysting medium under transmission electron microscope. The total numbers of cells were counted 
from a single experimental work; each individual cell was examined to record the presence of clefts 
or electron lucent vesicles. A minimum of 100 cells was analysed per incubation period under 
encystation. Data are presented as different Pie charts representing incubation time; within 
individual charts, there are percentages which represent the average proportion of cells with the 
number of clefts or ELVs.     
 
5.2.5 Ultrastructural investigation on G. intestinalis trophozoites under the effect of 
LY294002 
Experiments were carried out to investigate the effect of LY294002 on 
ultrastructure of G. intestinalis trophozoites. In the results section of Chapter 4, the effect of 
LY294002, a PI3K inhibitor, was shown to induce growth inhibition of trophozoites under 
growth medium. Here, the ultrastructures of trophozoites under LY294002 treatment were 
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observed under TEM. LY294002-treated trophozoites display substantial changes in the 
morphology of the ultrastructure of the cells over the period of 24 hours. The morphology 
of the cells shows disorientated peripheral vesicles and the peripheral structures were 
abnormal in comparison to normal trophozoites (Figure 5.16, panel a-c). Peripheral vesicles 
in trophozoites treated with LY294002 display an increase in size of the vesicles 
throughout the cytoplasm of the cell (Figure 5.16, panel a and b), when compared to 
untreated control (Figure 5.12). Trophozoite morphology and the organisation of vesicles 
throughout the cytoplasm was significantly altered after a 48 hour incubation period in 
LY294002. These changes include the appearance of peripheral vesicles forming double 
layers of vesicles in some areas of trophozoites adjacent to the surface of the plasma 
membrane (Figure 5.16, panel d). This can be compared to untreated control shown in 
Figure 5.12. In Figure 5.16, panel e, large and pleomorphic cells were observed upon close 
inspection. Similar findings in the appearance of Giardia cells were also observed recently 
when LY294002 was added during encystation, viewed using electron microscopy 
(Bittencourt-Silvestre et al., 2010). An increase in the size of peripheral vesicles has been 
described in trophozoites incubated with sterol biosynthesis inhibitors on growth EPI 
(24(R,S),25-epiminolanosterol) (Maia et al., 2007). The diameters of peripheral vesicles in 
Giardia trophozoites after EPI treatment were reported to be within the range of 2.3 to 3.7 
µm compared with the average size of 1.54 µm in a number of trophozoite peripheral 
vesicles treated with  LY294002 over a period of 48 hours (Figure 5.16, panel b and e). 
These peripheral vesicles are the essential component of the endosomal/lysosomal system 
of the protozoan and it is possible that inhibition of PI3K by LY294002 caused interference 
in membrane lipid composition, trafficking and permeability (Lanfredi-Rangel et al., 1998, 
Maia et al., 2007).                
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Figure 5.16: Giardia trophozoites incubated for 24 and 48 hours in the presence of LY294002. 
TEM images showing (panel a and c) trophozoites treated with LY294002 at 50 µM after 24 hours; 
a displays a coronal section of trophozoite surrounded with peripheral vesicles (PV) and c displays 
a cross-section of trophozoite cells with flagellar axonemes (A), flagellar (F). The presence of 
LY294002 alters the appearance of PV in b, d and e Giardia trophozoite cells treated with 
LY294002 at 50 µM after 48 hours. Disorganised PV can also show that enlargement of PV is 
common in some cells. VD, ventral disk; MB, median body; N, nucleus. Scale bars 2 µm. 
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Figure 5.17: Ultrastructural studies of G. intestinalis treated with LY294002. 
Analysis of morphological changes in the appearance of clefts or ELVs in Giardia cells treated with 
LY294002 under a TEM. The total numbers of cells were counted in a single experimental work 
and each individual cell was examined to record the presence of cleft or ELV. Minimum of 100 
cells were analysed per incubation period with LY294002 treatment. Data are presented as different 
Pie charts representing incubation time; within individual charts, there are percentages which 
represent the average proportion of cells with the number of clefts or ELVs.  
 
Another important finding to add to the evidence that trophozoites treated with 
LY294002 initiate encystation-like processes are described here through the increased 
number of clefts or prolonged appearance of clefts in the cytoplasm. The general view of 
Giardia LY294002-treated trophozoites under normal growth medium is illustrated here 
and the number of clefts/ELVs were counted using TEM (Figure 5.18). Ultrastructure of 
many trophozoites treated with PI3K inhibitor over 24 hours in Figure 5.17 has shown an 
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average of 47% of cells with clefts or ELVs. The percentage of cells with clefts or ELVs 
decreased down to 37% after 48 hours of incubation; however, this increases up to 54% 
after a 72 hour incubation period (Figure 5.17). Upon close inspection, Figure 5.18, panel b, 
shows ELVs in the central region of the protozoan adjacent to the nucleus and others 
distributed near the peripheral vesicles. This is in contrast to the control sample in Figure 
5.12, where untreated control cells show no presence of ELVs. Due to the effect of 
LY294002-treatment after 48 hours, changes in peripheral vesicles pattern were shown. In 
this micrograph, an increase in cytoplasmic space between the peripheral vesicles was 
observed throughout the cell (Figure 5.18, panel d). Internalisation of the flagella shown in 
Figure 5.18, panel d, suggests that Giardia treated with LY294002 may have initiated an 
encystation-like process. Concomitant with internalisation of the flagella and the formation 
of ESVs, an important observation shows ESV-like vesicles in trophozoites after 72 hours 
of LY294002 treatment (Figure 5.18, panel f inset). 
Experimental results of G. intestinalis after 72 hours of incubation with LY294002 
treatment in growth culture medium, and trophozoites under encysting medium, were 
compared using micrographs taken from TEM (Figure 5.19). Unfortunately, it was not 
possible to observe any cyst formation in Giardia cultures under encysting medium after 72 
hours. However, previous studies indicated that under encystation conditions, only about 
4% of trophozoites in culture showed morphological indication of encystation (Maia et al., 
2007). Figure 5.19, panel b and e, highlight Giardia cell death by the disruption of cell 
membrane under encysting medium, it was possible to confirm that this might be a natural 
consequence of encystation under in vitro conditions. Control-DMSO cells illustrated the 
normal shape of trophozoites, complete with the regular organelles within the cytoplasm 
after 72 hours of incubation (Figure 5.19, panel a and d). LY294002-treated cells on the 
other hand demonstrate disorganisation of the peripheral vesicles surrounding trophozoite 
cells. The numbers of trophozoites with these enlarged peripheral vesicles reached an 
average of 45% of the total number of cells counted in multiple single random fields of 
view after trophozoites were treated with LY294002 for 72 hours. It is important to 
mention that in one TEM image, you may or not see the translucent clefts or ELVs, but this 
does not mean that the cell did not contain any clefts or ELVs. This is because it was a thin 
slice of the sample in one particular image. Therefore, many fields of views on TEM were 
taken and a population of cells were quantified for clefts or ELVs.    
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Figure 5.18: Giardia intestinalis treated with LY294002 over a period of 72 hours. 
TEM images of Giardia trophozoites treated with LY294002 for: 24 hours a and b, 48 hours c and 
d, 72 hours e and f. The left panel display a general view over a random field of view and the right 
panel shows a coronal section of a single cell within that population. a, overview of 24 hours 
LY294002 incubation of trophozoites showing peripheral vesicles (PV) and a ventral disk (VD). b 
and d highlight morphological changes in ventral disk structure, arrowheads in b show the presence 
of ELVs and the appearance of large and pleomorphic cells, c and e. f shows a structure that is 
similar to ESV-like vesicles with electron dense material embedded within; inset f with arrowheads 
highlighting ESV-like vesicles. F, flagellar; N, nucleus; A, flagellar axonemes. Scale bars 2 µm; 
inset f 500 nm. 
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Figure 5.19: 
Comparison of 
Giardia 
trophozoites 
treated with 
LY294002 against 
Giardia 
trophozoites 
incubated in 
encystation 
medium. 
TEM images of a 
and d control-
DMSO treated 
trophozoites over 72 
hours, b and e 
Giardia incubated in 
encystation medium 
over 72 hours, c and 
f trophozoite cells 
treated with 
LY294002 at 50 µM 
over 72 hours. a The 
control DMSO 
outline normal 
characteristic of 
trophozoites in the 
general view with 
several nuclei (N) 
presence in some 
sections. d display a 
coronal section 
surrounded by 
peripheral vesicles 
(PV), two nuclei (N) 
and flagellar 
axonemes (A) within 
the cell. b and e 
have shown that 
encystation medium 
is toxic to encysting 
cells over a period of 
time. The general 
view on trophozoites 
treated in c highlight 
significant changes 
with the appearance 
of large and 
disorganised 
peripheral vesicles 
surrounding the cell 
f. AM, amorphous 
material; VD, 
ventral disk; F, 
flagellar. Scale bars 
2 µm. 
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5.2.6 CWP2 immunofluorescence study in G. intestinalis 
The previous study using SEM and TEM approaches presented evidence to suggest 
that trophozoite cells under normal growth medium can be seen to trigger the early stage of 
encystation-like process after they were treated with PI3K inhibitor LY294002 within 48 
hours. With this in mind, anti-Cyst Wall Protein 2 (CWP2) antibodies were used to label 
the LY294002-treated cells. This should allow the detection of the early triggering of 
encystation process. The positive control for this experiment was Giardia trophozoites 
incubated in encysting medium over a period of 48 hours and stained with CWP2 antibody 
(Figure 5.20). The immunofluorescence images of encysting cells exhibit both nuclei and 
abundant CWP2 staining within encystation-specific secretory vesicles (ESVs). 4’,6-
diamidino-2-phenylindole (DAPI) was use to label the nuclei by binding to A-T rich 
regions in DNA (Figure 5.20, panel c-f). The negative control in this experiment was 
established as exponentially growing trophozoites under normal growth medium, which 
were fixed and membrane permeable. Result in Figure 5.20, panel a and e, illustrated that 
control treatment did not display CWP2 antibody labelling on trophozoite cells. 
 Immunofluorescence images in Figure 5.21 revealed that trophozoites treated with 
PI3K inhibitor LY294002 exhibit positive CWP2 fluorescence signals when trophozoites 
have been incubated with anti-CWP2 antibody. The proportion of LY294002-treated 
trophozoites demonstrated that CWP2 was on average 95% compare to none observed on 
positive CWP2 staining in the control-DMSO treated with anti-CWP2 antibody (see Figure 
5.21, panel e). This result of LY294002-treated trophozoites positive CWP2 staining 
resembles the positive appearances of CWP2 staining in Giardia incubated in encysting 
medium over 48 hours (Figure 5.20, panel e). Furthermore, the specific CWP2 staining is 
similar to the observation of ESVs under SEM micrographs represented by membrane 
surface protrusion. Quantification of the specific ESVs staining using anti-CWP2 varies 
from one trophozoite to another with approximately 20 – 45 ESVs in each LY294002-
treated trophozoite. The ESVs staining in both LY294002-treated cells and Giardia cells 
under encysting medium appear to be distributed throughout the cell. 
  
                 
 
 
168 
 
 
Figure 5.20: Immunofluorescence microscopy of G. intestinalis encysting cells stained with 
anti-CWP2. 
Microscopic images showing (a, c and e) control trophozoites under normal growth medium. a, 
1:250 anti-CWP2 fluorescence staining. c, 10 µg/ml Dapi staining in the nuclei of trophozoite and 
e, Dapi staining merged with DIC image showing the outline of each cell. b, d and f represent 
encysting cells incubated over 48 hours and stained using 1:250 anti-CWP2 fluorescence antibody 
with Dapi staining. f, represent merged images of both staining used and DIC. Scale bars are all 10 
µm. 
169 
 
 
Figure 5.21: CWP2 staining in LY294002-treated cells. 
Immunofluorescence microscopy images showing: a, c, e - control-DMSO treated trophozoites and 
b, d, f LY294002-treated trophozoites incubated over 48 hours. a – f cells were stained with 1:250 
primary mouse anti-CWP2 antibody followed by 1:500 secondary goat anti-mouse FITC antibody. 
c and d illustrate 10 µg/ml DAPI staining of control-DMSO and LY-treated trophozoite, 
respectively. e and f show merged image with DIC. Scale bars are 10 µm. 
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5.3 Discussion 
The aim of using scanning and transmission electron microscopy in this Chapter 
was to investigate whether the inhibition of PI3K in Giardia trophozoite cell cultures leads 
to the initiation of the stage encystation. SEM and TEM experiments were carried out to 
analyse, compare and count G. intestinalis cells. Moreover, electron microscopes are a 
powerful tool that can be used to investigate the effect of LY294002 on Giardia 
trophozoites ultrastructure in vitro. In an attempt to differentiate trophozoites to form 
complete cysts, the encystation experimental procedure used was reported to produce up to 
50% of cysts that resemble type I cysts, which have characteristics of a smooth oval-shape, 
described by Gillin et al. (1989) (Kane et al., 1991). The trophozoites were grown to 
confluence in growth medium containing 0.5 mg/ml of bovine bile at pH 7.1 at 37oC and 
had their medium replaced with encystation medium containing 10 mg/ml of bovine bile, at 
pH 7.8. The incubation time with encystation medium for maximum numbers of cysts was 
reported to be 96 hours at 37oC (Kane et al., 1991).  
 Encystation experiments to produce G. intestinalis cysts were attempted with the 
aim of studying the ultrastructure of this protozoan using SEM and TEM. The morphology 
studied concentrated on the differentiation from trophozoites to encysting cells followed by 
the formation of mature cysts. Obtaining mature cysts from cultures containing trophozoites 
incubated with encystation medium proved difficult, with the apparent loss of a large 
number of cells after 72 hours incubation and any round oval-shaped Giardia cells appear 
to be non-viable under SEM. If the complete encystation process was to be achieved, it is 
recommended that the original encystation medium is used (Gillin et al., 1989). The initial 
experiment on encystation did show the appearance of encysting and cyst cells in the 
previously reported chapter 4 under the light microscope. When scanning electron 
microscopy was used, however, all of the samples were fixed and prepared for observation 
under electron microscopy; therefore, time was an important factor in completing this 
experimental work.  
However, it was still possible to detect modification of the protozoan shape from 
trophozoites to encysting cells, small surface protrusions and shortening of cells were 
observed in images taken by SEM. This may indicate that encystation had been triggered 
through incubation of trophozoites in encysting medium. It has been shown that the 
appearance of a large number of protrusions was distributed throughout the protozoan 
surface during encystation process by scanning electron microscopy (Bittencourt-Silvestre 
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et al., 2010). These surface protrusions or membrane blebs have been reported to represent 
the ESVs that are under the cell plasma membrane, although still little is known about the 
process of ESVs releasing their cyst wall materials to be deposited extracellularly 
(Benchimol, 2004). Within the ultrastructure of Giardia cells incubated in encystation 
medium, the observation under TEM illustrated the appearance of clefts and ELVs over a 
period of 72 hours. In the first 24 hours, Giardia cell populations containing clefts and 
ELVs under encystation medium reached approximately 82% of the total number of cells. 
However, the observations at 48 and 72 hours showed a lower percentage of cells 
containing clefts and ELVs with values of 54% and 52%, respectively. Nonetheless, these 
structures suggest Giardia cells were undergoing differentiation; these results are in 
agreement with previous studies showing cells at different phases of the encystation process 
(Lanfredi-Rangel et al., 2003). Furthermore, early immuno-microscopic studies of 
encystation proposed that ESVs arise from a, “flattened cisterna”. With this in mind, the 
ultrastructural and histochemical kinetic analyses suggest that the ESVs arise from clefts, 
which are dilated ER cisternae (Lujan et al., 1997, Lanfredi-Rangel et al., 2003). However, 
no mature ESVs were observed in our experimental work. Another characteristic showing 
that trophozoite ultrastructural changes were taking place during the process of 
differentiation was the internalisation of the flagella. Under TEM, it was apparent that after 
24 hours of trophozoites incubated in encystation medium, one flagellum is in the process 
of internalization, as shown by T|EM (Luchtel et al., 1980, Midlej et al., 2009).  
 The data in this chapter focus on the fact that the PI3K inhibitor LY294002 alters 
the appearance of trophozoites under normal growth medium. Some of the characteristic 
morphological alterations were observed after LY294002 treatment; these included the 
presence of cell surface membrane protrusions, elongated cell shape, inhibition of 
cytokinesis, irregular flagella beating, presence of large vacuoles in the cytoplasm, 
disorganisation of the peripheral vesicles in number of cells, internalisation of the flagella 
and initiation of the encystation-like process. Some of these observations are in agreement 
with the findings when trophozoites were treated with the LY294002 inhibitor of PI3K. 
The experimental work on ultrastructural studies on the effect of PI3K inhibitor found that 
LY294002 causes disorganisation of the peripheral vesicles throughout the cytoplasm and 
observed large and pleomorphic cells in cells treated with PI3K inhibitor (Bittencourt-
Silvestre et al., 2010). Additionally, trophozoite cultures treated with LY294002 appear to 
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initiate the early stages of encystation in terms of the appearance of ESVs and cyst wall 
protein (CWP) up-regulation due to the inhibition of PI3K (Tovar, unpublished data). 
It was important to report that during the preparation of Giardia cells for electron 
microscopy, after fixing the cells and series of washes, LY294002-treated cells were found 
to be short in numbers compared to control-DMSO treated cells. An explanation for this 
could be that LY294002-treated cells are unable to attach onto the glass coverslip like the 
untreated cells. The attachment of Giardia trophozoites treated with LY294002 may have 
been dysfunctional; therefore, unattached trophozoites treated with PI3K inhibitor were 
washed away and discarded. Treatment with LY294002 may initiate an encystation-like 
process that would lead to the initiation of cellular differentiation, which may affect the 
mechanism of attachment as cysts do not need to have adhesive ability. However, the 
mechanism of attachment in G. intestinalis trophozoites remains unclear and only 
hypotheses have been proposed. The ventral disc component was identified to contain 
contractile proteins involved in adherence for the contraction of the disk (Adam, 2001). 
This component is distinctive and it covers the entire ventral surface of the trophozoites and 
is crucial to the structure of Giardia pathology. Several reported microtubule targeting 
drugs tested on Giardia affect the ventral disc structures; these include benzimidazoles, 
metronidazole and nitazoxanide, and emphasises the importance of the Giardia ventral disk 
as a focus point as a target for the treatment of giardiasis (Oxberry et al., 1994, Cedillo-
Rivera et al., 2002, Mariante et al., 2005). 
 The early stages of encystation, explained in previous chapters, starts when external 
signals trigger the synthesis, processing and transport of cyst wall components and ESVs 
are assembled to the surface of encysting cells forming cyst wall (Lujan et al., 1997). SEM 
images illustrated approximately 18.2% of Giardia cells showing cell surface vesicular 
spots/protrusion after 24 hours of incubation under encysting medium. After 24 hours of 
incubation, LY294002-treated cells showed 14.6% and 18.0% of cells with surface 
vesicular spots/protrusions at a LY294002 concentration of 15 µM and 50 µM, 
respectively. Both conditions continue to show Giardia cells with surface protrusions/spots 
after 48 hours incubation period. These protrusions of vesicles on the cell surface 
membrane have been suggested to represent the number of encystation vesicles below the 
surface of the cells (Lanfredi-Rangel et al., 2003, Bittencourt-Silvestre et al., 2010). The 
images from TEM show that Giardia cells treated with LY294002 under normal growth 
medium and Giardia cells under encystation medium display cleft structures within the 
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cytoplasm. These examples of clefts and ELVs under normal growth culture medium were 
approximately 8.6% in cells with one cleft or ELV and 4.7% in cells with more than two 
clefts or ELV structures. LY294002-treated cultures display 29.4% and 17.6%; Giardia 
under encysting medium displays 55.4% and 26.9% of cells with one cleft or ELV and cells 
with two or more clefts or ELVs after 24 hours incubation. Ultrastructure analysis in recent 
findings have identified that ELVs were only observed in cells undergoing the encystation 
process. The same encysting cells could have both ELVs and ESVs present; these two 
vesicles appear to be distinctively different and were verified by using an anti-CWP1 
antibody that specifically labels both a constitutive cyst wall protein and labels the ESVs 
(Gillin et al., 1989, Midlej et al., 2012). Moreover, the peripheral vesicles were measured 
and compared to ELV to ensure that they were not the observed ELVs in the encysting 
cells.     
 Experimental work describing Giardia cells when PI3K inhibitor LY294002 was 
added at the beginning of the encystation process were carried out to examine the effect of 
LY294002-treated cells under encysting medium with the control being DMSO-treated 
cultures. Initially, after 24 hours, both LY294002-treated cultures and control-DMSO-
treated cultures displayed less than 26% of visible vesicular protrusions of the cell surface 
membrane and less than 12% of dividing Giardia treated cells. After 48 hours of 
incubation, however, LY294002-treated cultures reached 60.2% of cells showing vesicular 
cell surface protrusions and 15% of dividing Giardia treated cells, but more than 80% of 
these counted displayed irregular flagella beating and overall abnormal morphology. The 
control-DMSO treated cells on the other hand show 39.3% of cells with surface protrusions 
and less than 5% of dividing Giardia treated cells. This suggests that PI3Ks are important 
in trophozoites under normal conditions and differentiating cells during encystation. Recent 
findings have shown that there is an increase in the expression of PI3Ks during the 
encystation process in Giardia cells and that LY294002 demonstrates an inhibitory effect 
on encysting cells after the encystation process was launched. This indicates that PI3Ks 
may be the key regulator during the process of encystation (Hernandez et al., 2007, 
Bittencourt-Silvestre et al., 2010). 
 The results show that both SEM and TEM have provided significant data and 
important information on the effect of the PI3K inhibitor LY294002 in G. intestinalis 
cultures. Evidence such as the appearance of clefts and ELV structures, which may suggest 
that LY294002-treated cells under normal growth medium trigger the initiation of 
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encystation-like process; however, no mature cysts were identified in LY294002-treated 
cultures. Therefore, the addition of PI3K inhibitors to trophozoite cell cultures can block 
the Giardia cell cycle and even though encystation process is initiated through CWPs 
production, cell differentiation is not completed due to the inhibition of PI3Ks. These 
observations are in agreement with Cox et al. (2006), who stated that Giardia PI3Ks play 
an important role in extracellular-initiated signalling (class I PI3K) and intracellular vesicle 
trafficking (class II PI3K). Due to the difficulty in obtaining the ultrastructure of cysts from 
encystation medium, it was not possible to compare the effect of LY294002 on encysting 
cultures. Future work should assess whether CWP2 was expressed and transported to the 
surface of the cells by ESV in both control (untreated cultures) and LY294002-treated 
cultures. The difficulty encountered in this experimental work was the need to use electron 
microscopy to analyse many Giardia cells to search for alterations in morphology that may 
have occurred during the addition of LY294002 or encysting medium, as the latter process 
is not synchronised and thus consumes time. 
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CHAPTER 6:  Discussion 
 
6.1 Research hypothesis 
This research concentrates on phosphoinositide 3-kinase (PI3K) signalling 
pathways in Giardia intestinalis. PI3Ks are a family of enzymes with a crucial role in the 
regulation of cellular mechanisms that have been extensively studied in mammalian and 
yeast cells. The studies of PI3Ks have provided an abundance of knowledge at which one 
can build on to examine in other cellular systems. The diplomonad G. intestinalis 
parasitises the gastrointestinal tract of humans and mammals causing to giardiasis present 
as an interesting prospect as a model organism to study. Important findings show that 
Giardia processes such as cell growth, proliferation, differentiation and vesicle trafficking, 
all of which are essential for parasite survival and disease transmission, may involve the 
PI3K signalling mechanism. Additional work to further characterise PI3K genes is required 
to identify and characterise putative ancillary components of lipid signalling cascades. 
Identifying a number of such components in the Giardia genome by homology searching 
could augment this knowledge. Investigating the putative functionality of these lipid 
signalling kinases in Giardia would confirm and provide evidence of the existence of these 
lipid signalling kinases. Moreover, previous work has identified and characterised two 
putative PI3K genes in G. intestinalis called GiPI3K1 and GiPI3K2, which represent 
homology to class I and class III PI3K isoforms, respectively. Therefore various reported 
inhibitor of PI3Ks and other inhibitors of the lipid signalling cascades were tested to 
provide further insights into the cellular signalling pathway and the regulatory pathways 
that involve parasite differentiation. Furthermore, attempting to determine whether PI3Ks 
in Giardia play an important role in cell growth and proliferation is essential and may 
provide insights when searching for new treatment of giardiasis.   
 
6.2 Summary of findings 
The bioinformatics results in chapter 3 primarily established that the G. intestinalis 
genomes encodes at least two PI3Ks (GiPI3K1 and GiPI3K2) and two GSKs (GiGSKa and 
GiGSKb). The two Giardia PI3K isoforms, GiPI3K1 and GiPI3K2, have been shown to 
share homology to the class I and III PI3Ks, respectively. The two homologues of GSK 
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isoforms in the giardial genome have been shown as the closest homologues to GSK-3α 
and GSK-3β, respectively. Giardia GSKs are likely to be functional proteins, since their 
sequence alignments with functionally characterised GSK-3 using ClustalW highlighted 
important conserved functional residues between the sequences. The presence of substrate 
binding sites, ATP binding sites, active sites are all conserved in the sequence alignments 
between Giardia GSKs and structurally known GSK-3. Furthermore there is evidence of 
conserved primed substrate recognition binding site within the serine/threonine kinase 
catalytic domain in Giardia GSKs that is required for specific binding with substrates that 
need priming phosphorylation. 
Subcellular localisation in Giardia GSKs suggests that GiGSKa may localise in the 
cytoplasmic space, whereas GiGSKb is likely to be localised in the nucleus or cytoplasm. 
These findings are in agreement with the localisation of other GSK-3s in mammalian cells; 
therefore, GiGSKa may be involved in a phosphorylation reaction by PKB which will 
activate cyclin D downstream leading to cell cycle arrest. GiGSKb is nuclear localised and 
may be involved in cell cycle regulation.        
The experimental results in chapter 4 began by presenting the effect of various 
inhibitors that have been reported to inhibit PI3K and GSK-3. Of these inhibitors 
experimented to inhibit PI3K activity, only one PI3K inhibitor exhibits a cytostatic effect 
on G. intestinalis. The PI3K inhibitor LY294002 was shown to inhibit Giardia trophozoite 
proliferation in a concentration-dependent manner when trophozoites were treated with 
LY294002 ranging from 10 – 75 µM. The concentration of LY294002, approximately 25 – 
30 µM. can significantly inhibit Giardia, with an up to 50% decrease in population of 
trophozoites compared to the DMSO-treated control culture. Trophozoite culture expose to 
50 µM of LY294002 almost completely stopped cell proliferation over a period of 48 
hours. Interestingly, upon the removal of LY294002, a reversible effect was observed 
whereby Giardia trophozoites previously exposed to LY294002 continued to proliferate 
after fresh culture medium was added to replace the culture medium with a PI3K inhibitor. 
Therefore, the PI3K inhibitor may stimulate cell cycle arrest at G1 in trophozoites. With all 
of this evidence, it is possible to suggest that PI3K activity in G. intestinalis plays an 
important role in control of the parasite cell cycle. Another plausible argument could be 
that some of the PI3K-inhibited trophozoites remain stationary as the result of the parasite 
initiating encystation process. Therefore, G2 arrested cells may start encystation but not 
necessarily complete encystation process. Encystation experimental work highlighted the 
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low yield in encysting/cysts cells culture treated with PI3K inhibitor LY294002 with a high 
percentage of these cells resulted in an incomplete cyst formation after 48 hours. This result 
suggests that PI3K activity in G. intestinalis is not only important in trophozoite 
proliferation but also crucial in the differentiations stage during the encystation process. 
PIP3 data show that the level of PIP3 in normal trophozoites is in the same range as the cells 
under encystation medium for 48 hours. This may provide further evidence that the 
presence of PI3K activity is active in both cell grown trophozoites and differentiating 
trophozoites under the encysting process.  
  The other two PI3K inhibitors examined were wortmannin and PI-103. Both 
wortmannin and PI-103 did not show any effect on trophozoite proliferation compared to 
the control. The latter was reported to specifically inhibit PI3K with an IC50 of 1 µM in 
vitro using mammalian purified protein (Bains et al., 2007). PI-103 specific inhibitor of 
PI3K may be specific for PI3Ks in mammalian cells and may not inhibit Giardia PI3Ks due 
to the differences in amino acids important for the enzyme functionality of Giardia PI3Ks. 
These important differences in amino acids may be vital for substrate and inhibitor binding. 
This speculation is based on the observation that in trophozoite culture, a concentration up 
to 5 µM of PI-103 treated to these parasite failed to show any significant effect on positive 
growth inhibition when compared to DMSO-treated control cultures. The common inhibitor 
of PI3K, wortmannin, which was reported to inhibit PI3K with an irreversible reaction 
(Walker et al., 2000) shows no effect on trophozoite proliferation. This finding is consistent 
with that of Cox et al. (2006), who made attempts by testing the activity of the stock 
solutions on mammalian cells to detect phosphorylated PKB levels and repeated the 
addition of wortmannin to ensure that it was not due to instability of the inhibitor. In 
contrast, studies by Hernandez et al. (2007) illustrated that overnight incubation of Giardia 
trophozoite treated with wortmannin at concentration of 2.5 – 20 µM showed a significant 
decreased in the number of trophozoite proliferation. The significant effect on trophozoite 
proliferation in this study is probably due to the non-specific effect of wortmannin on 
trophozoite culture. Since the recommended treatment is between 0.05 – 0.5 µM, non-
specific effects is likely to be the explanation for the decreased in the number of cells in 
Giardia. Moreover, it is known that wortmannin-insensitive PI3K have been found in yeast. 
It has been reported that yeast Vps34 is 1200x less susceptible to wortmannin inhibition 
than its human homologue (Walker et al., 2000 and Cox et al., 2006). It is important to note 
that key residues within the ATP/wortmannin binding regions are different in yeast Vps 34 
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to class III isoforms. Giardial PI3Ks demonstrate that they too have residues differ at the 
same positions shown for yeast Vps 34; thus, this may be another explanation for 
wortmannin insensitivity (Cox et al., 2006). 
To further investigate whether LY294002 has an effect on trophozoite proliferation 
was a result of the downstream inhibition of glycogen synthase kinase-3 (GSK-3). The 
inhibitors of GSK-3 examined were lithium chloride (LiCl) and CT99021. Both inhibitors 
had no effect on trophozoite proliferation when various concentrations ranging from 0.5 – 
10 µM for CT99021 (with reported IC50 of 1 µM) and 1 – 20 mM for LiCl (with reported 
IC50 of 5 mM). Using the double inhibitor experimental study, it was possible to conclude 
that LY294002 does not inhibit GiGSKs. This conclusion is based on the experiment that in 
trophozoite cultures with increasing LY294002 treatment in constant concentration of 
CT294002; the numbers of trophozoite cells appears to decrease in a concentration 
dependent manner. Moreover the second double inhibitor experiment result found that 
increasing the concentration of CT99201 and treatment with LY294002 did not release the 
block caused by PI3K inhibition. Therefore, this double inhibitor experiment concluded 
that the effect of LY294002 on trophozoites culture was due to PI3K inhibition. 
 Encystation experimental work exposing trophozoites under encysting medium to 
PI3K inhibitor LY294002 resulted in a small number of encysting/cyst cells. It is important 
to investigate whether PI3K is indeed required during the beginning of the encystation 
process. Evidences gathered in chapter 4 highlighted significant differences in the number 
of cells with trophozoites morphology after 24 hours of incubation period in control culture 
(DMSO-treated) compared to LY294002-treated culture. The cultures treated with PI3K 
inhibitor LY294002 show approximately 82% of cells with trophozoites morphology in 
comparison to 45% of trophozoites that should be observed. This result suggests that PI3K 
activity is required at least during initiation of the encystation process and that it may be 
due to the inhibition of PI3K as Giardia culture in encysting medium resulted in inefficient 
encystation process. 
To further investigate the effect of PI3K inhibitor LY294002 on G. intestinalis, 
scanning and transmission electron microscope approaches were utilised. These two 
techniques would address the observation of Giardia cells at the ultrastructural level. A 
scanning electron microscope (SEM) was use to examined Giardia cells under high 
magnification and resolution, which provides detailed observations on all of the 
morphological changes at the ultrastructural level. The second technique, transmission 
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electron microscopy (TEM) was used to monitor within the inner layers of trophozoites and 
encysting cells to provide ultrastructural images of the internal morphological changes that 
may have taken place. The images of vegetative trophozoites were examined using both 
techniques and showed the expected appearance of trophozoite cell morphology both 
within the inner layers of the cell and the round pear-shape-like ultrastructure. The process 
of encystation in vitro to observe Giardia trophozoite differentiating into a cyst was 
attempted, but no cyst morphology was detected under the encysting culture. An 
explanation into this difficulty of cyst production could be that subcultures of Giardia in 
vitro may cause deficits in the parasite virulence over time; in this particular case, Giardia 
trophozoites differentiate into mature cysts. It is well-known that the laboratory usually 
obtained the parasite once it has been passage through animal in vivo. A recently reported 
experiment using Leishmania infantum demonstrated that virulence deficit caused by 
successive in vitro passages results from an inadequate capacity to differentiate into 
amastigote forms (Moreira et al., 2012).    
However evidence of trophozoite initiating the process of encystation was 
successful under both SEM and TEM approaches. This conclusion is based on the 
observation of electron-lucent vesicles (ELVs) and clefts. These clefts which are dilated 
endoplasmic reticulum cisternae then eventually transformed into encystation specific 
vesicles (ESVs) (Lujan et al., 1997, Lanfredi-Rangel et al., 2003). Moreover the observed 
ELVs have been reported to only be identified in cells undergoing encystation process. 
SEM images have provided evidence of vesicular spots cells showing protrusion on the 
surface of Giardia cells. These vesicular protrusions have been reported to represent the 
increasing number of ESVs below the surface of the cell differentiating plasma membrane 
(Lanfredi-Rangel et al., 2003, Bittencourt-Silvestre et al., 2010). These evidence 
demonstrate that both SEM and TEM have provided confirmation that some of the 
trophozoites in cell culture have entered the initiation stage of the encystation process. 
Trophozoite culture exposed to the PI3K inhibitor LY294002 for24 and 48 hours displayed 
vesicle protrusion on the cell surface membrane. As mentioned before, this characteristic 
surface membrane protrusion identified using SEM, and suggests that there are ESVs 
underneath the surface of the differentiating plasma membrane. Moreover, data from SEM 
images demonstrate LY294002-treated cells remains stationary over the period of 24 and 
48 hours. This observation is based on the increasing number of doublet cells compared 
with the control culture, which could be due to the inhibition of PI3K activity that is 
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required to complete cell division. Evidence that LY294002-treated cells may initiate the 
process of encystation were observed through TEM images, as an increased number of 
clefts and ELVs were counted and compared to the control cells under encysting medium. 
This conclusion suggests that trophozoites entering the process of encystation may be 
regulated by PI3K, as PI3K could have a block on normal trophozoites initiating 
encystation; once this block is released, the process of encystation is initiated. The block on 
encystation may be released due to reduced PI3K activity.      
 
6.3 Limitations of approaches used and ideas for improvement  
The first improvement required in this project which unfortunately failed is the in 
vitro production of mature cysts through the process of encystation. It is known that not all 
Giardia trophozoites differentiate once triggered to initiate process of encystation 
differentiate to form cysts. Moreover, the attempt to use different encystation medium 
protocol for example, as reported by Gillin et al. (1989), may prove be successful in 
producing cysts cells. Alternatively, the reason why Giardia trophozoites may not complete 
the formation of cysts could be due to the loss of structural virulence due to continuous 
passage in vitro, as previously mentioned. This approach could be improved by using a 
fresh passage of the in vivo isolate of Giardia trophozoites because the Giardia encystation 
process is completed in vivo inside the gut and intestine, which is where the natural niche of 
trophozoites differentiates into cysts. 
The immunofluorescence experimental approach encountered difficulty when 
attempts were made to use antibodies against iron-binding protein, and the anti-iron sulphur 
cluster S (anti-IscS). These are two of the mitochondrial marker proteins required for iron 
sulphur cluster biosynthesis to a labelled double membrane-bound structure within Giardia 
cells. However, this approach was unsuccessful and it was not possible to reproduce the 
IscS labelling in Giardia cell due to strong background signals that labelled the whole cell. 
It was not possible to detect any specific localized staining signal within the cellular 
compartment of trophozoite cell. Primary antibodies, anti-IscS, were diluted in an attempt 
to remove background unspecific binding; the following dilutions were made: 1:250, 1:500, 
1:1000, 1:1500, 1:2000, 1:3000 and 1:5000. The concentration of primary antibody anti-
IscS in the reported paper was 1:250, however even after x20 the concentration use in the 
previous paper, the whole cell still has background staining but no specific staining signal 
labelling the small cellular structures were observed after 1:5000 dilutions. Other 
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approaches to reduce background labelling were completed by increasing the number of 
washes between the incubation periods with gentle agitations and washing with PBS-Triton 
to remove non-specific binding. However, it is important to obtain a balance between the 
number of washes and the number of cells remaining attached to the coverslip as 
detachment of Giardia cells often takes place after a series of washes using PBS-T. 
As an alternative approach to detect the localisation of IscS, transmission electron 
immunomicroscopy may allow possible detection under thawed frozen cryosections of 
glutaraldehyde-fixed Giardia, as previously reported by Tovar et al. (2003). Furthermore, 
double-labelling of anti-IscS and anti-CWP2 can be incorporated for their viewing under 
TEM immunomicroscopy and further quantitative techniques can be more effective as the 
specific labelling of the antibodies use will be clearly visible. 
 
6.4 Implications of research and future work 
This research on the study of phosphoinositide 3-kinase in G. intestinalis allows the 
continuous building of intracellular signalling pathways in Giardia that regulate the 
proliferation of trophozoites and differentiation in the cell during encystation process. The 
finding in the first chapter focuses on the components of the functional intracellular 
signalling pathway PI3Ks (GiPI3K1 and GiPI3K2 resemble class I and class III, 
respectively) and GSKs (GiGSKa and GiGSKb are similar to GSK-3α and GSK-3β, 
respectively), which have been shown to exist in G. intestinalis. It is likely that the latter 
GiGSKa regulates its activity with PKB and cyclin D in the cytoplasm whilst GiGSKb may 
be localised in nuclei that are involved in cell cycle regulation. Together with works done 
on the existence of a functional PI3K signalling pathway component in Giardia, it is a 
challenge to further contribute to an understanding of Giardia signalling pathways.   
The cytostatic effect of the PI3K inhibitor LY294002 on trophozoite culture has 
provided many opportunities to further investigate the role of PI3Ks in G. intestinalis. The 
intracellular signalling pathway in G. intestinalis involving PI3Ks has been linked to other 
Giardia genes encoding phosphoinositide-metabolising enzymes, for example phosphatase 
and tensin homologue deleted on chromosome 10 (PTEN) and PI4K. Moreover, in addition 
to PKB involvement in phosphorylating other signalling components that are central to the 
intracellular signalling pathway (Hers et al., 2011), PKB can further phosphorylate the 
downstream enzymes of GSK-3 that are responsible for many cellular processes, for 
example cell cycle arrest in mammalian cells. The study of PI3K intracellular signalling in 
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mammalian cells provided a platform to further investigate other signalling components, 
starting with PI3K in G. intestinalis. To verify whether the product of PI3K class I in 
Giardia is present, PIP3 mass ELISA assay was utilised. The results revealed that there are 
measurable amount of PIP3 in both Giardia trophozoites and encysting cells. However, 
improvements in the future experiments on the identification of this PIP3 and other 
polyphosphoinositol family members can be detected through using a liquid 
chromatography-mass spectrometry approach. Although this method requires time and 
sample preparation, this technique will identify the phosphoinositiol family and there will 
be an improved understanding of PI3Ks activity in Giardia.            
To further expand the study of intracellular signalling in G. intestinalis, 
investigation into proteomics studies may contribute to provide a list of protein content in 
Giardia. Using a tandem mass spectrometry approach described by Faso et al. (2013), this 
may identify a number of proteins responsible for the Giardia intracellular signalling 
pathway. More importantly, quantitative analysis of G. intestinalis proteome using tandem 
mass spectrometry could identify the changes in protein abundance before and after the 
addition of LY294002. This mass spectrometry approach can further provide evidence 
together with scanning and transmission electron microscopy that supports the hypothesis 
that the inhibition of PI3K in trophozoites leads to the initiation of the encystation process. 
This method can be applied to study of the encystation process in Giardia cells, in the 
experiment using PI3K inhibitor LY294002 to observe the changes in protein content that 
may be involved in PI3K signalling. 
It is important to consider that not all trophozoite cells are at the same stage in the 
cell cycle. Therefore, experiments are required to examine whether GiPI3K1 or GiPI3K2 
affect the vegetative trophozoite by potentially blocking the process of encystation at the 
Gap 2 phase of the cell cycle (Bernander et al., 2001). This is due to the hypothesis 
indicating that by inhibiting PI3Ks, the block at the G2 phase of the cell cycle is released, 
thus initiating trophozoites to differentiate into cysts. Using fluorescence-activated cell 
flow cytometry, analysis of trophozoite cultures can distinguish whether cell cycle arrest 
takes place at G2 (contains 8N cellular ploidy) or Gap 1 or S phase (contain newly divided 
trophozoites with 4N cellular ploidy) (Bernander et al., 2001). Furthermore it is essential to 
accurately know that the majority of these cells are at the G2 phase; the same can be said 
about the trophozoites under encyst medium. The flow cytometry approach can determined 
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by assessing at what stage the majority of these cells are within the cell cycle phase 
(Reaume et al., 2013). 
 
6.5 Conclusion  
In conclusion, this research project shows the overall observation of G. intestinalis 
intracellular signalling pathways surrounding PI3K and GSK. LY294002, an inhibitor of 
PI3K, has shown the importance of PI3K activity in Giardia for controlling both the 
trophozoite proliferation process and the early stages of the encystation process in Giardia 
cellular cycle. The data shown have ruled out the possibility that LY294002 is inhibiting 
GSK activity in Giardia trophozoite cell.  Also it has shown that PI3K activity is present in 
both vegetative trophozoite and encysting cells of G. intestinalis through the detection of 
the production of PIP3. Scanning electron microscopy and transmission electron 
microscopy examined vegetative trophozoites that had been exposed to PI3K inhibitor; it 
was shown that inhibition of PI3K in trophozoites leads to initiation of the early stages of 
the encystation process in G. intestinalis. Furthermore, the activity of PI3K may be 
involved in the development of a cyst wall in encysting cells through the regulation of 
CWP2 expressions.  
Overall, the current work should not only expand our knowledge of PI3K studies 
but should also assist researchers in the future work regarding the PI3K signalling cascade. 
Moreover, this research has the potential to branch out into drug targeting work and further 
expand the study of parasitology in intracellular signalling research.       
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